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The metabolic diversity of natural products in higher plants appears to be driven 
out of their necessity to adapt and survive in different ecological environments. Among the 
vast amount of natural products found in nature, triterpenes are widely distributed across 
higher plants. Triterpenes serve as precursors of essential membrane sterols in primary 
metabolism and have diverse roles in secondary metabolism, including defense and 
regulation. These complex chemical structures can be leads in drug discovery.  
Oxidosqualene cyclases (OSCs) are enzymes that generate the ring systems of 
triterpenoids through cyclization of (3S)-oxidosqualene. With the arrival of the genomic 
era, genome mining has become a reliable strategy to give a comprehensive accounting of 
triterpenoids in organisms whose genome is available. The model plant Arabidopsis 
thaliana has provided through genome mining the first complete picture of triterpene 
skeletons produced by a single plant species. Now, the availability of different genomes 
opens up the possibility of exploring the metabolic capabilities of other plant clades. This 
thesis uses genome mining and heterologous expression in the yeast Saccharomyces 
cerevisiae to explore the biosynthetic diversity of oxidosqualene cyclases in Arabidopsis 
and Lactuca, two small clades of the Brasicaceae and Asteraceae families. 
OSCs have been widely studied in A. thaliana but barely identified in the 
Arabidopsis lyrata genome. Phylogenetic analysis comparing both organisms was used to 
discover the presence of nine putative OSCs.  Three A. lyrata OSCs with interesting 
differences from their A. thaliana orthologs were expressed in yeast. The product profile 
of each enzyme was thoroughly characterized by NMR and GC-MS.  AlyPEN4 showed a 
similar product profile to its ortholog in A. thaliana, making as its major product thalianol. 
Analysis of the minor products revealed a novel triterpene, 25-nor-9β-methylpodioda-
5(10),17,21-trienol. Expression of AlyPEN6 illustrated a notable example of orthologous 
genes with different product profiles; the ratio of seco-β-amyrin to seco-α-amyrin was 
72:0.7 in AlyPEN6 and 38:19 in AthPEN4. Finally AlyPEN9 proved to be a rather accurate 
β-amyrin synthase, with no ortholog in A. thaliana, which instead performs accurate -
amyrin synthesis with AthLUP4. Interestingly, AlyLUP4 is a pseudogene.  
Lactuca sativa, the first organism of the Asteraceae family to have its genome 
available, is a promising model system for studying triterpene synthesis. Here I present 
progress toward characterizing the triterpene product profile of the Lactuca genus in order 
to understand the evolutionary relationships among different plant clades.  Manual splicing 
of its genome uncovered 17 putative OSCs. An improved product profile of six previously 
characterized oxidosqualene cyclases from Lactuca is reported. Also, a novel cyclase was 
discovered; it makes nematocyphol as its major product and 39 other compounds, including 
lupane type rearranged products. One of these compounds, lup-19(21)-en-3β-ol, was found 
for the first time as part of the product profile of an OSC.  
This work shows that Arabidopsis and Lactuca both have a unique set of 
oxidosqualene cyclases and make a majority of known OSC products, including -amyrin, 
-amyrin, lupeol, and other common triterpenes. Most of the triterpenes in Arabidopsis are 
also present in Lactuca, but the many rearranged lupane skeletons from nematocyphol 
synthase in Lactuca are almost absent in Arabidopsis.  
Each plant species or clade synthesizes its own set of triterpene secondary 
metabolites based on selective pressure that guides mutation of existing or duplicated OSC 
genes to a new OSC that enhances survival and reproductive success. Perhaps OSC genes 
easily evolve to a new gene for making common triterpenes, whereas OSCs making 
uncommon triterpenes like nematocyphol evolved through a narrower and less probable 
set of mutations.  
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the genome. The tree was constructed by maximum likelihood using MEGA version 6.11 
Multiple sequence alignments were generated in MegAlign from amino acid sequences 
with Clustal W Method using default parameters. After experimental analysis, the gene in 
blue turned out to be a mixed amyrin synthase.  
Figure 5.8. Comparison of active-site residues in human LAS42 and corresponding residues 
of Lactuca sativa OSCs.  
Table 5.7. Summary of analytical evidence for tirucalla-8,24-dien-3-ol synthase products 
identified in the 4 L in vivo experiment.  
Scheme 5.1. Mechanism of the formation of L. serriola tirucalla-8,24-dien-3-ol synthase 
products.  
Table 5.8. Summary of analytical evidence for L. sativa mixed amyrin synthase products 
identified in the 2 L in vitro experiment.  
Scheme 5.2. Mechanism of the formation of L. sativa mixed amyrin synthase products. 
xvii 
 
Table 5.9. Table summary of analytical evidence for L. serriola mixed taraxasterol 
synthase products identified in the 2 L in vitro experiment. 
Scheme 5.3. Mechanism of the formation of L. serriola mixed taraxasterol synthase 
products. 
Table 5.10. Table summary of analytical evidence for L. serriola lupeol synthase products 
identified in the 2 L in vitro experiment.  
Scheme 5.4. Mechanism of the formation of L. serriola lupeol synthase products. 
Scheme 5.5. Mechanism of the formation of L. serriola cycloartenol synthase products. 
Table 5.11. Summary of analytical evidence for L. serriola cycloartenol synthase products 
identified in the 2 L in vitro experiment.  
Table 5.12. Table summaries of names, numbering and analytical evidence for compounds 
found in lettuce plant extracts.  
Scheme 5.6. Summary of the products found in the plant extracts of the various parts of 
lettuce.  
Figure 5.11 Analytical evidence of curcurbitadienol in watermelon seeds.  
Figure 5.12. Molecular phylogenetic tree of Lactuca sativa OSCs found by manual 
splicing of the genome. Genes within the β-amyrin, germanicol synthase clade and 
dammarenediol synthase are considered putative. The tree was constructed by maximum 
likelihood using MEGA version 6.11 Multiple sequence alignments were generated in 
MegAlign from amino acid sequences with Clustal W Method using default parameters. 
Figure 5.13. Comparison of active site residues of NEM putative orthologs. 
Figure 5.14. Comparison of active-site residues in human LSS42 and corresponding 
residues of Lactuca OSCs from L. sativa, L. serriola and L. perennis.  
Figure 5.15. Molecular phylogenetic tree of Lactuca OSCs. Expressed OSCs from the 
Lactuca family (L.sativa or L. serriola) are the ones preceded by the name in black. The 
tree was constructed by maximum likelihood using MEGA version 6.11 Multiple sequence 
alignments were generated in MegAlign from amino acid sequences with Clustal W 
Method using default parameters. 
Figure 5.16. Classification of the characterize OSC from Lactuca genus by its accuracy. 
P1/∑Pi is the ratio of the major product to the total amount of products; P1/P2 is the ratio of 
the major product to the second most abundant product. 
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CHAPTER 1 
 
Introduction 
 
1.1 Biosynthesis of Secondary Metabolites  
 
1.1.1 The Role of Natural Products in Plants 
 
Plant secondary metabolites refer to those compounds that are normally not 
required by a plant to survive and reproduce, but under “special” circumstances play an 
important role in the adaptation to its surroundings. The environmental challenges differ 
widely among plants, hence the variety of secondary metabolites found in nature.1  
Since plants are vulnerable sessile organisms, secondary metabolites are part of 
their protection; when the plant is threatened by external factors, like pathogens and 
herbivores, a chemical response is triggered and secondary metabolites are produced.2  
Secondary metabolites protect plants against microorganisms, herbivores and 
competing plants.3 Secondary metabolites can find use as biologically active compounds 
and drugs.1 For example, betulinic acid has a cytotoxic effect over cancer cells4,5 and 
vaccaroside B is an antimicrobial agent.6 Secondary metabolites have a lot of possible 
applications. Their biosynthetic pathways hold a great potential for the production of novel 
compounds. 
Among the wide variety of secondary metabolites that plants can synthesize, one 
can find terpenoids, a functionally and structurally diverse group in which triterpenoids are 
included. Triterpenoids are derived from the precursor oxidosqualene (or squalene or 
dioxidosqualene). As secondary metabolites, triterpenes play a very important role in the 
survival of plants. For example, the triterpenoid curcubitacine-E that comes from cucumber 
roots acts as a chemical pesticide against nematodes.7 
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1.1.2 Triterpenes 
 
The word triterpene might be restricted to hydrocarbons, but its common usage 
includes oxidosqualene cyclization products, such as -amyrin, the C30H50O alcohol shown 
in Figure 1.1. Over 100 triterpene skeletons have been identified.8 Further oxygenated 
triterpenes and other metabolites are triterpenoids.  
Triterpenoids are part of a large and structurally diverse family of natural products 
called terpenoids, which are derived from C5 isoprene units. Terpenoids are classified 
according to the number of isoprene units involved in their construction (Figure 1.1).9 The 
biosynthetic pathway for the formation of the subclasses of terpenoids starts with the basic 
isoprene units found in nature: isopentenyl pyrophosphate (IPP) and its isomer 
dimethylallyl pyrophosphate (DMAPP), which derive from the mevalonate pathway.10 
IPP and DMAPP coexist in allylic isomerization equilibrium. These two molecules 
undergo an electrophilic addition (DMAPP as an allylic cation is attacked by the double 
bond of IPP) forming geranyl pyrophosphate (GPP, C10). By the same mechanism, 
subsequent additions of IPP form farnesyl pyrophosphate (FPP, C15) and geranylgeranyl 
pyrophosphate (GGPP, C20). Head-to-head condensation of two GGPPs makes carotenes, 
whereas condensation of two FPPs produces squalene (C30 triterpene precursor).
9 In 
eukaryotes squalene is terminally epoxidized to (3S)-2,3-oxidosqualene by squalene 
monooxygenase. Cyclization of oxidosqualene is the key step in the biosynthesis of 
triterpenes. This reaction is catalyzed by enzymes called oxidosqualene cyclases (OSCs), 
which fold the substrate and do cyclization via carbocation chemistry.   
Classical natural product isolation was originally the foundation for the discovery 
of novel triterpenes in plants; however the introduction of modern molecular biology 
techniques allowed the identification and characterization of the enzymes responsible for 
triterpene biosynthesis. The primary route for the discovery of new triterpenes and OSCs 
now relies on genome mining approaches11 and the accessibility to genomic information.12 
Arabidopsis thaliana, a plant from the rosids clade, was the first organism from the plant 
kingdom whose genome was fully sequenced.13 This model organism became an extremely 
popular system for studying many aspects of the biology of plants, in particular 
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characterization of natural products. The next section describes the strategy used in this 
work to present a complete picture of triterpenes in individual plant species.  
  
 
 
 
Figure 1.1. Schematic representation of the number of isoprene units involved in the 
construction of the terpene building blocks.9a 
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1.2 Genome mining in Arabidopsis thaliana: Model Organism for the Study of 
Secondary Metabolism 
 
Arabidopsis thaliana, a model organism in the plant field, has become an extremely 
popular system for studying many aspects of the biology of plants at the genetic level, 
including the production of secondary metabolites.14  
Before genomes of organisms were available, the isolation of new secondary 
metabolites relied mainly on purification of plant extracts, sometimes guided by the 
detection of bioactivity. In A. thaliana traditional-organic approaches found only four 
nonsterol triterpenoids: β-amyrin, α-amyrin, lupeol and trinolupeol.15 This can be 
explained by the fact that most secondary metabolites are produced only when and where 
they are needed. Now, with the A. thaliana genome available, it is possible to have a 
detailed picture of the triterpene metabolism in this model organism. 
A. thaliana was the first plant whose genome had been fully sequenced. This model 
system has many advantages for genome analysis, which includes easy cultivation, a rapid 
life cycle, and a relatively small nuclear genome.13 Among the enzymes that A. thaliana 
uses to make secondary metabolites are oxidosqualene cyclases (OSCs). Since 1993, OSCs 
from A. thaliana have been studied extensively and have revealed an amazing variety of 
triterpene skeletons.16a  
A. thaliana has 13 functional OSCs (Figure 1.2).11a,16 Over the past two decades 
elucidating the triterpene product profile of this plant has been an effort pursued by many 
scientists. The interest over these enzymes is not only the discovery of novel triterpenoid 
structures, but also the understanding of the enzymatic mechanism by which they are 
produced. For this purpose, one can use the information revealed by taking a closer look at 
genomic sequence. 
The use of genome mining strategies11 has allowed the expansion of the number of 
known triterpenoids that can be found in organisms like A. thaliana. This strategy has led 
to new methodology for studying enzymes and their mechanisms of action, for discovering 
novel compounds, and for metabolic engineering. Genome mining allows study of genes 
that are rapidly further metabolized or not routinely expressed. This is a way to find novel 
natural products that normally are absent or hard to obtain. 
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Figure 1.2. The 13 OSCs from A. thaliana are separated in three phylogenetic groups CAS 
(pink), LUP (green) and PEN (purple). Each OSC is represented with its major enzymatic 
product. 
 
1.3 Diversity of OSCs in Plants 
 
Although Arabidopsis has given a general insight of OSC evolution, the availability 
of other genomes opens up the possibility for understanding the genetic basis of differences 
between plants. More than 80 OSCs have been characterized from plants, using 
heterologous yeast expression and genome analysis.17   
OSCs play an important role in both primary and secondary metabolism. OSCs 
involved in the primary metabolism of plants cyclize oxidosqualene via a chair-boat-chair 
(C-B-C) cationic intermediate to form cycloartenol, the sterol precursor in the plant 
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kingdom. These enzymes are ubiquitous to the plant kingdom and appear to be the 
evolutionary ancestor of plant OSCs of secondary metabolism.18 
Cyclization of oxidosqualene via chair-chair-chair (C-C-C) substrate folding is 
mainly responsible for formation of triterpene skeletons in secondary metabolism. Some 
of these OSCs make common triterpenes such as β-amyrin and lupeol, while others 
generate uncommon triterpenes that have been detected only in a specific family. An 
uncommon example is shionone, a major product of shionone synthase from Aster 
tataricus.19 Common skeletons are usually present across families, but each plant species 
or genus will usually have its own subset of triterpene skeletons.20 This metabolic 
diversification in higher plants is often associated with the need to adapt and survive in 
different environments.21 
The two plant organisms that are the focus of this work, A. lyrata and L. sativa, will 
serve as examples of how often triterpene skeletons between species are conserved and 
which ones are unique to a given species.   
 
1.4 Comparative Genomic Study: Arabidopsis and Lactuca Genome 
 
 Sequenced genomes offer the opportunity to investigate in depth triterpene 
biosynthesis. To date, more than 80 genomes from the plant kingdom are available, among 
them the genomes of Arabidopsis lyrata22 and Lactuca sativa.23  
The first candidate of this comparative study is a close relative to A. thaliana. The 
A. lyrata genome, available in 2010, was sequenced with the purpose to expand the 
understanding of the genus Arabidopsis. A. lyrata has a relatively small genome (207 Mb) 
compared with A. thaliana (125 Mb), from which it diverged roughly 10 million years ago. 
My manual splicing of the genome gave 14 putative OSCs. In principle, one would need 
to study all 14 OSCs to be able to have a comprehensive accounting of the triterpene 
structures that this plant can make. However, information about triterpene product profile, 
orthology and expression of OSCs in A. thaliana makes the study of this close relative 
easier. 
The Compositae Genome Project (CGP) and the Lettuce Genome Sequencing 
Project23 are completing an ongoing effort to sequence the genome of common lettuce, 
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Lactuca sativa. Related efforts led to the creation of an EST (expressed sequence tag) data 
set from the Lactuca genus, with the expectation that this kind of approach will help to 
elucidate differences between genomes, and will open the possibility of discovering genes 
that might confer disease resistance in plants. Once the genome of L. sativa was spliced, 
17 putative OSCs were discovered, which suggests that triterpene biosynthesis may play a 
significant role in the secondary metabolism of lettuce. While much remains to be 
understood about Lactuca disease resistance, triterpene metabolites have been known to be 
involved in resistance to pathogens in other plants.24  
 
1.5 Overview 
 
This thesis uses genome mining methodologies and phylogenetic analysis of plant 
genomes to explore the biosynthesis of triterpenes between two distant eudicot clades.  
In Chapter 3, phylogenetic comparison of closely related species illustrates the 
advantages of model organisms. Identification of novel OSCs in A. lyrata was based on 
their differences to OSCs in A. thaliana, without expression of a whole new set of OSCs. 
Chapter 4 utilized a different approach to genome mining. EST mining has been 
used when the genome of an organism is not available. The sequence of nematocyphol 
synthase was assembled using the basic local alignment search tool (BLAST) to search in 
Lactuca EST libraries for putative OSCs. Creation of EST libraries of the Lactuca genus 
was done with the expectation that, even without a sequenced genome, one can discover 
genes that might confer disease resistance in plants.  
Finally, the theme of Chapter 5 is genome mining of Lactuca sativa, a potential 
model organism of Asteraceae. This chapter presents the progress made towards the 
characterizing additional OSC product profiles from the Lactuca genus.  
This work shows that, although Arabidopsis and Lactuca have a unique set of 
oxidosqualene cyclases, most of the triterpenes that have been characterized within 
Arabidopsis are also present in Lactuca. Contrasting with this convergent evolution, each 
distant genus contained an OSC making an uncommon set of triterpenes. Additional 
contrasts include the greater genetic similarity of the studied Lactuca species vs. 
Arabidopsis species and the higher loss of functional OSCs in A. lyrata vs. A. thaliana.  
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CHAPTER 2 
 
Materials and Methods 
 
2.1 Materials 
 
Restriction enzymes, BstEII digest lambda DNA, 100 bp DNA ladder, Gel Loading 
Dye Blue (6x), Quick Ligation Kit and Escherichia coli DH5 (High Efficiency) 
competent cells were purchased from New England BioLabs (Beverly, MA). pGEM®-T 
Vector System was purchased from Promega (Madison, WI). PCR was performed with a 
TripleMaster PCR system (Eppendorf, Westbury, NY) and PCR ExTaq polymerase from 
TaKara Bio Inc. Gel purifications were performed using the Qiagen Gel Extraction Kit 
(Qiagen, Inc., Valencia, CA). Bacterial and yeast media components were obtained from 
United States Biological (Swampscott, MA). Heme (in the form of hemin chloride), 
ergosterol, bis(trimethylsilyl)trifluoroacetamide (BSTFA), Triton X-100, 
deoxyribonucleic acid sodium salt from salmon testes (D1626 ssDNA ~2000 bp), Tween 
80, and organic solvents were from Sigma-Aldrich (St. Louis, MO). Glass beads for in 
vitro reactions were purchased from BioSpec Products (Bartlesville, OK). Accubond (J&W 
Scientific/Agilent) and Strata Phenomenex (Torrance, CA) SPE cartridges (1, 2, 5 and 10 
g silica) were used with a standard SPE vacuum manifold. TLC silica gel 60 plates (250 
µm thickness) were from EMD Chemicals.  
 
2.2 Gas Chromatography-Mass Spectrometry (GC-MS) 
 
Gas chromatography-mass spectrometry analysis of samples was executed using an 
Agilent 6890N/GC 5973 MSD or a 7890N GC/5975N MSD. The following methods 
describe the specific conditions for each type of column configuration: 
Method A: Agilent 6890N/GC 5973 MSD equipped with a Restek Rxi-35Sil MS 
30 m x 0.25 mm x 0.25 µm column, 2.8 mL/min He flow rate, oven at 110 ºC (held 1 min), 
30 ºC/min to 270 ºC, 0.5 ºC/min to 280 ºC (held 8 min). 
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Method B: Agilent 6890N/GC 5973 MSD equipped with a Restek Rxi-5Sil MS, 60 
m x 0.18 mm x 0.1 µm column, 1 mL/min He flow rate, oven at 110 ºC (held 1 min), 30 
ºC/min to 274 ºC, 0.2 ºC/min to 279 ºC, and  4 ºC/min to 290 ºC  (held 3 min). 
Method C: Agilent 7890N GC/5975N MSD equipped with a Restek Rxi-5Sil MS, 
30 m x 0.25 mm x 0.1 µm column, 2.6 mL/min He flow rate, oven at 110 ºC (held 1 min), 
40 ºC/min to 200 ºC, 30 ºC/min to 260 ºC, 1 ºC/min to 275 ºC. 
Methods A, B or C (see above) were used to elute the sample components using 
helium as carrier gas maintained at a constant flow rate. Mass spectra were acquired with 
electron-impact ionization at 70 eV in full scan mode from 50 to 650 m/z. Samples (2 µL) 
were injected splitless mode into an inlet heated to 280 ºC. Triterpene TMS ethers were 
identified using Agilent Chemstation software by comparing their GC retention time (tR) 
and mass spectra against information in our databases and MS libraries.     
Trimethylsilyl (TMS) ether derivatives of triterpene alcohols (Scheme 2.1) were 
prepared by dissolving the sample in diethyl ether, and the desired aliquot of 0.1-10% was 
transferred to a GC vial containing a 200 µL insert. After evaporation of the solvent, the 
sample was diluted in 30 μL pyridine, followed by addition of 30 μL BSTFA. The vial was 
sealed with a cap with Teflon liner, kept at 70 °C for 30 to 45 min and used directly for 
GC-MS analysis.  
  
 
 
Scheme 2.1. TMS Derivatization of triterpene alcohols. 
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2.3 Nuclear Magnetic Resonance (NMR) 
 
1D (1H, 13C) and 2D (HSQC, HMBC, NOESY and COSYDEC) nuclear magnetic 
resonance (NMR) spectra were acquired as described in Castillo et al.1 on 600 and 800 
MHz Varian Inova and Bruker Avance spectrometers equipped with cryogenic probes. 
Samples were prepared with deuterated chloroform (CDCl3) (Cambridge Isotope 
Laboratories Inc., Tewksbury, MA) that was filtered through activated basic alumina and 
used to transfer the sample to a thin or thick-walled 5 mm glass tube2 (Wilmad LabGlass 
Co., Vineland, NJ). 1H Chemical shifts in 1D and 2D spectra were referenced to internal 
tetramethylsilane at 0 ppm. 13C shifts were referenced to -0.02 ppm for the 2D experiments 
or in 1D 13C spectra to the CDCl3 triplet at 77.00 ppm. In HSQC spectra
 13C isotope effects 
on 1H NMR triterpene chemical shifts were minor relative to those of the tetramethylsilane 
reference and left unadjusted.  
For crude extracts of plant material or yeast cultures, sample preparation often 
required filtration through a silica plug or a 1-g SPE cartridge prior the addition of CDCl3. 
The crude extract, usually 30 mg in weight, was dissolved in 20 mL hexanes or ether and 
loaded in a 1 g SPE cartridge, then air or vacuum was applied. The eluent was collected in 
a 20 mL scintillation vial, evaporated and stored under vacuum to remove any trace of 
water or solvent. 
Preparation of in vitro samples for ratio determination often involved small scale 
saponification. This was often carried out after the removal of oxidosqualene and ergosterol, 
in order to avoid artifacts that might form during saponification of the crude sample. Since 
the in vitro procedure does not use saponification of yeast cell to obtain the triterpene 
alcohols, the samples also contained triglycerides and other cell debris that were not 
completely removed during SPE purification and could interfere with the NMR analysis.  
 
2.4 High Performance Liquid Chromatography (HPLC) 
 
Reversed-phase HPLC separation of complex triterpene mixtures was carried out 
using an Agilent 1100 HPLC system with a Rheodyne 7125 injector and ultraviolet (UV) 
detection at 210 nm. C18 reversed-phase columns of several sizes were used based on the 
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amount of material that was injected onto the instrument. For preparative scale, a C18 
Phenomenex Prodigy column, 250 x 21.2 mm, 5 µm particle size was used. For semi-
preparative scale, a C18 Phenomenex Sphereclone column, 250 x 10.0 mm, 5 µm particle 
size, was needed and finally, for analytical scale an Imtakt Cadenza column, 250 x 4.6 mm, 
3 µm particle size was used. 
Samples were prepared for injection by first dissolving the sample in 200 µL of 
chloroform (CHCl3), followed by addition of 800 µL of methanol (MeOH) and filtration 
through glass wool. The final sample (1 mL total) was then loaded onto a 2 mL loop prior 
to injection. A linear gradient of methanol–water was used to elute the triterpenes out of 
the column. Flow rates varied from 8 mL/min to 0.5 mL/min based on the column size that 
was used. 
 
2.5 OD600 Measurement of Yeast Cultures with Ultraviolet-Visible Spectroscopy (UV-
Vis)  
 
In vitro cultures were harvested using optical density as the measure of saturation. 
Optical density was measured using a Shimadzu UV-1601 spectrometer at 600 nm. An 
aliquot of 100 µL was removed from the culture flask under sterile conditions. The sample 
was placed in a 10 mm UV-grade polymethylmethacrylate (PMMA) cuvette from VWR 
International Inc. (West Chester, PA.), and diluted with 900 µL of deionized water. 
Absorbance results were multiplied by a factor of 10 to obtain the optical density of any 
given culture. 
 
2.6 Centrifugation  
 
Centrifugation (at variable speed) of DNA samples and small scale in vitro 
reactions was done using 1.5 mL microcentrifuge tubes with Eppendorf Centrifuge models 
5430R (temperature controlled) and 5415D. Large scale yeast cultures were centrifuged in 
50 mL conical tubes using an Eppendorf Centrifuge 5810R, typically at 3800 rpm for 10 
min. 
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2.7 Incubators  
 
Bacterial (E. coli) and yeast plates were grown in Fisher Scientific Isotemp 
incubators at 30 ºC for yeast and 37 ºC for bacterial plates. Liquid cultures of E. coli were 
incubated at 37 ºC in a New Brunswick Scientific Co. G24 Enviromental Incubator Shaker 
with constant shaking at 250 rpm. For S. cerevisiae cultures a New Brunswick G25 or 
Classic C25 floor shaker was used; both incubators were set at 30 ºC with shaking at 250 
rpm. 
 
2.8 Oligonucleotides  
 
Custom designed oligonucleotides for sequencing and PCR amplification were 
synthesized by Sigma-Aldrich Life Science (The Woodlands, TX). Oligonucleotides were 
dissolved in Milli-Q water to give a final concentration of 100 pmol/µL. An aliquot of the 
100 pmol/µL solution was then used to make a 20 pmol/µL stock solution for PCR 
reactions. Stock solutions were stored at -20 ºC. 
 
2.9 Polymerase Chain Reaction (PCR) 
 
Polymerase chain reactions (PCR) were executed in an Eppendorf (Hamburg, 
Germany) Mastercycler Gradient thermocycler. The following set of programs was used 
for either genomic DNA amplification of a specific exon and/or intron of any given cyclase, 
DNA mutagenesis, screening of annealing temperature, RT-PCR or addition of suitable 
restriction sites. 
SSLP (A55E030): 39 cycles with initial temperature of 95 ºC, 30 s, annealing 
temperature of 55 ºC, 30 s, 72 ºC, 30s and final extension of 72 ºC for 5 min.  
CAPS (A56E180): 39 cycles with initial temperature of 95 ºC, 30 s, annealing 
temperature of 56 ºC, 30 s, 72 ºC, 180 s and final extension of 72 ºC for 5 min. 
CAPS60 (A60E180):  39 cycles with initial temperature of 95 ºC, 30 s, annealing 
temperature of 60 ºC, 30 s, 72 ºC, 180 s and final extension of 72 ºC for 5 min. 
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CAPS60M:  35 cycles with initial temperature of 95 ºC, 30 s, then  94 ºC, 3 min, 
94 ºC, 15 s, 50 ºC, 30 s, 72 ºC, 180 s for ten cycles, then 15 cycles of 94 ºC, 15 s, 72 ºC, 
180 s + 5 s per cycle and final extension of 72 ºC for 10 min. 
CAPSGRAD60: 39 cycles with initial temperature of 95 ºC, 30 s, annealing 
temperature of 58±8 ºC, 30 s, 72 ºC, 60 s and final extension of 72 ºC for 5 min. 
CAPSGRAD120: 39 cycles with initial temperature of 95 ºC, 30 s, annealing 
temperature of 58±8 ºC, 30 s, 72 ºC, 120 s and final extension of 72 ºC for 5 min. 
PCR reactions contained a DNA template (genomic DNA, synthetic gene or cDNA 
1-10 ng), a forward primer (20 pmol), a reverse primer (20 pmol), 5 µL of suitable buffer 
(10 x PC2 or ExTaq buffer) and deoxyribonucleotide triphosphate (dNTP) (10 mmol each). 
To the PCR mixture ExTaq Polymerase or Taq Polymerase (1-2 U) and 10 x PC2 buffer 
(5 μL) or ExTaq Buffer (5 μL) were added, followed by Milli-Q water for a total reaction 
volume of 50 μL.  
DNA mutagenesis was generally carried out by introducing the desired mutation 
into the gene through PCR amplification with modified oligonucleotides. A mutation was 
usually designed by substituting a codon with minimal change to the DNA sequence. 
Unique restriction sites used for cloning were found either in the initial DNA sequence 
within 50 bp of the mutation, or by artificially introducing the site by nucleotide 
substitution without changing the amino acid sequence, also within 50 bp of the mutation. 
That the desired mutation was introduced without changing other amino acids was 
established by sequencing the insert in the expression construct. Products of DNA 
mutagenesis were ligated to a pGEM®-T Vector System to avoid possible problems with 
enzymatic digestion. 
 
2.10 Genomic DNA Extraction (Leaf Preps) 
 
Genomic DNA extraction of plant tissue (leaf preps), was done according to 
Klimyuk et al.3 with minor alterations to the original protocol. One or two leaf pieces were 
cut and placed into the bottom of a labeled 1.5 mL microcentrifuge tube that was pre-
chilled on dry ice. After collecting the plant material on dry ice, it was ground with a pre-
chilled plastic microfuge tube pestle, and then returned to dry ice. Once all the leaves (if 
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multiple samples were prepared) were ground, 10 µL of 0.5 N NaOH was added and left 
to thaw at RT. The next step, which is critical for the integrity of the sample, was to briefly 
spin the sample and incubate the samples in a 100 ºC sand bath for exactly 30 s. Once the 
30 s are up, 100 µL of LP II Buffer (20 mL of 0.5 M Tris, pH 8.0 with 100 µL 0.5 M EDTA, 
pH 8.0) was added to neutralize the NaOH in the sample. The tubes containing the genomic 
DNA extracts were left to rest at – 20 ºC overnight before they were used for PCR analysis. 
 
2.11 RNA Extraction and cDNA Synthesis using Reverse Transcriptase 
 
RNA was extracted from several parts of the plant at different growing stages: 
seedlings, rosette leaves and flowering plants. RNA extraction was done in RNAse free 
material and surfaces that were cleaned with 70% ethanol.   
4 mL of Tri Reagent per tube (Sigma-Aldrich St. Louis, MO) were added to a 15 
mL Falcon tube followed by the addition of selected frozen crushed plant material. The 
tubes were left to sit at room temperature for ~5 min, then they were centrifuged at 3000 
rpm for 15 min and the supernatant was transferred into new 15 mL Falcon tubes. 
Chloroform was added to each tube (0.4 mL of chloroform per mL of Tri Reagent), and 
then the closed tubes were manually shaken at room temperature for 5 min.  
The chloroform layer was divided into 1-3 microcentrifuge tubes and 0.5 mL of 
isopropyl alcohol was added per mL of supernatant. The samples were kept at room 
temperature for 10 min, then they were centrifuged (12 000 rpm, 10 min at 4 ºC) and the 
supernatant aspirated. The RNA pellet was washed with 1 mL of 75% EtOH and 
centrifuged again at 7500 rpm for 5 min at 4 ºC. Following centrifugation, the supernatant 
was discarded and the cell pellet was dried at room temperature for 10 min. The pellet was 
finally dissolved in 50 µL of DEPC-water.  
Prior to the synthesis of cDNA, the RNA template was treated with the Zymo 
Research DNA-free RNA kit (Zymo Research Corp. Irvine, CA). Once the RNA template 
was free of DNA, an aliquot (10 pg – 500 ng) of RNA was used with the appropriate 
primers to synthesize cDNA using the SuperScript III kit (Invitrogen Carlsbad, CA). 
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2.12 DNA Plasmid Purification  
 
Mini-prep isolation of DNA was done using a modified version of alkaline lysis 
methodology.4 An isolated colony from a bacterial transformation plate was inoculated into 
2 mL of selective LB media and grown at 37 ºC overnight with constant shaking. The cells 
were harvested by centrifugation and resuspended in 200 µL P1 buffer (50 mM Tris-HCl 
pH 8.0, 10 mM ethylenediaminetetraacetic acid (EDTA), and RNase A (0.1 mg/mL)). Once 
the cell pellet was dissolved, 200 µL of P2 buffer (200 mM NaOH, 1% sodium dodecyl 
sulfate (SDS) (w/v)) were added to lyse the cells. The suspension was mixed by gently 
inverting the tube a couple of times and was incubated at room temperature for 5 min. The 
cell lysis was neutralized by adding 200 µL of P3 buffer (3 M potassium acetate, 1.88 M 
acetic acid), mixed by inversion and let it sit for 5 to 10 min on ice. The mixture was then 
transferred into a 1.5 mL microcentrifuge tube and centrifuged. Following centrifugation, 
the supernatant was transferred into another 1.5 mL microcentrifuge tube. Precipitation of 
DNA was carried out by adding 1 volume of isopropyl alcohol and incubated at -20 ºC for 
30 min or longer to increase DNA yield, after which the plasmid DNA was pelleted by 
centrifugation for 30 min at 12 000 rpm and 4 ºC. The supernatant was removed by pipet, 
and the pellet was resuspended in 47 µL of TE8 buffer (10 mM Tris-HCl, pH 8.0, 0.1 mM 
EDTA). To this mixture, 100 µL of 100% ethanol (EtOH) was added, along with 3 µL of 
5 M NaCl. The tube was left on ice for 30 min (or 4 ºC overnight) and centrifuged (12 000 
rpm, 10 min, 4 ºC). The ethanol (EtOH) was pipetted off and the pellet was allowed to air 
dry before it was resuspended in 50 µL TE8. DNA mini preps were stored at -20 ºC. 
For preparative DNA purification (maxi prep), a 50 mL E. coli culture was grown 
in selective LB media overnight. Before the cells were harvested, a glycerol was prepared 
by mixing 0.8 mL of culture with 0.8 mL of 80% glycerol in water solution and was stored 
at -80 °C. The remaining cells were pelleted by centrifugation, and the DNA was purified 
from the pellet by ion exchange chromatography using High Purity Plasmid Midiprep 
System (Marligen Biosciences). The DNA purification was done by following the kit 
instructions.   
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2.13 DNA Restriction Digestion 
  
Enzymatic digestion to assess how successful was the plasmid construction was 
done by taking an aliquot of purified plasmid DNA (1-3 µL). The DNA was then digested 
in a 25 µL total volume reaction. Preparative restriction digestion reactions for subcloning 
were performed in 50-100 µL final volume. The digestion reactions details were executed 
following the manufacturer recommendations (New England Biolabs Catalogs & 
Technical References).  
  
2.14 DNA Gel Electrophoresis Analysis  
 
Agarose gels for the analysis and purification of DNA fragments were prepared 
according to the needs of the experiment. Depending on whether a preparative or analytical 
gel electrophoresis of DNA was being done, agarose concentration of gels changed based 
on the size of the bands. For 1-8 kbp DNA fragments 1% agarose was used and for 
fragments yielding bands < 900 bp the agarose concentration was increased to 2%. 
TAE buffer was prepared as a 50x stock solution by dissolving 242 g of Tris base, 
57.1 g glacial acetic acid, 37.2 g Na2∙EDTA∙(H2O)2, with pH 8.5 to a final volume of 1 L. 
Analytical gels were prepared by combining the correct amount of agarose with 500 mL 
1x TAE buffer. For preparative gels, 0.283 g of guanosine per 1 L of 1x TAE (GTAE) was 
added to minimize DNA damage under UV light. 
Analysis of DNA samples was done by supplementing each sample with 10x gel 
loading buffer (0.25% bromophenol blue, 0.25% Xylene Cylanol, and 25% Ficoll 400 in 
100 nM EDTA). Samples were loaded into lanes alongside an appropriate DNA marker 
(100 bp DNA Ladder, 1 kbp DNA Ladder or BstEII digested  DNA). The run time and 
voltage used on each gel was adjusted according with the needs of the experiment (ranges 
from 73 V to 110 V). Progress on the mobility of the DNA bands was monitored by the 
use of UV light or by the position of the blue dye.  
DNA fragments run on preparative gels were excised with razor blades and eluted 
with QIAquick Gel Extraction Kit (Qiagen) following the manufacturer manual. DNA 
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fragments run on analytical gels were used for mapping or DNA quantification. BstEII 
digested  DNA was used as a reference of size and weight. 
 
2.15 DNA Ligation 
 
Purified DNA bands from preparative electrophoresis gel were ligated using the 
Quick Ligation Kit from New England Biolabs. When the DNA came from a gel purified 
PCR amplicon, pGEM®-T Vector System (Promega) was used. The insert to vector ratio 
was typically 3:1 calculated using NEBioCalculator. However, for small pieces (230 bp -
500 bp) it was recommended to use an 8:1 fold molar excess of insert to vector. The excess 
of insert to vector minimized the possibility of generating empty vector plasmids during 
the ligation reaction. 
After ligation, the mixture was immediately used for bacterial transformation, 
except in the case of pGEM®-T Vector System in which the ligation reaction was left 
overnight at 4 ºC to increase the number of transformants.  The expression vectors used for 
subcloning of all the genes described in this work were pRS426GAL or pRS424GAL.5  
 
2.16 DNA Sequencing 
 
Sequencing of all DNA samples used in this work was performed by Lone Star 
Labs (Houston, TX) or SeqWright, Inc. (Houston, TX). Constructs at various stages of 
assembly, as well as final expression vectors, were sequenced in order to ensure correct 
protein expression.  Sequencing was also necessary for cDNA and synthesized genes and 
portions of genomic DNA. 
 
2.17 Bacterial Media 
 
Luria-Bertani [lysogeny] broth (LB media) (10 g/L tryptone, 5 g/L yeast extract, 
and 5 g/L NaCl) supplemented with an appropriate selection antibiotic was used to grow 
E. coli cultures. The media was sterilized under pressure by autoclaving at 121 ºC for 35 
min, and then cooled at room temperature before the addition of the filtered sterilized 
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antibiotic solution (100 µg/mL ampicillin or 50 µg/mL kanamycin). Solid LB media was 
prepared following the steps above except for the addition of agar (15 g/L) prior to 
sterilization. Stock solutions of selection antibiotics (25 mg/mL) were stored at -20 ºC. 
 
2.18 Bacterial Transformation 
 
NEB DH5α Competent E. coli (High Efficiency) cells from New England BioLabs 
were used for bacterial transformation following the protocols provided by the 
manufacturer. The 5 Minute Transformation Protocol was used for products of ligation 
because the efficiency is 10% of the High Efficiency Transformation Protocol; this 
decrease in efficiency allowed us to select individual colonies for Miniprep screening. The 
High Efficiency Transformation Protocol was used only when the plasmid DNA was 
verified by sequencing (synthesized genes) or when a different antibiotic (besides 
ampicillin or kanamycin) was used.  When SOC medium was not available, LB media was 
used. LB agar selective plates were utilized to incubate the antibiotic-resistant transformed 
cells overnight at 37 ºC.  
 
2.19 Yeast Strains 
 
Two types of Saccharomyces cerevisiae yeast strains were used in this work: 
EHY416 and RXY6.7 In vivo production of cyclase products was done using the yeast strain 
EHY41 (MATa upc2-1 pGal1-trHMG1:LEU2). EHY41 is a genetically engineered strain 
that has the native sterol pathway intact. In addition, it has two important modifications: 
(1) a dominant mutation in the Upc2p transcription factor (Upc2-1) that deregulates the 
sterol pathway downstream and broadly increases the flux of sterol biosynthesis; (2) an 
important mutation that allows the overexpression of a truncated version of the 
hydroxymethylglutaryl coenzyme A reductase (trHMGR1). HMGR performs the rate-
limiting step in sterol biosynthesis; overexpression of this enzyme dramatically increases 
sterol precursor biosynthesis.  
Including a foreign OSC in this system means that it must compete with the host’s 
native lanosterol synthase for the substrate (3S)-oxidosqualene, but due to the increase in 
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the carbon flux, the foreign triterpene production should also increase. Expression of OSCs 
in this system allows for the production and isolation of large amounts of the compounds 
of interest (10 mg per liter). This is important if one is looking for minor products and we 
need enough material to perform structure characterization; however, we also get lanosterol 
metabolites that make analysis and purification a challenge.  
In an in vivo system a concern is that triterpene products might get further 
metabolized and thus compromise quantification. Yeast strain RXY6 avoids this and other 
concerns about in vivo systems. RXY6 is a genetically engineered strain that was used for 
the in vitro experiments. It has several modifications that allow expression of our foreign 
cyclase without exposure to any endogenous substrate. The first modification, a deletion 
of ERG7 (lanosterol synthase), removes the native oxidosqualene cyclase. The second 
modification is a deletion of ERG1 (squalene epoxidase), thereby preventing epoxidation 
of squalene to form (3S)-oxidosqualene and ensuring that any cyclization occurs after cell 
lysis, when oxidases are inactivated by low NADPH levels. Those two modifications 
preclude the formation of the OSC products and their metabolites in vivo. Finally, there is 
an interruption in the heme biosynthetic pathway, which makes the yeast behave as if it 
were growing under anaerobic conditions and thus can import ergosterol from the medium. 
Because the RXY6 strain cannot biosynthesize ergosterol or heme, they must then be 
included in the medium. 
The in vitro reaction is carried out by breaking open the yeast cells and introducing 
racemic oxidosqualene into the cell homogenate at optimal pH. Even though the in vitro 
system provides a clean picture of the product profile of the OSC of interest, it also has 
some disadvantages. The system is fed with racemic oxidosqualene; most OSCs react 
almost exclusively with the S isomer, leaving the R isomer largely untouched.  Triterpene 
artifacts from nonenzymatic cyclization of leftover 3R-oxidosqualene are generated during 
purification and easily confused with authentic OSC products.8 Thus, oxidosqualene must 
be removed promptly after incubation. Although, there are no concerns about further 
metabolism during in vitro reactions, there is a clear disadvantage in the amount of 
recovered since the yield of triterpene alcohols per liter of culture is at most roughly 1 to 2 
mg. 
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2.20 Yeast Media 
 
Preparation of yeast media was customized based on the yeast strain used and the 
type of plasmid used for expression. YP media (10 g/L yeast extract, 20 g/L peptone) was 
used for yeast strains that did not carry plasmids. Cultures of yeast strains containing 
transformed plasmids with selection markers were grown in synthetic complete (SC) media 
(1.7 g/L yeast nitrogen base, 5 g/L ammonium sulfate, 2 g/L amino acid mixture).  
Amino acid stock mixtures were prepared by combining 10 g of leucine with 2 g 
each of alanine, arginine, asparagine, aspartic acid, cysteine, glutamine, glutamic acid, 
glycine, histidine, isoleucine, lysine, methionine, phenylalanine, proline, serine, threonine, 
tryptophan, tyrosine, valine, adenine, and uracil. Amino acid mixtures lacking uracil (SC-
Ura) or tryptophan (SC-Trp) were prepared according with the selective marker that was 
used. Regardless of the media that was used, RXY6 yeast strains had to be supplemented 
with ergosterol (20 µg/mL) Tween 80 (5 g/L), and hemin chloride (13 µg/mL).  
Besides the addition of amino acids, the media also contained either dextrose or 
galactose as a carbon source with a final concentration of 20 g/L. Solid media was prepared 
by addition of 7.5 g of agar to the carbon source.  Dextrose was used in agar plates or liquid 
media when cultures were being scaled to the desired volume prior to expression. On the 
other hand, galactose was used in the last scaling up step as the inducing sugar.  
Stock solutions of media components were prepared as 2x solutions, by dissolving 
components in 500 mL of Milli-Q water and autoclaving at 121 ºC for 20-35 min. Stock 
solutions of heme and ergosterol were prepared as 100x Heme (65 mg hemin chloride, 25 
mL absolute EtOH, 25 mL deionized H2O and 0.75 mL of 1 M NaOH) and 100x ergosterol 
solution (20 mg ergosterol, 5 mL absolute EtOH and 5 mL Tween 80). All yeast cultures 
were grown at 30 ºC, 250 rpm in sterile Erlenmeyer flasks or 50 mL Falcon tubes. 
 
2.21 Yeast Transformation 
 
Yeast transformation of Saccharomyces cerevisiae strains EHY41 and RXY6 was 
done following a modified version of the high efficiency lithium acetate method9 by 
Schiestl & Gietz. A 10 mL yeast culture was grown to saturation in YP medium 
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supplemented with heme and ergosterol when required (RXY6). Cells were harvested by 
centrifugation (3000 rpm, 5 min at 4 ºC). The cell pellet was resuspended in 15 mL of 
sterile Milli-Q water, centrifuged and the supernatant was discarded. This process was 
repeated two more times. After the final round of washing, the cells were suspended in 100 
µL of sterile water. While the cells were washed, single stranded DNA from salmon sperm 
(carrier SS DNA) was placed in boiling water for 5 min and chilled in ice while cells 
harvesting was completed. 
Yeast transformation components were added to the 50 mL centrifuge tube 
containing the newly washed cells in the following order: 100 µL of ssDNA, 25 µL of 
plasmid DNA (~1 µg of DNA) and 2 mL of yeast transformation buffer (40% polyethylene 
glycol (PEG) 3350, 0.1 M lithium acetate, 10 mM tris buffer (pH 7.5), 1 mM EDTA, and 
100 mM dithiothreitol (DTT). The tube contents were mixed by vortexing and incubated 
either for 45 min (with vortex mixing every 15 min) at 42 ºC or overnight (12-16 h) at room 
temperature. Following this incubation 15 mL of sterile Milli-Q water was added, and the 
cells were pelleted by centrifugation. The pellet was washed two more times. After the 
supernatant was discarded, the cell pellet was suspended in 1 mL of sterile water and 
streaked on two selective plates with a sterile pipette tip.  
The plates were incubated at 30 ºC until transformant colonies appeared. Yeast 
colonies grown on the selective transformation plates were then inoculated into 10 mL of 
selective liquid media with dextrose, grown to saturation and used for preparation of a 
glycerol stock and for further in vivo and in vitro assays. Glycerol stock solutions were 
prepared by mixing 0.8 mL of culture with 0.8 mL of 80:20 glycerol-water and were stored 
at -80 °C.   
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2.22 Synthesis of (±)-2,3-oxidosqualene 
 
Racemic oxidosqualene was synthesized from squalene following the procedure 
described by Nadeau and Hanzlik.10  
 
 
 
Scheme 2.2. Synthesis of (±)-2,3-oxidosqualene. 
 
2.23 Preparation of (±)-2,3-oxidosqualene Solution 
 
Preparation of a (±)-2,3-oxidosqualene solution was done following the method 
described by P. G. Bodager.11 Two hundred mg of synthetic, racemic oxidosqualene were 
weighed in a tared 100 mL round-bottomed flask, to which 2 g Triton X-100 were added. 
To this mixture ca. 15 mL methylene chloride were added, and the mixture was 
mechanically stirred at room temperature until homogeneous. The methylene chloride was 
then completely removed by rotary evaporation. To this mixture, 7.84 mL deionized water 
were added to a final volume of 10 mL. This clear solution was mechanically stirred to 
homogeneity and was stored at -20 °C until use. 
 
2.24 Small Scale in vivo Assay 
 
Small scale in vivo expression of OSCs was carried out in order to confirm whether 
a cyclase was successfully expressed. The preliminary results that come from this type of 
experiment provide insight into how to plan the experiments for quantification and product 
isolation.  
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A 10 mL culture was inoculated from a single colony into Synthetic Complete 
media with 2% dextrose. The culture was grown at 30 °C with constant shaking at 250 rpm. 
Once it reached saturation, the culture was used to inoculate two 100 mL cultures with 
Synthetic Complete media and 2% galactose to induce expression. Once the culture 
reached saturation, the cells were harvested by centrifugation in pre-weighed 50 mL Falcon 
tubes. After centrifugation, the cell pellet weight was obtained by subtracting the weight 
of the empty Falcon tube from the final weight (with cells). Once the weight was recorded, 
the cell pellet was resuspended in 5 mL of 10% KOH (w/v) in 80% EtOH (v/v) per gram 
of cells, and incubated in a 70 °C water bath for 3 h.  
Following saponification, the cell debris was removed by centrifugation, and the 
supernatant was kept. The volume of the solution was increased by adding 10 mL of water, 
and the aqueous solution was extracted three times with 15 mL of hexanes. The combined 
hexanes layers were washed with brine and concentrated by evaporation to dryness in a 
250 mL round-bottomed flask. The resulting sample was then transferred into a pre-
weighed 20 mL scintillation vial using 10 mL of diethyl ether. The solvent was evaporated 
under nitrogen, after which the mass of the crude non-saponifiable lipids (NSL) was 
determined by weight difference and recorded. The sample was dissolved in 1 mL of 
diethyl ether and a 0.5% aliquot was taken for GC-MS analysis. 
 
2.25 Large Scale in vivo Assay 
 
Large scale in vivo cultures were used to determine minor products of cyclases, and 
often provided enough material for the characterization of unknown compounds. The scale 
of these experiments ranged from 2 L to 8 L and depended of the level of expression of 
any given cyclase. 
Cultures were grown following the small scale in vivo procedure up to the 100 mL 
stage. At that point, the carbon source used in the small scale in vivo assay was substituted 
with dextrose. Once the 100 mL cultures reached saturation, each culture was split and 
inoculated into 1 L Synthetic Complete media with 2% galactose. Cultures were left to 
grow under the previously described conditions until they reached saturation.  
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Once the cultures reached saturation, they were poured into pre-weighed 50 mL 
Falcon tubes, centrifuged and weighed.  The cell pellets were left at -20°C for 1 h, so that 
it was easier to transfer them into a 1 L autoclaving Pyrex bottle for saponification. The 
combined cell pellets were resuspended in 5 mL of 10% KOH (w/v) in 80% EtOH (v/v) 
per gram of cells, covered with aluminum foil and left for 3 h in a 70 °C water bath. 
Following saponification, the supernatant was recovered by decanting it into a 1 L 
round-bottomed flask. The cell debris was then washed once with EtOH and the mixture 
was left to settle until the cell material was at the bottom of the flask. The EtOH layer was 
decanted and combined with the rest of the supernatant.  
The removal of ethanol is a key step for this procedure and it was done by rotatory 
evaporation. Ethanol is a significant part of this mixture; large amounts of ethanol present 
during extractions not only increase the volume of the sample, making it more complicated 
to handle, but also increase the possibility of forming microemulsions12 during extraction.  
The remaining aqueous phase was extracted with 6 x 50 mL of hexanes. The 
combined hexanes layers were washed with brine and, dried over anhydrous sodium sulfate, 
after which the solution was concentrated by rotary evaporation. The mass was recorded 
and an aliquot from the crude was taken for GC-MS and NMR analysis. 
 
2.26 Small Scale in vitro Assay 
 
Small scale in vitro assays (100 mL) in the yeast RXY6, were necessary to 
determine whether the OSC was correctly expressed in yeast and to test the optimal pH for 
any given enzyme. The pH range tested went from pH 6.0 to pH 7.2. 
Initial cultures were grown by inoculating one single colony into 10 mL of 
Synthetic Complete media with dextrose, supplemented with ergosterol, heme (in the form 
of hemin chloride) and Tween 80. The cultures were grown to saturation at 30 °C shaking 
at 250 rpm. After saturation, the 10 mL culture was split in two and inoculated into 100 
mL of Synthetic Complete media with 2% galactose as carbon source, and supplemented 
with heme and ergosterol. These cultures were grown to an optical density (OD600) of ca. 
6.0. Once it was reached, the cells were harvested by centrifugation in pre-weighed 50 mL 
Falcon tubes so that the mass of the cell pellets could be determined. The cells were 
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resuspended in 1 mL of 0.1 M sodium phosphate buffer per gram of cells. The cells were 
kept on ice until lysis. A solution of racemic oxidosqualene, 20% Triton X-100 and water 
was added to the mixture to give a final substrate concentration of 0.5 mg/mL. 
The cell mixture was divided in 1.5 mL microcentrifuge tubes (1 mL per tube) 
containing 200 µL borosilicate glass beads and lysed using a Scientific Industries Genie 
Cell Disruptor for two periods of 3 min, with one minute resting on ice in between. The 
enzymatic reaction was allowed to incubate at room temperature for 1 day. An aliquot of 
the cell homogenate was taken seconds after the procedure was completed and it was 
analyzed by TLC. The eluents used were first diethyl ether (to separate the triterpenes from 
the buffer mixture) and then methylene chloride. The TLC plate was submerged in a 
solution of p-anisaldehyde stain and developed on a hot plate.  
Three spots corresponding to squalene, ergosterol and oxidosqualene indicated that 
the substrate had been added. After one day of incubation at room temperature and before 
the work up of the in vitro reaction, a TLC was taken to determine whether it had one or 
more spots in addition to the initial components; such new spots were expected to 
correspond to oxidosqualene cyclization products.  
The reactions were quenched with two volumes of ethanol, and the cell debris was removed 
by centrifugation. The aqueous layer was extracted with 3 x 25 mL of hexanes. The hexanes 
layers were combined in a round-bottomed flask and concentrated by rotatory evaporation. 
The crude extract was transferred into a pre-weighed scintillation vial with diethyl ether 
and dried under a stream of nitrogen, after which the mass was obtained. An aliquot was 
taken for GC-MS analysis, in order to confirm the expression of the cyclase and to get an 
estimate of the percent conversion of oxidosqualene to enzymatic cyclization products. 
 
2.27 Large Scale in vitro Assay 
 
Large scale in vitro assays were done to determine product ratios unbiased by 
metabolism and to compare results with those from EHY41 type experiments; RXY6 was 
the strain used in these experiments. The scale of the experiments was dependent of the 
level of expression of each cyclase. The usual scale ranged from 2 L to 4 L.13 
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Initial cultures were grown by inoculating one single colony into 10 mL of 
Synthetic Complete media with dextrose, supplemented with ergosterol, heme (in the form 
of hemin chloride) and Tween 80. The cultures were grown to saturation at 30 °C with 
shaking at 250 rpm. After saturation, the 10 mL culture was split in two and inoculated into 
two 100 mL liquid cultures. Once the cultures reached saturation they were inoculated into 
1 L Synthetic Complete media containing in 2% galactose. Once the cultures reached an 
optical density (OD600) of ca. 6.0, the cells were harvested by centrifugation in pre-weighed 
50 mL Falcon tubes to determine the mass of the cell pellets. The cells were resuspended 
in 1 mL of 0.1 M sodium phosphate buffer per gram of cells. A solution of racemic 
oxidosqualene, 20% Triton X-100 and water was added to the mixture to give a final 
concentration of 0.5 mg/mL substrate. The cells were kept on ice until lysis. 
The cell mixture was divided in 1.5 mL microcentrifuge tubes (1 mL per tube) 
containing 200 µL borosilicate glass beads and lysed using a Scientific Industries Genie 
Cell Disruptor for two periods of 3 min, with one minute resting on ice in between.  
An alternative version of this procedure was used for Arabidopsis lyrata OSCs, in 
which after lysis the contents of the 1.5 mL microcentrifuge tubes were combined into a 
50 mL Erlenmeyer flask, and it was then that the racemic oxidosqualene was added. The 
enzymatic reaction was allowed to incubate at room temperature for 1 day. An aliquot of 
the cell homogenate was taken seconds after the procedure was completed and analyzed 
by TLC. The eluents used were first diethyl ether (to separate the triterpenes away from 
the buffer mixture), and then methylene chloride. The TLC plate was submerged briefly in 
a solution of p-anisaldehyde and heated on a hot plate.  
Three spots corresponding to squalene, ergosterol and oxidosqualene indicated that 
the substrate was added. After one day of incubation at room temperature, and before the 
work up of the in vitro reaction, a TLC was taken to determine whether it had one or more 
spots in addition to the initial components; these spots will correspond to oxidosqualene 
cyclization products.  
The reactions were quenched with two volumes of ethanol, and the cell debris was 
removed by centrifugation. The ethanolic supernatants were combined into a round-
bottomed flask, and most of the ethanol was removed by evaporation at low heat (to avoid 
potential decomposition or non-enzymatic cyclization of the excess of oxidosqualene 
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present in the mixture). The aqueous layer was extracted with 6 x 50 mL of hexanes. The 
hexanes layers were combined in a round-bottomed flask and concentrated by rotatory 
evaporation. The crude extract was transferred into a pre-weighed scintillation vial with 
diethyl ether and dried under a stream of nitrogen, after which the mass was obtained. An 
aliquot was taken for GC-MS analysis, in order to confirm the expression of the cyclase 
and to get an estimate for the percent conversion of oxidosqualene to enzymatic cyclization 
products. Further purification and spectral analysis usually followed after confirmation of 
successful OSC expression.  
 
2.28 Laboratory Growth Conditions for Arabidopsis lyrata subs. lyrata14 
  
Arabidopsis lyarata sub. lyrata seeds from ABRC #CS22696 or Hobart, Indiana 
donated by Greg Livovich and Alyssa A. Nyberg were sterilized and then suspended in 
200 L of sterile 0.1% agar, follow by stratification at 4 °C for seven days.  
Under sterile conditions, the seeds (60 per plate) were transferred with a sterile 
Pasteur pipette into Plant Nutrient Medium (PN) supplemented with 0.5% sucrose plates, 
taped with one round of micropore tape, labeled and left at ca. 23 °C until germination. On 
the twentieth day, seedlings were transferred into pots and left in a plant growth room at 
23 °C with 24 h light for two weeks, with watering twice a week.  
Two week old rosettes were then placed at 4 °C for vernalization15 in order to help 
them bolt (grow stem). The plants were kept at 4 °C with 24 h light for four weeks; during 
this period they were lightly watered every week. After the vernalization process was over, 
the plants were transferred back to the plant room (23 °C with 24 h light), with watering 
twice a week. The rosettes started to show stems after one week and flowers after 20 days. 
During the flowering period, the plants required waterabout three or four times a week to 
secure good seed production. 
Most populations of North America Arabidopsis lyrata sub. lyrata are out-
crossing/cross pollination plants,16 which means that to get seeds requires two types of 
populations, with manual fertilization once the seeds germinate and become adult plants.  
Additional details and photographs could be found in Appendix B.  
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2.29 Extraction of Triterpene Alcohols from Plant Tissue 
 
Extraction of triterpene alcohols from plant tissue was done following Shan, H. et 
al.17 Minor adjustments to the protocol were made according to the needs of the experiment. 
Fresh aerial tissues from Arabidopsis lyrata or Lactuca sativa were harvested in order to 
analyze the triterpene alcohols that had been produced in each part of the plant. For 
Arabidopsis lyrata the following parts were collected: flowers, pedicels, rosebuds, siliques, 
stem, roots, stem leafs, seeds and rosettes leaves. For Lactuca sativa the parts that were 
analyzed were flowers, stem, roots, leaves and seeds.  
The plant tissue was extracted in two steps. First, cuticular wax lipids were obtained 
by soaking the tissue in hexanes (2 x 20 mL per gram of tissue) for 1-2 h per extraction. 
This process avoided cutting plant tissue or breaking open any cells. After extraction with 
hexanes, the plant parts were ground and the internal lipids were extracted with a 1:1 
mixture of methanol/methylene chloride (20 mL per gram of tissue).  Hexanes extracts and 
methanol/methylene chloride extracts were kept separate for each part of the plant with the 
purpose of differentiating the triterpene alcohols present in the circular wax from the ones 
present inside the cells (internal lipids). 
The samples were left overnight with constant magnetic stirring. While hexanes 
extracts were evaporated to dryness, the methanol/methylene chloride extracts were treated 
by removing methylene chloride under vacuum, leaving only the methanolic extracts. If 
saponification was required for these samples, it was done according to the in vivo 
procedure described in this work. Once saponification was done, the samples were allowed 
to cool to room temperature and the excess MeOH was removed by rotatory evaporation. 
The remaining aqueous material was then extracted six times with 50 mL of hexanes. The 
combined hexanes layers were washed with brine and concentrated by rotatory evaporation 
to dryness in a 250 mL round-bottomed flask. The resulting sample was then transferred to 
a pre-weighed 20 mL scintillation vial using 10 mL of diethyl ether. Each organic phase 
was evaporated to a residue comprising the non-saponifiable internal lipids. Aliquots were 
taken for GC-MS analysis and the samples were purified further when required.  
  
 
32 
 
2.30 Purification of Triterpene Alcohols  
2.30.1 Solid Phase Extraction (SPE) 
 
Purification of crude extracts from saponification, in vitro reactions and plant 
extracts was done by normal phase SiO2 SPE chromatography. This step was necessary for 
further spectral analysis and product isolation. Solid Phase Extraction (SPE) purification is 
a method that has proved to be reliable for these types of experiments. It is a very 
reproducible technique that requires less solvent and time than a conventional 
chromatography column. This type of purification allows separation of any of the crude 
components that are mixed with the triterpene alcohols. The components of a typical 
sample are OSC products, linear triterpenes (squalene, oxidosqualene, and 
dioxidosqualene), native yeast sterols, long-chain lipids, and tocopherols.  
Regarding the differences of the accumulated compounds in the yeast strains or 
plant extracts used for this work, the following strategy was adopted for all of them in order 
to make the analysis of the fractions faster and to maintain consistency within the method, 
especially when it was necessary to choose samples for GC-MS analysis.  
For large-scale assays (usually ~200 mg crude samples) the size of the SPE 
cartridges was 10 g for methylene chloride/diethyl ether purification, and 5 g for the diethyl 
ether/hexanes gradient purification system. The size of the fractions collected during SPE 
purification was 8 mL.  
For the yeast strain RXY6, the main goal was to remove the excess of 
oxidosqualene from the crude sample, in order to avoid possible non-enzymatic cyclization 
of oxidosqualene. Previous studies in our laboratory8 had demonstrated that oxidosqualene 
cyclizes on silica gel under acidic conditions. On the other hand, purification of crude 
extracts from the yeast strain EHY41 presents another type of challenge, that is the removal 
of ergosterol and derivatives that may come from saponification. 
In order to begin purification, the crude extracts were loaded into a 10 g SPE 
cartridge and eluted from the stationary phase using the gradient described in Table 2.1.  
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Table 2.1. Solvent gradient for a standard methylene chloride/diethyl ether solvent system 
used with 10 g SiO2 cartridges. 
 
Fraction  
% Et2O in 
DCM 
1-29 0 
30-37 100% 
 
 
Variation of this method regarding column size and/or number of fraction collected 
were adjusted according to the necessities of the experiment. The majority of the 
oxidosqualene (in case of RXY6) and squalene will elute within the first 3 fractions; 
fractions 4 to 15 will contain triterpene alcohols (and 4,4-dimethyl sterols); fraction 23 to 
28 will usually include the majority of ergosterol; most triterpene diols will elute within 
fractions 30 to 34; and some late diols (like taraxastanediols) will elute in fraction 36. This 
method removes all the squalene from the sample, as well as a majority of ergosterol. As 
an added benefit for oxidosqualene cyclases that produce triterpene diols, elution with 
100% diethyl ether after 29 fractions of methylene chloride elutes the diol products, 
providing clean separation of these products in the first chromatographic step.  
Subsequent purification of the combined triterpene fractions that came from the 
methylene chloride gradient is generally performed with hexanes/ether gradients such as 
the ones presented in Table 2.2. This second SPE serves the purpose of removing the traces 
of ergosterol, squalene and (when required) oxidosqualene from the sample. Triterpene 
alcohols usually elute in fractions 18 to 34, fractions 35 to 42 will contain the traces of 
ergosterol, and triterpene diols elute in fractions 43 to 49; late diols will come in fractions 
52 to 55. 
 
 
 
 
 
34 
 
Table 2.2. Solvent gradient for a standard hexanes/diethyl ether solvent system used with 
5 g SiO2 cartridges. 
 
Fraction  
% Et2O in 
Hexanes 
Fraction  
% Et2O in 
Hexanes 
1-2 0 27-32 10% 
3-6 1% 33-38 20% 
7-12 2% 39-46 30% 
13-18 3% 47-54 50% 
19-26 5% 55-60 100% 
 
2.30.2 Preparative Thin Layer Chromatography (PTLC) 
 
Preparative TLC (PTLC) was used in this work mainly for the recovery of 
compounds that could not be separated by SPE. Pre-coated Silica Gel 60 (thickness 250 
µm) plates were used for all PTLC purification.  
The first step of this procedure starts by pre-washing the plates in ether (if the 
development system is 2:1 hexanes/ether), or methanol/methylene chloride 1:1 mixture (if 
methylene chloride was used). The wash solvent was left to run up to the top, after which 
the plate was left to dry overnight at 120 ºC. The next day the plate was taken from the 
oven and cooled to room temperature. The sample (no more than 20 mg for a 20 x 20 cm 
plate) was dissolved in a minimal amount of diethyl ether and loaded as a thin line 20 mm 
from the bottom of the plate, after which the plate was placed in a PTLC chamber with 
approximately 200 mL of solvent. Once the solvent migrated to a pre-determined distance, 
the plate was taken out of the chamber and let air dry. A small vertical strip (20 mm) was 
cut, stained with p-anisaldehyde and analyzed for distribution of separated components. 
The areas of interest were scraped off the glass with a razor blade and collected into small 
columns, from which the compounds were eluted with diethyl ether. The PTLC fractions 
were analyzed by GC-MS and NMR.   
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CHAPTER 3 
 
Exploring Triterpene Diversity in a Genus of Rosids: Study of Arabidopsis lyrata and 
its Evolutionary Relationship with Arabidopsis thaliana 
 
This chapter explores triterpene biosynthesis in the Arabidopsis genus, which 
belongs to the Brassicaceae family of the Rosids clade. Specifically, phylogenetic analysis 
and OSC product profiles of A. lyrata are described. 
A. lyrata was studied because its genome has been sequenced1 and it is closely 
related to the model plant A. thaliana. The high level of knowledge that has been developed 
over the years in the characterization of A. thaliana OSCs simplified the study of A. lyrata 
OCSs.   
This project illustrates the use of model organisms and genome mining to elucidate 
similarities and differences between closely related organisms. What differentiates this 
study from A. thaliana genome mining is that information about orthology between the two 
species facilitated the characterization of triterpene products in A. lyrata, without having 
to express all of its OSCs. 
Phylogeny and active-site amino acid sequence comparisons helped to assess which 
cyclases will be different enough that their characterization might be important in order to 
complete the product profile of A. lyrata. These key OSCs were chosen for one of two main 
reasons: because they were not present in the A. thaliana genome or because they were 
different enough from their closest homolog that the product profile might be significantly 
different. 
This chapter includes phylogenetic analysis of the A. lyrata OSCs, and the results 
of yeast heterologous expression of A. lyrata PEN4 (thalianol synthase), A. lyrata PEN6 
(seco-β-amyrin synthase) and A. lyrata PEN9 (β-amyrin synthase).  
Products are numbered from highest to lowest amount, starting with 1 for the major 
product of each enzyme. Gene sequences, spectral data, and additional information can be 
found in the Appendix. 
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3.1 Background and Previous Work  
 
Before this project became part of my research, Dorianne Castillo, Aparna Bhaduri 
and Lina Hu tried to characterize the product profile of AlyLUP6, AlyPEN7 and AlyPEN8, 
three of the OSCs found only in A. lyrata. However, none of these OSCs were successfully 
expressed in yeast. Soon after starting work in this project, I established that the preceding 
experiments done on A. lyrata failed because the synthetic clones ordered were faulty. 
Sequencing analysis revealed that two synthetic genes had a foreign DNA piece inserted 
in the middle of the coding sequence, thus making them nonfunctional. First I removed the 
foreign DNA sections, which were human errors created during the commercial gene 
synthesis. However, as described later in this chapter, further analysis and experimental 
results on the repaired sequences indicated that both are pseudogenes. The third 
commercially synthesized gene was erroneously constructed as a chimera, with an exon 
from an adjacent OSC. I eventually corrected this problem, but heterologous expression in 
yeast gave no triterpene products.  
After these setbacks, the remaining A. lyrata OSCs were extensively analyzed to 
choose the best candidates for heterologous yeast expression. This analysis involved 
comparisons of phylogeny and sequence identity with A. thaliana OSCs. One criterion for 
each OSC gene was its overall sequence and active site sequence identity to the closest A. 
thaliana homolog. The second criterion was the A. lyrata OSC not having an ortholog in 
A. thaliana. The first criterion was fulfilled by AlyPEN4 and AlyPEN6 and the second by 
AlyPEN9. 
 
3.2 Experimental Procedures 
 
3.2.1 Phylogenetic Analysis of Arabidopsis lyrata Genome 
 
Genomic DNA sequences for A. lyrata were downloaded from Phytozome2 and 
assembled into 10 different contigs using SeqMan.3 Manual splicing was carried out by 
aligning corresponding A. thaliana OSC coding sequence with A. lyrata genomic DNA in 
order to find the exons by locating the splicing sites. The A. thaliana OSCs were 
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downloaded from NCBI BioSystems database.4 Multiple sequence alignments were 
generated in MegAlign (DNASTAR) from amino acid sequences with Clustal W Method 
using default parameters. Maximum likelihood trees were constructed using MEGA 
version 6.5  
Use of these tools to deduce the coding sequence of A. lyrata OSCs raised some 
concerns. Table 3.1 lists those putative OSCs from A. lyrata that had some potential 
splicing errors that will result in nonfunctional enzymes. All these potential errors were 
insertion/deletion of nucleotides within the putative coding sequence. The results section 
of this chapter will address the details of these putative OSCs. 
 
Table 3.1. Putative OSCs with sequence conflict. 
 
Putative 
OSC 
General details of sequence conflict 
LUP2 
Genomic DNA sequence of putative AlyLUP2 from Phytozome has 4 
extra nucleotides at the end of the first exon when compare to the A. 
thaliana ortholog. This will add 7 amino acids to that exon, making it 
longer than the exon in the ortholog in A. thaliana. 
LUP3 
Confirm whether the genomic DNA sequence from Phytozome has an 
extra adenine at the end of the last exon, this would result in a protein 
that is 14 amino acids longer than the average OSC length (760 aa).6 
LUP4 
Confirm whether the genomic DNA sequence of putative AlyLUP4 
from Phytozome does not have a guanosine in the middle of an exon 
when compare with its A. thaliana ortholog; if missing this would 
generate a frameshift. 
LUP5 
Confirm if the genomic DNA sequence from Phytozome has two extra 
nucleotides in the middle of an exon; if so it generates a frameshift. 
LUP6 
Confirm if the genomic DNA sequence from Phytozome has two extra 
nucleotides in the middle of an exon; if so it generates a frameshift. 
Putative AlyLUP6 was spliced using as a template its closest A. thaliana 
homolog LUP1. 
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PEN7 
Confirm if the genomic DNA sequence from Phytozome has two extra 
nucleotides in the middle of an exon; if so it generates a frameshift. 
PEN8 
Confirm if the genomic DNA sequence in Phytozome does have any 
errors. 
After the experimental data was analyzed, genes highlighted in red appeared to be pseudogenes. 
 
3.2.2 Genomic DNA Experiments  
 
3.2.2.1 Genomic DNA Extraction from A. lyrata Leaf and PCR Amplification 
 
Genomic DNA extraction of Arabidopsis lyrata was done using a modification of the 
method “Alkali treatment for rapid preparation of plant material for reliable PCR analysis” 
from Klimyuk, et al.6 PCR programs are listed in Chapter 2. 
 
3.2.3 Plasmid and Yeast Strain Construction 
 
3.2.3.1 Cloning of Arabidopsis lyrata OSCs 
 
3.2.3.1.1 Gene Synthesis of AlyPEN4, AlyPEN6 and AlyPEN9 
  
Table 3.2 shows those genes that were synthesized for heterologous expression in 
yeast. Criteria for the synthetic genes are described below: 
The A. lyrata genes were found by doing BLASTN of the closest A. thaliana 
homologs against the A. lyrata genome. Our lab revised the computer spliced sequences 
based on a comparison to A. thaliana homologs. Then the gene synthesis company did 
codon optimization for Saccharomyces cerevisiae G/C content, removed direct DNA 
repeats, and prevented stable RNA secondary structures of the gene. The gene was 
produced synthetically and put into an ampicillin vector pUC57 by GenScript® or in 
pMA/pMK vector by GeneOptimizer® with designated restriction sites SalI and NotI.  The 
plasmids were digested with Sal I and Not I restriction enzymes, gel purified, and cloned 
into the yeast expression vector pRS426GAL carrying the URA3 selective marker. The 
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resultant plasmids containing the 2.3 kbp ORF are listed in Table 3.2. All the inserts were 
sequenced to confirm the coding sequence. 
 
Table 3.2. List of A. lyrata genes synthesized for this project.  
 
Plasmid Gene name 
Closest 
homolog 
Cloning 
vector 
Company 
pMMG13.2 
A. lyrata PEN4 
Aly884705/916218 
AthPEN4 pUC57 GeneScript 
pMMG14.2 A. lyrata PEN6 Aly477013 AthPEN6 pUC57 GeneScript 
pMMG9.1 A. lyrata PEN9 Aly316749b AthPEN6 pUC57 GeneScript 
pMMG6.2 
A. lyrata LUP6 
Aly894488/926001 
AthLUP1 pMA GeneArt 
pMMG7.0 
A. lyrata PEN7 
Aly865365/896876 
AthPEN3 pMK GeneArt 
pMMG10.1 
A. lyrata PEN8 
Aly316749a 
AthPEN6 pMA GeneArt 
  
Sequencing revealed that A. lyrata LUP6 and A. lyrata PEN7 had 1339 bp of 
unknown sequence in the middle of the protein coding sequence. 
The GeneArt version of A. lyrata PEN8 also had problems.The last exon of this 
synthetic gene belongs to another putative OSC AlyPEN9, thus making this construct a 
chimera. AlyPEN8 and AlyPEN9 are putative OSCs that are contiguously encoded within 
the A.lyrata genome; AlyPEN8 comes first, then AlyPEN9. The computer spliced sequence 
provided by Phytozome2 was spliced incorrectly keeping most of the AlyPEN8 coding 
sequence, but mistakenly deleting the last exon of AlyPEN8 and most of the exons of 
AlyPEN9 except for the last one. The final construct was a mixture of pieces from AlyPEN8 
and AlyPEN9, thus a chimera. PCR-mutagenesis and synthesis of the correct exon for 
AlyPEN8 was done following methods in Chapter 2. The solution to this splicing problem 
yielded a new putative OSC AlyPEN9.  
Table 3.2 shows the name of the genes used for this work in black. Names in orange, 
are the names used by Phytozome.2 Phytozome sequences were used often as a reference 
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for manual splicing and proofreading, but since they were often only fragments of the genes, 
they are given only as a reference. The final version of each A. lyrata gene can be found in 
Appendix C. 
 
3.2.3.2 Yeast Strains Construction  
 
The plasmids mentioned in the previous section were used to transform 
Saccharomyces cerevisiae strains RXY6 and EHY41 using the lithium acetate method 
(Chapter 2). RXY6 transformants were selected on synthetic complete medium lacking 
uracil, solidified with 1.5% agar, and supplemented with 2% glucose, 13 mg/L hemin 
chloride, 20 mg/L ergosterol, and 5 g/L Tween 80. EHY41 transformants were selected on 
synthetic complete medium lacking uracil, solidified with 1.5% agar, and supplemented 
with 2% glucose. 
 
3.2.4 In vivo and In vitro Experiments towards the Characterization of AlyPEN4, 
AlyPEN6 and AlyPEN9 Synthases Product Profile  
 
4 L cultures of EHY41 with the respective cyclase (see Table 3.3) were grown in 
synthetic complete medium lacking tryptophan and containing 2% galactose as a carbon 
source. The cultures were grown to saturation at 30 ˚C with shaking at 250 rpm. After 
centrifugation, the cell pellets were saponified with 5 mL of 10% KOH (w/v) in 80% EtOH 
(v/v) per gram of cells for 4 h at 70 ˚C. Following saponification, the supernatants were 
separated by decantation, and the excess ethanol was removed by rotatory evaporation. The 
aqueous layers were then extracted with 8 x 100 mL hexanes. The combined hexanes layers 
were concentrated to dryness by rotatory evaporation in a round-bottomed flask, then 
transferred to a pre-weighed scintillation vial and evaporated under nitrogen. The crude 
NSLs (~170 mg) were analyzed by GC-MS (Figure 3.1) and NMR spectroscopy.   
RXY6 cultures (2-3 L) with the respective cyclase (see Table 3.3) were grown in 
synthetic complete medium lacking uracil and containing 2% galactose as a carbon source. 
The cultures were grown to saturation at 30 ˚C with shaking at 250 rpm. The cell pellets 
were harvested by centrifugation when an OD600 of approximately 6.0 was reached. The 
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cell pellets were resuspended in 1 mL of 0.1 M sodium phosphate buffer per gram of cells, 
and then racemic oxidosqualene (OS) solubilized in Triton X-100 (0.25% final 
concentration) was added to give a final concentration of 1 mg of racemic OS per mL of 
homogenate.  The homogenates were divided into 50 microcentrifuge tubes (per cyclase) 
containing ~100 borosilicate glass beads. The cells were lysed by beadbeating using a cell 
disruptor 3 x 3 min with 5 min intervals on ice. After 24 h incubation at room temperature 
(ca. 25 °C), the reactions were quenched with two volumes of ethanol and the cell debris 
was removed by centrifugation. Following centrifugation, the ethanol in the samples was 
almost completely removed by rotatory evaporation. The remaining aqueous phase was 
partitioned between hexanes and water and extracted with 6 x 100 mL of hexanes. The 
hexanes layers were combined, washed with 50 mL of brine, dried over anhydrous Na2SO4 
to give a crude extract that was analyzed by GC-MS and NMR. In total, three crude extracts 
were analyzed. 
 
Table 3.3. In vitro and in vivo experiments of A.lyrata OSCs. 
 
 
Yeast Strain 
Constructs 
Culture size  pH* Cell pellet g 
Crude 
mg 
A EHY41[pMMG13.2] 4 L N/A 75 165 
 RXY6[pMMG13.2] 3 L 7 28 170 
B EHY41[pMMG14.2] 4 L N/A 68 155 
 RXY6[pMMG14.2] 3 L 7 29 190 
C EHY41[pMMG9.1] 4 L N/A 83 177 
 RXY6[pMMG9.1] 2 L 7 24 70 
* pH of RXY6 incubations; not applicable (N/A) to in vivo yeast cultures (EHY41). 
 
The samples were then purified by SPE (solid phase extraction) chromatography. 
Each crude was dissolved in 2 mL of hexanes and loaded onto a 5 g SiO2 SPE column 
(Phenomenex). Fractions (60 x 8 mL) were collected using diethyl ether (Et2O)/ hexanes 
gradients described in Chapter 2. 
Fractions containing the triterpene alcohols and triterpene diols (usually but not 
limited to fractions 19 to 33 for triterpene alcohols and fractions 45 to 50 for triterpene 
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diols) were combined to yield a sample of triterpene alcohols and one of triterpene diols 
(Table 3.4). These samples were used for GC-MS, 1H NMR and HSQC analysis.  
Combined fractions of RXY6 experiments containing triterpene alcohols were 
subjected to small scale saponification to eliminate triglycerides and other impurities in 
order to obtain a cleaner NMR spectrum. This procedure was not necessary for EHY41 
experiments, since extractions of triterpene alcohols from this strain involves 
saponifications as the first step. 
 
Table 3.4. Summary analysis of A.lyrata OSCs. 
 
 
Yeast Strain 
Constructs 
SPE Fractions 
triterpene alcohols 
Mass 
mg 
SPE Fractions 
triterpene diols 
Mass 
mg 
A EHY41[pMMG13.1] 22-35 24 40-43 ~2 
 RXY6[pMMG13.1] 24-35 10 41-43 ~1 
B EHY41[pMMG14.1] 21-35 25 43-45 3.5 
 RXY6[pMMG14.1] 21-35 10 43-45 ~1 
C EHY41[pMMG9.1] 23-30 17.7 34-35 ~2 
 RXY6[pMMG9.1] 6-8 18.9 10 ~2 
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Figure 3.1. A: GC-MS chromatograms of the crude extract of the 4 L EHY41[pMMG13.2] 
culture. B: GC-MS chromatograms of the crude extract of the 3 L RXY6[pMMG13.2] 
incubation. pMMG13.2 corresponds to AlyPEN4 (thalianol synthase). Retention times in 
panel B are shorter than in panel A because the GC column was older and thus less retentive.   
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Figure 3.2. A: GC-MS chromatograms of the crude extract of the 4 L EHY41[pMMG14.2] 
culture. B: GC-MS chromatograms of the crude extract of the 3 L RXY6[pMMG14.2] 
incubation. pMMG14.2 corresponds to AlyPEN6 (seco-amyrin synthase). Retention times 
in panels A and B due to different ages of the GC column. 
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Figure 3.3. A: GC-MS chromatograms of the crude extract of the 4 L EHY41[pMMG9.1] 
culture. B: GC-MS chromatograms of the crude extract of the 2 L RXY6[pMMG9.1] 
incubation. pMMG9.1 corresponds to AlyPEN9 (-amyrin synthase). 
 
3.2.5 Extraction of Arabidopsis lyrata seeds 
 
 A. lyrata seeds (0.5 g) were soaked twice in 20 mL of hexanes. The crude extract 
was recovered by removing the solvent using rotatory evaporation, leaving behind 8 mg of 
crude extract.  After the hexanes extraction, the seeds were crushed with mortar and pestle 
and soaked in 10 mL of 1:1 methylene chloride/ methanol per gram of tissue for a day with 
gentle stirring. Most of the methylene chloride was rotatory evaporated to give a 
methanolic residue of the modified Folch extract.  
After centrifugation, the methanolic extracts were saponified with 10% KOH (w/v) 
in 80% EtOH (v/v). Following saponification, the supernatant was decanted, and the 
methanol was removed by rotatory evaporation. The aqueous layer was then extracted with 
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8 x 50 mL hexanes. The combined hexanes layers were concentrated to dryness by rotatory 
evaporation in a round-bottomed flask, then transferred to pre-weighed scintillation vials 
and evaporated under nitrogen. The non-saponifiable lipids (NSLs) crudes were weighed 
and analyzed by GC-MS and NMR spectroscopy. Further purification was done following 
the procedures outlined in Chapter 2. 
 
 
 
Figure 3.4. GC-MS chromatograms of the crude seed extracts from A. lyrata. A: the crude 
hexanes extract of seeds surface. B: the crude NSLs of the Folch extract. 
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3.3 Results 
 
3.3.1 Phylogenetic analysis of OSCs from A. lyrata 
 
 
 
Figure 3.5. Phylogenetic tree of A. lyrata OSCs derived from the initial manual splicing 
of the genome. The tree was constructed by maximum likelihood using MEGA version 6.5 
Multiple sequence alignments were generated in MegAlign from amino acid sequences 
with Clustal W Method using default parameters. Based on experimental evidence and/or 
sequence analysis, genes in red appeared to be pseudogenes. 
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Analysis of genomic sequences and computer-spliced cyclases from A. lyrata 
indicated nine putative OSCs. The Experimental and Discussion sections of this Chapter 
explain how it was decided which genes were considered full length functional OSCs. 
Figure 3.5 shows the phylogenetic tree of A. lyrata, and Figure 3.6 gives the active site 
sequence alignment for the various cyclases. Similar phylogenetic analysis and sequence 
alignments comparing A. lyrata with A. thaliana are presented in the Discussion section.  
 
 
 
Figure 3.6. Comparison of active site residues in human LSS7 and corresponding residues 
of A. lyrata OSCs.  
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3.3.2 Product Profile of A. lyrata PEN4  
 
The product profile of A. lyrata PEN48 was determined by HSQC and GC-MS 
mixture analysis as described in Shan, H. et al.9 and Castillo et al.22 Ratios for the diols 2, 
10 and 14 were derived from the HSQC spectrum of the crude extract of the NSL, while 
the ratios for the triterpene monoalcohols were obtained from the HSQC of 
EHY41[pMMG13.2] SPE Fractions 22-35. Analysis of HPLC fractions by GC-MS was 
used to confirm the presence of any given product as part of the product profile, particularly 
minor products. Scheme 3.1 shows an overview of the formation of thalianol 1 and how 
oxidosqualene is distributed between the product profiles of AlyPEN4.  
 
 
 
 
Scheme 3.1. Mechanism of formation of thalianol 1, the major product of AlyPEN4. The 
role of intermediate cations Ia and Ib in product formation is discussed in Section 3.4.2 
(Mechanism and Product Profile of A. lyrata PEN4). 
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Table 3.5 presents a comprehensive picture of the product profile of AlyPEN4 and 
its ortholog in AthPEN4. Figure 3.7 shows a bar graph comparison between the minor 
products of A. lyrata and A. thaliana PEN4. Compound numbering follows the A. lyrata 
PEN4 product profile, from highest to lowest amounts. 
 
Table 3.5. Summary of AlyPEN4 thalianol synthase products identified in the 4 L in vivo 
experiment.  
 
Product 
# 
Product 
A.lyrata  
%amount 
A.thaliana 
%amount 
Group* Ref** 
1 thalianol 93 92 T 10 
2 14-epiarabidiol 2 2 T 8 
3 
25-nor-9β-methylpodioda-5(10),17E,21-
trien-3-ol 
1.6 1.8 T (a) 
4 14-epithalianol 0.9 1.1 T 8 
5 ∆7-14-epithalianol 0.8 0.8 T 10 
6 13αH-malabarica-14Z,17E,21-trien-3-ol 0.5 0.6 T 10 
7 13αH-malabarica-14E,17E,21-trien-3-ol 0.2 0.5 T 10 
8 camelliol C 0.1 0.2 M 11 
9 tirucallol-8,24-dienol 0.08 0.09 D 13 
10 (20S)-dammar-24-ene-3,20-diol 0.05 0.08 D 14 
11 
9αH-polypoda-7,13E,17E,21-tetraen-3-
ol 
0.05 0.03 B (b) 
12 13αH-malabarica-14(27)-trien-3-ol 0.04 0.16 T 14 
13 polypoda-8,13E,17E,21-tetraen-3-ol 0.03 0.1 B 11 
14 arabidiol 0.03 0.07 T 11 
15 13βH-malabarica-14(27)-trien-3-ol 0.02 0.04 T 14 
16 dammara-20,24-dien-3-ol 0.02 0.02 D 15 
17 13βH-malabarica-14E,17E,21-trien-3-ol 0.01 0.04 T (c) 
18 dammara-20(22)E,24-dien-3-ol 0.01 0.02 D 16 
19 
9αH-polypoda-8(26),13E,17E,21-tetraen-
3β-ol 
0.01 0.01 B 17 
20 tirucalla-7,24-dien-3-ol 0.01 0.01 D 13 
21 germanicol 0.01 0.01 O 18 
22 taraxasterol 0.01 0.01 U 19 
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23 β-amyrin 0.01 0.01 O 20 
24 α-amyrin 0.01 0.01 U 21 
25 ψ-taraxasterol 0.01 0.01 U 19 
26 ∆7-thalianol <0.01 0.15 T 10 
27 13βH-malabarica-14Z,17E,21-trien-3β-ol <0.01 0.03 T 17 
* M: monocycles B: bicycles T: tricycles D: dammaranes U: ursanes O: oleananes 
** References: (a)  No reference exists because neither C14 epimer of compound 3 is known. (b) Nguyen, L. 
H. D.; Harrison, L.J. Phytochemistry 1998, 50, 471-476. (c) Kolesnikova, M. D., Ph.D. Thesis, Rice 
University, 2008.  
 
54 
 
 
 
Figure 3.7. Product profile comparison between minor products of A. lyrata and A. 
thaliana. Violet bars represent the product profile of AlyPEN4 and pink bars represent the 
product profile of AthPEN4. 
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Figure 3.8. NMR assignments and atom numbering for 25-nor-9β-methylpodioda-
5(10),17E,21-trien-3β-ol 3. 
 
AlyPEN4 third major product 25-nor-9β-methylpodioda-5(10),17E,21-trien-3β-ol 
3 is a triterpene alcohol previously unknown. Its structure was determined on the course of 
this work. 
This compound was partially isolated from the 4 L EHY41 triterpene mixture by 
reversed-phase HPCL analysis. The partial purification from preparative reversed-phase 
HPLC gave a fraction (Fx 43) that contained a 3:3:1 ratio of ∆7-thalianol epimer 5, 25-nor-
9β-methylpodioda-5(10),17E,21-trien-3β-ol 3, thalianol 1, and other products. 1H NMR, 
HSQC, HMBC, and COSYDEC spectra were acquired for this mixture and used to 
determine C-C and C-H connectivities in order to assign the chemical shifts for this 
structure (Figure 3.8). The chemical shifts shown in Figure 3.8 are estimated as accurate to 
±0.001 ppm for 1H and ±0.01 ppm for 13C except for underlined values (±0.003 ppm and 
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±0.03 ppm) and 1H values given to two decimal places (±0.01 ppm). Chemical shifts are 
not corrected for strong coupling. 
Quantum mechanical calculations (performed by William K. Wilson) were done in 
order to confirm experimental chemical shifts and study the C14 configuration. The 
calculations were done as described by Shan, H. et al.9 and Castillo et al.22 on a 25-carbon 
model structure shown in Figure 3.9. GIAO chemical shifts were calculated at the 
B3PW91/6-311G(2d,p)//B3LYP/6-31G* level for 4 side chain conformers of the 14R 
epimer and 19 conformers of the 14S epimer.  
Preliminary data for observed and calculated chemical shifts are compared in Table 
4.3 and Table 4.4. The calculated chemical shift for 25-nor-9β-methylpodioda-
5(10),17E,21-trienol 3 validates the initial assignments of the observed chemical shifts for 
13C and 1H.  
  
 
 
Figure 3.9. C13-C14 rotamers for the C25 model of 25-nor-9β-methylpodioda-
5(10),17E,21-trien-3β-ol used for quantum mechanical modeling calculations. The 14S 
configuration is shown with R=H. 
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Table 3.6. Comparison of the observed and calculated 13C NMR chemical shifts for 3. 
 
13C atom Obs δ Calc δ 
∆ 
Obs δ vs Calc δ 
C-1 23.53 24.8 1.3 
C-2 26.92 28.1 1.2 
C-3 76.12 75.6 -.6 
C-4 38.88 38.9 .0 
C-5 131.42 132.8 1.4 
C-6 26.13 27.0 .9 
C-7 20.91 21.6 .7 
C-8 53.86 54.5 .6 
C-9 46.43 46.9 .4 
C-10 137.37 137.1 -.3 
C-11 34.80 33.6 -1.2 
C-12 38.11 38.6 .5 
C-13 43.00 43.6 .6 
C-14 45.63 47.2 1.6 
C-15 33.11 32.4 -.7 
C-16 26.79 27.6 .9 
4-Me 25.18 24.9 -.3 
4-Me 21.20 20.8 -.4 
9-Me 20.61 20.8 .2 
13-Me 18.72 18.8 .0 
14-Me 14.29 16.3 2.0 
average deviation 
rms deviation 
0.43 
0.91 
These data are from 19 side-chain conformers of the 14S epimer. The conformers were side-chain variants 
of the rotamers shown in Figure 3.9. Because the set of side-chain conformers may be incomplete, these 
results are very preliminary. The separate corrections for the C4-C3-O-H rotamer heterogeneity are also 
preliminary, perhaps accounting for the substantial chemical shift deviations in ring A. The calculations for 
the 14R epimer (not shown) give greater deviations in the vicinity of C14 than for the 14S epimer. However, 
this may be due to the grossly incomplete set of conformers of the 14R epimer. Also, the fraction 43 sample 
should be purified and studied by NOESY as part of the determination of the C14 configuration. These 
calculations do strongly support the structure and NMR assignments for the carbons in the tricyclic ring 
system and nearby side-chain carbons.    
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Table 3.7. Comparison of the observed and calculated 1H NMR chemical shifts for 3. 
 
1H atom Obs δ Calc δ 
∆ 
Obs δ vs Calc δ 
H-1a 2.031 2.13 .09 
H-1b 2.133 2.20 .01 
H-2a 1.777 1.82 .05 
H-2b 1.618 1.59 -.02 
H-3a 3.458 3.53 .07 
H-6a 2.122 2.24 .12 
H-6b 2.134 2.23 .10 
H-7a 1.558 1.61 .05 
H-7b 1.622 1.62 .00 
H-8a 1.424 1.67 .25 
H-11a 1.282 1.39 .10 
H-11b 1.480 1.56 .08 
H-12a 1.739 1.79 .05 
H-12b 1.497 1.60 .11 
H-14 1.131 1.31 .18 
H-15a 1.461 1.44 -.02 
H-15b 1.009 1.03 .02 
H-16a 1.860 1.76 -.10 
H-16b 2.050 2.23 .18 
4-Me 1.039 1.11 .07 
4-Me .954 .97 .02 
9-Me .922 .98 .06 
13-Me .807 .87 .06 
14-Me .843 .75 -.09 
average deviation 
rms deviation 
0.06 
0.095 
See notes for Table 3.6.  
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Figure 3.10. HSQC spectrum of HPLC fraction 43, a mixture containing 14-epi-∆7-
thalianol 5, 25-nor-9β-methylpodioda-5(10),17E,21-trien-3β-ol 3, and thalianol 1 (3:3:1 
ratio) and other products. 
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3.3.3 Product Profile of A. lyrata PEN6  
 
A. lyrata PEN6 is an ortholog to A. thaliana PEN6.24 The major product seco-β-
amyrin 1, accounts for the 72% of the total of products. In addition to seco-β-amyrin 1, this 
cyclase makes at least 39 other triterpene alcohols. 
The product profile was determined using HSQC mixture analysis as described in 
Shan, H. et al.9 Ratios for the diols 13, 19 and 40 were determined from the HSQC of the 
crude extract of NSL, while the ratios for the triterpene alcohols were determined using the 
HSQC spectrum of EHY41[pMMG14.2] SPE Fx21-35. GC-MS analysis of HPLC 
fractions to confirmed the presence of each product, particularly minor products. Table 3.8 
presents a comprehensive list of the products of AlyPEN6 and its ortholog AthPEN6, and a 
proposed mechanistic pathway to each product is presented in Scheme 3.2.  
Figure 3.11 shows a bar graph comparison between the minor products of A. lyrata 
PEN6 and A. thaliana PEN6.18,23 Compound numbering follows the A. lyrata PEN6 
product profile, from highest to lowest amounts and is independent of the PEN4 and PEN9 
numbering. 
 
Table 3.8. Summary of AlyPEN6 seco-β-amyrin synthase products identified in the 4 L in 
vivo experiment. 
 
Product # Product 
A.lyrata % 
amount 
A.thaliana % 
amount 
Ref 
1 seco-β-amyrin 72 38 23 
2 lupeol 4 3 24 
3 polypoda-7,13E,17E,21-tetraen-3β-ol 4 5 17 
4 α-amyrin 3 3 21 
5 9αH-polypoda-8(26),13E,17E,21-tetraen-3β-ol 2 0.3 17 
6 bauerenol 2 6 25 
7 ∆8(26)-seco-β-amyrin 2 0.1 17 
8 δ-amyrin 2 1 26 
9 dammara-20,24-dien-3β-ol 1 6 15 
10 ψ-taraxasterol 1 1 19 
11 lupane-3β,20-diol 1 2 27 
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12 seco-α-amyrin 1 19 23 
13 (20S)-dammar-24-ene-3β,20-diol 1 2 14 
14 multiflorenol 1 1 28 
15 glutinol 1 < 0.1 29 
16 camelliol C  0.5 0.5 11 
17 isoursenol 0.4 5 30 
18 achilleol  0.4 0.2 11 
19 (20R)-dammar-24-ene-3β,20-diol 0.3 2 14 
20 butyrospermol 0.3 0.3 15 
21 13βH-malabarica-14Z,17E,21-trien-3β-ol 0.3 2 17 
22 nematocyphol 0.3 0.3 31 
23 dammara-20(22)E,24-dien-3β-ol 0.3 0.2 16 
24 ∆7-thalianol 0.2 0 -- 
25 13αH-malabarica-14E,17E,21-trien-3β-ol 0.2 0 10 
26 13βH-malabarica-14(27)-trien-3-ol 0.2 1 14 
27 taraxasterol 0.1 1 19 
28 taraxerol 0.1 0.4 32 
29 dammara-20(22)Z,24-dien-3β-ol 0.1 0.1 16 
30 β-amyrin 0.1 0 20 
31 germanicol 0.1 0 18 
32 isoeuphol 0.1 0.1 33 
33 isotirucallol 0.1 0.1 33 
34 γ-amyrin 0.1 0.1 34 
35 tirucalla-7,24-dien-3β-ol 0.1 < 0.1 12 
36 ∆7-14-epithalianol 0.1 0 -- 
37 isobauerenol < 0.1 < 0.1 35 
38 14-epithalianol < 0.1 0 8 
39 friedelin  0 0.1 29 
40 (20R)-taraxastane-3β,20-diol 0 < 0.1 36 
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Scheme 3.2. Proposed mechanistic pathways leading to PEN6 product profile. 
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Figure 3.11. Product profile comparison between minor PEN6 products of A. lyrata and 
A. thaliana. Blue bars represent the product profile of AlyPEN6 and green bars represent 
the product profile of AthPEN6.17, 23 Product 12*, which is the second major product in A. 
thaliana, is not shown so that minor products could be visible. 
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3.3.4 A. lyrata seeds plant extracts  
 
Table 3.9 shows a detailed summary of the triterpene alcohols found in A.lyrata 
seeds from Folch extraction and saponification. These results were obtained from HSQC 
of the NSL. 
 
Table 3.9. Summary of names, numbering and percentage amounts for compounds found 
in A. lyrata seeds extracts.  
 
Product # * Product name 
A. lyrata seed  
extracts, % total 
AlyPEN6  
% total 
1 seco-β-amyrin 71 71 
2 lupeol 4 2 
3 9αH-polypoda-7,13E,17E,21-tetraen-3β-ol 4 3 
4 α-amyrin 3.1 1.8 
5 9αH-polypoda-8(26),13E,17E,21-tetraen-3β-ol 2.3 1.7 
6 bauerenol 2.2 1.3 
7 ∆8(26)-seco-β-amyrin 1.5 1.6 
8 δ-amyrin 1.5 0.8 
9 dammara-20,24-dien-3β-ol 1.4 1.1 
10 ψ-taraxasterol 1.2 0.7 
11 lupane-3β,20-diol 0.9 0.7 
12 seco-α-amyrin 0.7 0.7 
13 (20S)-dammar-24-ene-3β,20-diol 0.7 0.7 
14 multiflorenol 0.5 0.6 
15 glutinol 0.5 0.7 
* Compound numbering follows the product profile of AlyPEN6. 
 
The table above also shows the comparison between the ratios of the triterpene 
product profiles of AlyPEN6 and the seeds extracts from A. lyrata. The ratios are 
remarkably similar, suggesting that the PEN6 products undergo little or no further 
metabolism. Only minor amounts of other secondary triterpene metabolites were detected. 
Thus, PEN6 is essentially the only OSC besides CAS that contributes to seed triterpenes. 
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The results also support the assumption that yeast heterologous expression of OSCs follows 
the product profile in plants.  
 
3.3.5 Product Profile of A. lyrata PEN9  
 
Table 3.10. Summary of AlyPEN9 β-amyrin synthase products identified in the 4 L in vivo 
experiment.   
 
Product # Product A. lyrata % amount Reference 
1 β-amyrin 81 20 
2 dammara-20,24-dien-3β-ol 3.2 15 
3 lupeol 2.7 24 
4 α-amyrin 2.2 21 
5 ψ-taraxasterol 2.0 19 
6 germanicol  1.8 18 
7 (20S)-dammar-24-ene-3β,20-diol 1.4 13 
8 δ-amyrin 1.2 26 
9 butyrospermol 1.1 15 
10 (20R)-dammar-24-ene-3β,20-diol 0.9 19 
11 taraxasterol 0.5 27 
* minor products 2 na 
* Minor products: taraxerol, tirucalla-7,24-dien-3β-ol, dammara-20(22)Z,24-dien-3β-ol, γ-amyrin, isoephol, 
dammara-20(22)E,24-dien-3β-ol, isotirucallol, multiflorenol.    
 
A. lyrata PEN9 does not have an ortholog in the A. thaliana genome. The major 
product β-amyrin 1, accounts for 81% of the total of products. In addition to 1, this cyclase 
makes at least 18 other triterpenes. 
The enzyme mechanism and product profile are presented in Scheme 3.3. The 
product profile was determined as described in Shan, H. et al.9 Ratios for the diols 7 and 
10 were determined from the HSQC of the crude extract of NSL, while the ratios for the 
triterpene alcohols were determined using HSQC of EHY41[pMMG9.1] SPE Fx 23-30. 
Analysis of HPLC fractions by GC-MS was used to confirm the presence of any given 
triterpene as part of the product profile, particularly minor products. Table 3.10 presents a 
detailed picture of the product profile of this enzyme. 
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Scheme 3.3. Proposed mechanistic pathways leading to PEN9 product profile. 
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3.4 Discussion 
 
3.4.1 Phylogenetic Analysis of OSCs in A. lyrata and A. thaliana 
 
The 14 putative OSCs of A. lyrata are shown in three phylogenetic groups (Figure 
3.12). Further analysis of genomic DNA, protein sequences, active site amino acids 
residues (Figure 3.13), and plant extracts indicated that A. lyrata has nine functional OSCs. 
The phylogenetic analysis of A. lyrata OSCs was the first step to identify putative 
OSCs, for that reason the following phylogenetic discussion will treat pseudogenes as 
putative OSCs since sequence ambiguities were confirmed later on in the study. 
A. lyrata OSCs can be grouped in three main categories: (1) those OSCs that share 
high overall sequence identity and have identical active site residues to their ortholog in A. 
thaliana, (2) those cyclases that have high sequence identity but some differences in active 
site residues, and (3) those which do not have an ortholog in the A. lyrata genome.  
 
 
 
Figure 3.12. The 14 OSCs from A. lyrata are separated in three phylogenetic groups CAS 
(pink), LUP (green) and PEN (purple). Putative pseudogenes are shown in red.   
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Figure 3.13. Comparison of active site residues in human LSS7 and corresponding residues 
of A. lyrata and A. thaliana OSCs. Putative pseudogenes are shown in red. 
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Figure 3.14. Phylogenetic tree of A. lyrata OSCs after manual splicing of the genome. The 
tree was constructed by maximum likelihood using MEGA version 6.5 Sequences were 
aligned with Clustal W using default parameters. 
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The OSCs that share high sequence identity (in parenthesis) and identical active 
site residues with their A. thaliana orthologs are AlyCAS (98%), AlyLSS (93%), AlyLUP1 
(93%), AlyLUP2 (92%), AlyLUP3 (95%), AlyPEN2 (94%). This high similarity strongly 
suggests that the product profile of these six enzymes would closely resembles the product 
profile of the already characterized OSCs from A. thaliana. 
The phylogenetic tree comparison (Figure 3.14) shows that three A. thaliana OSCs 
are absent from the A. lyrata genome: arabidiol synthase (PEN1), tirucalla-7,24-dien-3-
ol synthase (PEN3) and marneral synthase (PEN5). Thus, A. lyrata does not produce these 
compounds or their P450 metabolites.22,37 
AlyLUP5 (89%), AlyPEN4 (93%) and AlyPEN6 (93%) have high overall sequence 
identity to their orthologs in A. thaliana, but one or two differences in the active site 
residues. This will make them good candidates for expression (apart from pseudogene 
AlyLUP5) since changing an active site residue can change the catalytic outcome of the 
enzyme.38  
Also uncovered by the phylogeny is that four genes that are absent in A. thaliana’s 
genome were identified in A. lyrata: AlyLUP6 (84% to Ath LUP2), AlyPEN8 (82% to 
AthPEN6), AlyPEN9 (78% to AthPEN6) and AlyPEN7 (ortholog to AthPEN7 which is a 
pseudogene in A. thaliana). These novel OSCs are interesting candidates for study since 
their product profiles cannot be predicted reliably. However, note that AlyPEN7 and 
AlyPEN8 appear to be pseudogenes.  
In the LUP clade (Figure 3.12) several splicing issues arose. The first disagreement 
was found in the splicing of the first exon of AlyLUP2 (92%). This OSC was manually 
spliced using as a template its ortholog in A. thaliana; the only disagreement was that the 
genomic DNA sequence from Phytozome2 had 4 extra nucleotides at the end of the first 
exon. Genomic DNA sequence confirmed these nucleotides in the sequence, thus making 
a different splicing for AlyLUP2 first exon. 
AlyLUP3 (95%) had a similar problem; an extra nucleotide at the end of the last 
exon created a longer exon for this protein, adding 14 amino acids at the end. Even though 
AlyLUP3 has this extra 14 amino acids it seems that this does not affect expression of the 
OSC in the plant.  
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A. lyrata plant extracts from flowers and bud contained camelliol and 29-
hydroxycamelliol (previously found by Jing Jin in Capsella and later by Hui Shan and 
William Wilson in A. thaliana plant extracts). This information not only confirms the active 
presence of AlyLUP3 in the plant, but also suggests that the changes in the protein sequence 
do not affect the major product of the enzyme. A. lyrata and A. thaliana synthesize 
camelliol and its 29-hydroxy derivative when the bud and the flowers are being produced. 
This conservation of AlyLUP3 and the P450 during the 10 million year period since 
thaliana-lyrata divergence, when most ancestral OSCs were lost in at least one species, 
indicate an important role of these compounds in reproduction.     
Finally genomic DNA analysis helped to determine whether AlyLUP5 (89% 
identical to AthLUP5, with two changes in the active site, C337S and L702I), AlyLUP4 
(93% identical to AthLUP4, identical active site) and AlyLUP6 were pseudogenes. All of 
those cyclases had missing nucleotides within exons, problems that created frameshifts and 
thus shortened the length of the above OSCs significantly. Sequencing analysis supported 
my hypothesis that these OSCs are pseudogenes.  
Compared with these LUP clade differences, the PEN clade of A. lyrata suffers 
more changes relative to A. thaliana. In this clade, we have the absence of three OSCs of 
the A. thaliana genome (PEN1, PEN3 and PEN5) and also additional putative OSCs 
specific to A. lyrata (PEN7, PEN8 and PEN9). 
During the analysis of the genomic DNA sequence of AlyPEN7, it was found that 
the AlyPEN7 genomic sequence has an odd patch in which there are 2 nucleotides more 
than the AthPEN7 genomic sequence. The Phytozome2 database had that region spliced out 
so that the coding frame is maintained. However, doing so deletes the highly conserved 
EGGW sequence that corresponds to the DGGWGES sequence that is present in all 
expressed OSCs from A. thaliana. 
AlyPEN7 was spliced in silico using AthPEN3 as a reference. Both sequences were 
aligned and the introns were manually removed from the AlyPEN7 genomic sequence; the 
synthetic clone conserves the EGGW region. To prove whether the conflicted region has 
these extra two base pairs that create a frame, genomic DNA was extracted from A. lyrata. 
The conflict sequence was PCR amplified and sequenced. The results show that these extra 
nucleotides (A and T) are present in the genomic sequence of A. lyrata. The presence of 
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these two extra nucleotides in the exon with the DGGWGES sequence makes a frame shift 
that creates a stop codon. This evidence strongly suggests that AlyPEN7 is a pseudogene 
since the encoded protein is very short and lacks the EGGW region. 
 
 
Figure 3.15. Molecular phylogenetic tree of A. lyrata OSCs found by manual splicing of 
the genome. The tree was constructed by maximum likelihood using MEGA version 6.5 
Sequences were aligned with Clustal W using default parameters. 
 
The A. lyrata version of PEN8 that was available in Phytozome2 was proofread by 
manual splicing using as a template its closest homolog AthPEN6. The clone was compared 
against its genomic sequence and it was found that, what was previously spliced and 
expressed as AlyPEN8 was a chimera, i.e. AlyPEN8 from GeneArt contained the first exon 
of AlyPEN9. AlyPEN8 and AlyPEN9 are neighboring genes, so the computer splicing 
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missed an exon of AlyPEN9 which, upon a second round of comparison between genomic 
DNA and manually spliced genes, was found. Both PEN8 and PEN9 have no ortholog in 
A. thaliana and would be interesting to express. Figure 3.15 shows the final phylogenetic 
tree for A. lyrata.  
Genomic DNA sequencing, manual splicing and active site amino acid comparison 
helped to determine which cyclases were likely to be orthologs to the A. thaliana OSCs. 
Thanks to the previous studies on the model organism A. thaliana, most of the triterpene 
product profile of A. lyrata can be guessed based on analysis of the genome, with minimal 
experimental work. However there still are questions to be answered regarding the product 
profile of the four putative cyclases. Heterologous gene expression was necessary to 
elucidate the product profile of AlyPEN8 and AlyPEN9, since neither has an ortholog in A. 
thaliana, and it was also important to express AlyPEN4 and AlyPEN6 cyclases because of 
the possibility of changes in the product profile since both of them exhibit differences in 
the amino acid sequence of the active site when compared with their A. thaliana orthologs 
(Figure 3.16 and Figure 3.17).  
 
 
Figure 3.16. Comparison of active site residues of PEN4 orthologs. 
 
 
Figure 3.17. Comparison of active site residues of PEN6 orthologs. 
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AlyPEN4, AlyPEN6 and AlyPEN9 were successfully expressed in yeast; however 
expression of AlyPEN8 was not successful. AlyPEN8 is 82% identical to AthPEN6 and 
looks like a full length OSC. Although AlyPEN8 was modified using PCR to introduce the 
correct “last exon” (not the chimeric version synthesize by GeneArt), several attempts at 
expression in yeast gave no triterpenes. Possibly AlyPEN8 has undergone genetic drift and 
is no longer a functional OSC. There is no EST library for A. lyrata, so there is no evidence 
of expression of this putative OSC in the plant. An attempt to obtain cDNA of this cyclase 
was made using different parts of the plant, but PCR amplification with AlyPEN8 specific 
primers did not show any results.  
 
3.4.2 Mechanism and Product Profile of A. lyrata PEN4 
 
A. lyrata PEN4 is an ortholog to A. thaliana PEN4. The sequence identity between 
orthologs is 93%. Despite one change among the active site residues, the product profile of 
the A. lyrata ortholog is almost identical. The mechanism of formation of the product 
profile and ratios comparison between AlyPEN4 and AthPEN4 is illustrated in the results 
section Scheme 3.1, Table 3.5 and Figure 3.7. 
The major product for both enzymes is thalianol 1, previously characterized by 
Fazio et al.8 This compound comes from protonation of OS follow by cyclization to the 
tricyclic tertiary carbocation Ib. A series of rearrangements of Ib and subsequent 
deprotonation in the C9 position to 1 accounts for 93% of the total of products. En route to 
the formation of I, mono and bicyclic triterpenes are formed, these structures include 
camelliol C 8, ∆7-polypodatetraenol-9αH 11, ∆8-polypodatetraenol 13 and ∆8(26)-
polypodatetraenol-9αH 19. 
Similar rearrangement of Ia or Ib generates minor tricyclic products that account 
for 5.3% of total products, including the previously unknown 25-nor-9β-methylpodioda-
5(10),17,21-trienol 3. A small amount of cation Ia cyclizes to dammarane (0.18%) and 
ursane or oleanane (0.05%) triterpenes. 
AlyPEN4 and AthPEN4 are both quite product specific, with P1/P2 of 46 ±1 and 
P1/∑Pi is 0.93 ±1. OSCs that make mainly tricycles are less frequent than OSCs making 
tetracyclic and pentacyclic triterpenes. The fascinating PEN4 mechanism prevents ring 
75 
 
expansion by forming predominantly 13H cation Ib, which can form thalianol 1 but not 
undergo ring expansion to tetracycles and pentacycles.  
The products of thalianol synthase in A. thaliana are further metabolized by 
neighboring CYP450s22,39 (gene clusters), suggesting that thalianol oxidation products may 
play an important role in Arabidopsis. BLAST searching of the A. thaliana CYP450s 
studied by Castillo et al.22 gave close matches to their A. lyrata orthologs, which are 
annotated on NCBI as CYP705A2 (XM_002870201, i.e. THAS) and CYP705A5 
(XM_002863793, i.e. THAH). Thus, like LUP3 and its P450, PEN4 and its P450s have 
been highly conserved over the 10-million period that otherwise saw major changes in OSC 
phylogeny between A. thaliana and A. lyrata. 
 
3.4.3 Mechanism and Product Profile of A. lyrata PEN6 
 
A. lyrata PEN6 is 93% identical to A. thaliana PEN6, with two differences in active 
site residues. Although these two enzymes are orthologs, the major product of both 
enzymes, seco-β-amyrin (see Scheme 3.2), is made in different quantities (Table 3.8 and 
Figure 3.11). AthPEN6 was previously reported by Shibuya et al.23 in 2007 and a more 
detailed product profile is shown by Castillo et al.17 
En route to formation of seco-β-amyrin 1 (72%), 28% of the substrate is lost to the 
formation minor products, most of which (6.3%) are oleananes. Another 7.6% are ursanes, 
including seco-α-amyrin 12. The two most abundant minor products are lupeol 2 and 9H-
polypoda-7,13E,17E,21-tetraen-3β-ol 3. Formation of 3 is not surprising since this enzyme 
favors deprotonation of C8 cations to make ∆7 double bonds. The rest of the material goes 
to the formation of other lupanes, dammaranes, tricycles and monocycles. AlyPEN6 makes 
a larger portion of non-seco byproducts (43%) than AthPEN6 (25%),. Figure 3.11 compares 
graphically the product profile of both enzymes. 
The work with PEN6 is complemented with the seed extract information shown in 
Table 3.9. This analysis was aided by information that Hui Shan40 obtained from analysis 
of A. thaliana seed. She concluded that seco-β-amyrin synthase is expressed during seed 
formation in A. thaliana. Remarkably her seed triterpene profile matched closely the 
triterpene product profile of AthPEN6 from yeast heterologous expression. My AlyPEN6 
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results and A. lyrata seed analyses parallel the corresponding results for A. thaliana. The 
product profile found in the seed extracts of A. lyrata and the product profile obtained by 
heterologous expression of AlyPEN6 are quite similar (Table 3.9). This means that the 
mixture created by PEN6 in both species is left mostly untouched by further metabolism 
and uncontaminated by triterpenes from other OSCs of secondary metabolism.  
Although one can only speculate about the role of PEN6 in seeds, it seems that both 
organisms need seco-amyrin products in the seeds; maybe it is not about the ratio of seco-
α-amyrin to seco-β-amyrin, but that the major product present in seeds has to be mostly 
seco-amyrin type compounds.   
   
3.4.4 Mechanism and Product Profile of A. lyrata PEN9 
 
A. lyrata PEN9 is only 78% identical to A. thaliana PEN6, and it lacks an ortholog 
in the A. thaliana genome.  The active site residues best match the AthPEN6 active site, 
with two differences. During oxidosqualene cyclization AlyPEN9 and AthPEN6 form 
identical tetracyclic and pentacyclic cation intermediates, but by the end of the mechanistic 
pathway they make a very different profile of products. AlyPEN9 is a moderately product 
specific β-amyrin synthase (P1/P2 of 25 and P1/∑Pi is 0.8). A detailed mechanism of product 
formation and product ratios are in the Results section Scheme 3.3 and Table 3.9. 
The mechanism initiates a multi-step cyclization of (3S)-oxidosqualene to a 6-6-6-
5 carbocationic intermediate with an all-chair configuration. The resulting dammarenyl 
C20 cation could have its side chain up (17) or down (17) and this change governs the 
stereochemistry of the derivative products (see ref. 44 for an alternative mechanistic 
option). Butyrospermol 9 (1.1%) originates from the 17 epimer after three consecutive 
1,2-shifts and finally elimination of the axial H7. If water is appropriately present in the 
active site, dammarenediols 7 and 10 are formed (1.4% and 0.9%) by hydroxylation of the 
C20 cation. Alternatively, a simple proton elimination yields dammara-20,24-die-3-ol 2 
(3.2%). D-ring expansion followed by E-ring closure gives the lupanyl cation IV. Direct 
deprotonation without rearrangement gives lupeol 3 in 2.7% yield. The E-ring of IV can 
undergo ring expansion to form either germanicyl cation V or taraxasteryl cation VI. 
Cation V can lose a proton from C18 without rearrangement to form germanicol 6 (1.8%). 
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On the other hand, a series of 1,2- shifts followed by loss of H13 generates δ-amyrin 8 
(1.2%). After formation of VI, a series of rearrangements by 1,2-shift followed by 
deprotonation results in the formation of α-amyrin 4 (2.2%). Proton elimination from VI 
can yield taraxasterol 11 (0.5%) or ψ–taraxasterol 5 (2.0%). Finally, the intermediate cation 
V can follow a series of hydride shifts, with elimination of H12α giving β-amyrin 1 (81%). 
A. thaliana has two β-amyrin synthases located in the LUP clade, AthLUP4 and 
AthLUP2. AthLUP4 makes 74% β-amyrin and is considered to account for the formation 
of most of the β-amyrin found in A. thaliana stem wax. 41, 42, 43 A. lyrata does have an 
ortholog to AthLUP2 (34% β-amyrin, sometimes called a mixed amyrin synthase); 
however, it lost the LUP4 ortholog. One can speculate that maybe the ancestral parent of 
A. lyrata and A. thaliana had two sets of β-amyrin synthases; during species divergence, 
each plant conserved only one pair of β-amyrin synthases, which became characteristic of 
each organism. Preliminary results of A. lyrata plant extracts shows that, as well as in A. 
thaliana, the major product of leaf wax is β-amyrin. 
 
3.5 Final remarks 
 
The work presented in this chapter demonstrates the importance of model 
organisms in the study of natural products. The comprehensive study of triterpene 
biosynthesis in A. thaliana by heterologous yeast expression was the first step to 
understand the complex mechanism of formation of triterpene in plants. The work done in 
A. thaliana was the guide to study triterpene biosynthesis in the closely related organism, 
A. lyrata. With the availability of both genomes and the experimental data that was 
obtained for A. thaliana, the analysis of A. lyrata was easier to tackle. 
Genomic DNA analysis, active site comparison and protein expression were 
applied to the study of A. lyrata to determine the number of cyclases present in this 
organism, and the possible product profiles of each cyclase without the necessity of 
expression of the protein; especially in cyclases that were extremely similar to their 
orthologs. 
Based on the DNA study it seems likely that cyclases with high sequence similarity 
and identical active site residues would make the same major products as their A. thaliana 
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counterpart. When sequence similarity was high, but changes in the active site existed (for 
example, with AlyPEN4 and AlyPEN6), expression was required in order to verify if this 
would affect the major product or the product profile.  
Finally, cyclases that were discovered to be unique to this organism (AlyPEN8, 
AlyPEN9, AlyLUP6) were studied by DNA sequencing and/or protein expression, so that 
it could be determined if they were functional OSCs and what their product profile might 
be. When an ortholog is not available, it is hard to make any conclusion on the product 
profile of that particular OSC based only on sequence analysis. Protein expression has to 
be done in order to complete the triterpene product profile.  
At the end of this study, nine OSCs were proposed to be part of A. lyrata and only 
three OSCs were required to be expressed. The analysis of this plant was much easier than 
the model organism A. thaliana, because of all the background data that was available.  
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CHAPTER 4 
 
Exploring Triterpene Biosynthesis in the Lactuca Clade: Expressed-Sequence Tags 
(ESTs) Mining Reveals the First Nematocyphol Synthase   
 
This chapter describes the product profile of Lactuca perennis nematocyphol 
synthase (NEM), which is encoded by the EST/cDNA name CLPX12873 (GenBank Acc: 
DW077158).1 Because the Lactuca family has high sequence similarity between OSCs of 
different species (see Chapter 5), the L. perennis ortholog was chosen to be expressed in 
place of the already available pGCF18.5 construct, which has a frameshift mutation that 
created a pseudogene and explains the lack of expression.2 DW077158, with its almost 
identical active site amino acid sequence and high level of sequence similarity (94%) to 
Gia’s construct,2 was the closest homolog available.  
Work on this cyclase began prior to the availability of the L. sativa genome. Under 
those circumstances, the only possible source of cDNA material for Lactuca was expressed 
sequence tags (ESTs). ESTs mining approaches were the only way to find cyclases that are 
in the Asteraceae family,2 although this strategy only provides an incomplete picture of 
triterpene metabolism in Lactuca.  
Products are numbered from highest to lowest amount, starting with 1 for the major 
product (Table 4.2). Gene sequences, spectral data, and additional information can be 
found in the Appendix. 
 
4.1 Background and Previous Work  
 
The Lactuca genus is part of a large family of angiosperms called Asteraceae. The 
Asteraceae or Compositae family is a sister group to the Eurosids of which the reference 
plant, Arabidopsis thaliana is a member.  
As it has been seen with the model organism Arabidopsis thaliana, availability of 
the genome has allowed for the generation of a comprehensive accounting of triterpenes in 
this plant.3 However when the genome is not available other strategies, particularly ESTs 
libraries, are of enormous assistance in the process of the discovery of putative OSCs.4 
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When this project began, no Lactuca genomes were available, but a number of 
ESTs from both L. serriola and L. sativa and several other species of lettuce had been 
accessible for a number of years.5 The idea of a systematic analysis of the available ESTs 
to find putative OSCs came from the fact that triterpene metabolites have been known to 
confer resistance to herbivory in other plant systems.7 Moreover, it has been reported that 
traditional organic extraction from commercially available lettuce reveals several 
triterpene alcohols: α- amyrin, β-amyrin, germanicol and ψ-taraxasterol.8 
One purpose of the Compositae Genome Project was to study the differences 
between genomes so they could find the genes that are involved in pathogen resistance, 
since both species exhibit genetic variance at disease resistance loci.6 This could potentially 
facilitate engineering desired traits into lettuce, which is an agriculturally important crop.  
 
4.1.1 Identification of a Putative OSC via Basic Local Alignment Search Tool 
 
The Arizona Genomic Institute made publicly accessible EST libraries of a number 
of Lactuca species available at an affordable price. Using Arabidopsis thaliana 
cycloartenol synthase and basic local alignment search tool (BLAST), Gia Fazio2 identified 
several putative OSCs from L. sativa and L. serriola. Among them, she found one encoded 
by the L. serriola clone BU003176/QGG34F12 that was subcloned into an expression 
vector. The final construct was named pGCF18.5; however this construct contained a 
frameshift mutation. This mutation was determined to be a PCR error and, as described in 
Chapter 5, was fixed using site directed mutagenesis. However, neither the EHY41 nor 
RXY6 yeast transformants gave any triterpene product. At this point I abandoned this 
strategy and decided to BLAST BU003176 to search for a close homolog among the pool 
of other Lactuca ESTs. Among promising candidates, I chose the DW077158 sequence 
from L. perennis, from which pMMG12.3 was constructed and successfully expressed in 
RXY6 and EHY41, as described below. The open question remains whether the L. serriola 
ortholog is a pseudogene or contained a lab construction flaw.  
Using BU003176 sequence from L. serriola, a protein query versus translated 
sequence (tBLASTn) search was performed against the “ESTs Asterids” database.  This 
BLAST search resulted in three good hits from L. perennis that covered parts of the 
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BU003176 sequence; those ESTs are: DW094964, DW076889 and DW077158. SeqMan 
was used to assemble these three sequences using BU003176 as a template. As it turns out, 
these three ESTs belong to the same OSC,but cover different regions. The DW077158 
clone was chosen to be expressed because it was already available in our plasmid library. 
Additional ESTs, L. virosa (DW153103) and L. sativa (DY975354 and DY975590), were 
obtained from the BLAST search; this suggests that BU003176 could have close homologs 
in other species of Lactuca.  
The next section will provide details about phylogeny, plasmid and strain 
construction, along with purification and characterization of nematocyphol synthase 
(NEM) products. 
 
4.2 Experimental Procedures 
 
4.2.1 Plasmid and Yeast Strain Construction 
 
4.2.1.1 Cloning of Nematocyphol Synthase 
  
The clone DW017758 was obtained from Arizona Genome Institute AGI 
(www.genome.arizona.edu). Sequencing with pertinent primers confirmed the ~2.3 kbp 
cDNA sequence. SalI and NotI restriction sites were added by PCR amplification, and the 
amplicon was subcloned into pGEM-T vector system. The construct was then digested with 
SalI and NotI restriction enzymes and gel purified, and cloned into the yeast expression 
vectors pRS424Gal and pRS426Gal carrying the TRIP1 and URA3 selection markers, 
respectively.  The resultant plasmids containing the ~2.3 kbp gene were named pMMG12.2 
and pMMG12.3, respectively. The final constructs were sequenced with T3 and 426GalF 
primers. Sequencing confirmed that the pMMG12.2 and pMMG12.3 each contained a 2.3 
kpb coding sequence equivalent to DW017758.  
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4.2.1.2 Yeast Strains Construction 
 
The plasmid pMMG12.3 was used to transform Saccharomyces cerevisiae strain 
RXY6 (ERG1 and ERG7 mutant) and the plasmid pMMG12.2 was used to transform 
Saccharomyces cerevisiae strain EHY41 (containing a single-point mutation in the UPC2 
transcription factor (upc2-1) and overexpression of trHMGR1) using the lithium acetate 
method. RXY6 transformants were selected on synthetic complete medium lacking uracil, 
solidified with 1.5% agar, and supplemented with 2% glucose, 13 mg/L hemin chloride, 
20 mg/L ergosterol, and 5 g/L Tween 80. EHY41 transformants were selected on synthetic 
complete medium lacking tryptophan, solidified with 1.5% agar, and supplemented with 
2% glucose. 
 
4.2.2 In vivo Experiments toward Characterizing the Nematocyphol Synthase 
Product Profile 
  
An 8-L culture of EHY41[pMMG12.2] was grown in synthetic complete medium 
lacking tryptophan and containing 2% galactose as a carbon source. The cultures were 
grown to saturation at 30 ˚C with shaking at 250 rpm. After centrifugation, the 174 g pellet 
was saponified with 5 mL of 10% KOH (w/v) in 80% EtOH (v/v) per gram of cells for 4 h 
at 70 ˚C. Following saponification, the supernatant was separated by decantation, and the 
excess ethanol was removed by evaporation. The aqueous layer was then extracted with 8 
x 100 mL hexanes. The combined hexanes layers were concentrated to dryness by rotatory 
evaporation in a round-bottomed flask, before being transferred to a pre-weighed 
scintillation vial and evaporated under nitrogen. The crude NSLs (325 mg) and were 
analyzed by GC-MS (Figure 4.1) and 30 mg was used for NMR.  
The crude NSL were dissolved in methylene chloride and loaded onto a 10 g SiO2 
gel solid phase extraction column (Luknova). Thirty-seven 8 mL fractions were collected 
(via an SPE vacuum manifold) with methylene chloride as eluent, after which 8 additional 
fractions were collected with diethyl ether (Et2O). Each fraction was then analyzed by GC-
MS and those containing triterpene alcohols (fractions 4-13) and triterpene diols (fractions 
31-33) were separately combined. 
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Figure 4.1. a) GC-MS chromatograms from the 8 L EHY41[pMMG12.2] experiment: a) 
crude NSL extract and b) combined fractions of the SPE purified triterpenes.  
 
Additional purification of triterpene (alcohol) fractions was necessary for further 
separation of minor products. In addition, triterpene diol fractions also needed further 
purification since ergosterol was still a major component and would lower the quality of 
NMR spectra. The combined triterpene fractions (fractions 4-13 and 31-33) were thus 
dissolved in 2 mL of hexanes and loaded onto a 5 g SiO2 gel SPE column (Phenomenex); 
60 x 8 mL fractions were collected using diethyl ether (Et2O)/ hexanes gradients (0%, 1%, 
2%, 3%, 5%, 10%, 20%, 30%, 50%, and 100% diethyl ether). Fractions containing the 
triterpene alcohols and triterpene diols were combined to yield ca. 64 mg of triterpene 
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alcohols and ca. 5 mg of triterpene diols. Half of the combined fractions was stored and the 
other half was used for GC-MS and NMR analysis (1H NMR and HSQC).  
After NMR analysis the samples were recovered from the NMR tube by 
evaporation into a 1 dram vial. The triterpene alcohol sample (34 mg) was then prepared 
for preparative reverse phase HPLC separation/purification. The sample was dissolved in 
300 µL of methylene chloride, followed by addition of 700 µL of MeOH. The mixture was 
filtered through a glass wool plug to remove any insoluble particles out of the sample. 
Following equilibration of the HPLC system, the 1 mL sample was injected onto a 
Phenomenex Prodigy C18 column (250 x 21.2 mm, 5 µm particle size), and eluted with a 
linear gradient of 90-100% MeOH and a flow rate of 8 mL/min, UV detection at 210 nm, 
and collection of 1 min fractions. Fractions 30 to 80 were analyzed by GC-MS.  
Fractions 59, 60, 61 64 and 65 contained unfamiliar triterpenes. Fraction 59 
contained 17-epilupeol (24); fractions 60 and 61 neolupenol (7), tarolupenol (6) and DB-
friedolup-5-en-3-ol (19); fraction 64 tylolupenol A (3) and lup-19(21)-en-3β-ol (13) and 
fraction 66 and 67 nematocyphol (1). Fractions 59, 60, 61, 64 and 65 were analyzed by 
GC-MS, 1H NMR, HSQC and in some cases COSYDEC, HMBC and DEPT. 
Fractions 59, 60-61, 64, and 65 were further separated by analytical HPLC. 
Samples were dissolved in 200 µL of methylene chloride, followed by addition of 800 µL 
of MeOH, and filtered through a glass wool plug prior to injection to remove any solid 
particles.  The samples were injected onto an Imtakt Cadenza C18 column (250 x 4.6 mm, 
3 µm particle size) and eluted with a linear gradient from 88% to 100% MeOH, with a flow 
of 1 mL/min, UV detection at 210 nm, and collection of 1 min fractions. For each HPLC 
separation, fractions 40 through 60 were taken for analysis on GC-MS and NMR.   
 
4.2.3 In vitro Experiments toward Characterizing the Nematocyphol Synthase 
Product Profile 
 
A cell pellet (40 g) was obtained from a 2.5 L culture of RXY6[pMMG12.3] grown 
at 30 ˚C, 250 rpm in synthetic complete medium lacking uracil, with 2% glucose as a 
carbon source, supplemented with ergosterol (20 µg/mL) and hemin chloride (13 µg/mL), 
which was harvested when an OD600 of approximately 6.0 was reached.   The cell pellet 
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was resuspended in 0.1 M sodium phosphate buffer (40 mL, pH 7) and then racemic 
oxidosqualene (OS) solubilized in Triton X-100 was added to give a final concentration of 
1 mg of racemic OS per mL of homogenate.  The homogenate was divided into 46 
microcentrifuge tubes containing ~100 borosilicate glass beads. The cells were lysed using 
a cell disrupter 3 x 3 min with 5 min intervals on ice. After 24 h incubation at room 
temperature (ca. 23 °C), the reactions were quenched with two volumes of ethanol, and the 
cell debris was removed by centrifugation. Following centrifugation the ethanol was almost 
completely removed by rotatory evaporation. The remaining aqueous phase was 
partitioned between hexanes and water and extracted with 6 x 100 mL hexanes. The 
hexanes layers were combined, washed with 50 mL of brine and dried over anhydrous 
Na2SO4 to give ca. 250 mg of crude extract, which was analyzed by GC-MS. 
The sample was then purified by SPE (solid phase extraction). It was dissolved in 
methylene chloride and loaded onto a 10 g SiO2 gel column (Luknova). Thirty-seven 8 mL 
fractions were collected (via an SPE vacuum manifold) with methylene chloride as eluent, 
after which 8 additional fractions were collected with diethyl ether (Et2O). Each fraction 
was then analyzed by GC-MS, and those containing triterpene alcohols (fractions 4-10) 
and triterpene diols (fractions 30-35) were combined.  
Triterpene diol fractions were collected and separated for GC-MS and NMR 
analysis. However, additional purification of triterpene fractions was necessary for further 
removal of the traces of ergosterol and oxidosqualene. The combined triterpene fractions 
(4-10) were thus dissolved in 2 mL of hexanes, and loaded onto a 5 g SiO2 gel SPE column 
(Phenomenex); 60 x 8 mL fractions were collected using the diethyl ether (Et2O)/ hexanes 
gradient described in Table 4.1 
Fractions containing the triterpene alcohols and triterpene diols were combined to 
yield 3.5 mg of triterpene alcohols and ~1 mg of triterpene diols. These samples were used 
for GC-MS and NMR analysis. Proton NMR and HSQC spectra were collected for this 
sample.  
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Figure 4.2. a) GC-MS chromatogram of the crude NSLs extract aliquot of the 2.5 L 
RXY6[pMMG12.3] experiment.  
 
Table 4.1. SPE solvent gradient for purification of RXY6[pMMG12.3] products. 
 
Fraction  
% Et2O in 
Hexanes 
Fraction  
% Et2O in 
Hexanes 
1-2 0 27-32 10% 
3-6 1% 33-38 20% 
7-12 2% 39-46 30% 
13-18 3% 47-54 50% 
19-26 5% 55-60 100% 
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4.3 Results 
 
4.3.1 In vivo and in vitro Product Profile of Lactuca perennis Nematocyphol 
Synthase 
 
Nematocyphol synthase (NEM) was named after its major product nematocyphol 
(1), which accounts for 55% of its total products. In addition to nematocyphol (1), this 
cyclase makes at least 37 additional triterpenes, more products than reported for any other 
OSC (but fewer than the 40 products I observed in Chapter 3 for AlyPEN6).  
The enzyme mechanism and product profile are presented in Scheme 4.1 and 
Scheme 4.2, as well as Figure 4.3, which shows a graphical comparison of the product 
profile ratios for the in vivo and in vitro experiments. Product profiles of triterpene alcohols 
and triterpene diols were determined mainly by HSQC mixture analysis.9 Ratios for the 
diols 20, 32 and 35 were determined from the HSQC spectrum of the NSL, whereas the 
ratios for the triterpene alcohols were determined using the HSQC spectrum of 
EHY41[pMMG12.2] fractions18-34 GC-MS analysis of HPLC fractions confirmed the 
presence of many minor products. Table 4.2 presents a complete picture of the 
spectroscopic evidence for each compound of the product profile. 
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Scheme 4.1. Proposed mechanism of product formation by nematocyphol synthase. 
Formation of products from rearrangement of cation V to 1 and other rearranged lupeols is 
shown in Scheme 4.2. 
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Scheme 4.2. Mechanism of product formation en route to and beyond nematocyphol (1). 
 
 
Figure 4.3. Product profile of NEM determined from an 8 L in vivo experiment (blue bars) 
and a 4 L in vitro experiment (red bars). NMR error bars correspond to standard deviations 
in NMR signal areas. 
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Table 4.2. Summary of analytical evidence for L. perennis nematocyphol synthase 
products identified in the 8 L in vivo experiment.  
 
Product # 
Product 
Name 
% of 
Total 
GC-MS*  NMR Evidence Ref 
1 nematocyphol 55 A,B HSQC, 1D 20 
2 isoursenol 8.7 A,B HSQC, 1D 21 
3 tylolupenol A 7.6 A,B HSQC, 1D 22 
4 dammara-20,24-dien-3-ol 6.0 A,B HSQC, 1D 23 
5 butyrospermol 4.6 A,B HSQC, 1D 23 
6 tarolupenol 3.5 A,B HSQC, 1D 24 
7 neolupenol 2.2 A,B HSQC, 1D 25 
8 taraxasterol 1.5 A,B HSQC, 1D 26 
9 ψ-taraxasterol 1.3 A,B HSQC, 1D 26 
10 seco-α-amyrin 1.1 A,B HSQC, 1D 27 
11 isobauerenol 1.1 A,B HSQC, 1D 28 
12 lupeol 1.0 A,B HSQC, 1D 29 
13 lup-19(21)-en-3β-ol 0.8 A,B HSQC, 1D none 
14 α-amyrin 0.7 A,B HSQC, 1D 30 
15 tirucalla-7,24-dien-3-ol 0.6 A,B HSQC, 1D 31 
16 γ-amyrin 0.6 B HSQC, 1D 32 
17 18-lupane-3-ol 0.5 A,B HSQC, 1D 33 
18 lupane-3β,20-diol 0.4 A,B HSQC, 1D 34 
19 DB-friedo-lup-5-en-3β-ol 0.4 A,B HSQC, 1D 35 
20 (20S)-dammar-24-ene-3,20-diol 0.4 A,B HSQC, 1D 36 
21 bauerenol 0.3 A,B HSQC, 1D 37 
22 δ-amyrin 0.3 A HSQC, 1D 38 
23 euphol 0.2 A,B HSQC, 1D 39 
24 17-epilupeol 0.2 A,B HSQC, 1D 9 
25 neolup-13(18)-enol 0.2 A,B HSQC, 1D 40 
26 β-amyrin 0.2 A,B HSQC, 1D 41 
27 taraxerol 0.1 A,B HSQC, 1D 42 
28 isoeuphol 0.1 A,B HSQC, 1D 43 
29 isotirucallol 0.1 A,B HSQC, 1D 43 
30 rhoiptenol 0.1 A,B HSQC, 1D 44 
31 seco-β-amyrin <0.1 A,B HSQC, 1D 27 
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32 (20R)-dammar-24-ene-3,20-diol <0.1 A,B HSQC, 1D 36 
33 tirucalla-8,24-dien-3-ol <0.1 A,B HSQC, 1D 45 
34 dammara-20(22)E,24-dien-3β-ol <0.1 A,B HSQC, 1D 46 
35 (20R/S) -taraxasteindiol <0.1 A,B HSQC, 1D 47 
36 ∆7-thalianol <0.1 A HSQC, 1D 14 
37 dammara-20(22)Z,24-dien-3β-ol <0.1 A,B HSQC, 1D 46 
38 ∆8(26)-seco-β-amyrin  <0.1 A,B HSQC, 1D 27 
* GC-MS evidence using Method A and B, Chapter 2. 
-- Not reported, compound found by Maria Kolesnikova.  
 
 
One of the L. perennis nematocyphol synthase products, lup-19(21)-en-3β-ol (13), 
is a previously unknown compound whose structure was determined during course of this 
work. This compound was partially isolated from the 8 L EHY41 triterpene mixture by 
reversed-phase HPLC as a 3:1:1 ratio of tylolupenol A (3), isoursenol (2) and lup-19(21)-
en-3β-ol (13). This mixture was analyzed by GC-MS, 1H NMR, HSQC, HMBC, and 
COSYDEC. The NMR results were used to determine the structure of 13 from C-C and C-
H connectivities (Figure 4.4). Quantum mechanical calculations (performed by William K. 
Wilson) confirmed the chemical shift assignments and the position of the double bond. 
This will be described in the next section. 
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4.3.2 Quantum Mechanical Confirmation of C-19 Stereochemistry for lup-19(21)-
en-3β-ol 
 
 Quantum mechanical calculations, including GIAO predictions of NMR chemical 
shifts, were performed as described by Castillo et al.19 The C19-C20 rotamer populations 
for 13 were [A 0.499, B 0.498, and C 0.003] (Figure 4.5).  Comparison of observed and 
calculated chemical shifts in Table 4.3 and Table 4.4 validated the NMR signal assignments 
and the structure of 13. 
 
 
 
Figure 4.4. NMR assignments and atom numbering for lup-19(21)-en-3β-ol. Chemical 
shifts are estimated as accurate to ±0.001 ppm for 1H and ±0.01 ppm for 13C except for 
underlined values (±0.003 ppm and ±0.03 ppm) and 1H values given to two decimal places 
(±0.01 ppm). Chemical shifts are not corrected for strong coupling. 
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Figure 4.5 The side C19-C20 rotamers of lup-19(21)-en-3β-ol (13). GIAO predictions 
were made for each of these rotamers, whereas general chemical shift corrections for 
conformational heterogeneity of the C3-O rotamers were done as described previously.19 
 
Table 4.3. Comparison of the observed and calculated 13C chemical shifts for 13. 
 
13C atom Obs δ Calc δ 
∆ 
Calc δ - Obs δ 
C-1 38.7 38.1 -0.57 
C-2 27.4 28.1 0.71 
C-3 79.0 78.0 -1.06 
C-4 38.9 38.5 -0.36 
C-5 55.2 55.1 -0.11 
C-6 18.4 18.6 0.28 
C-7 34.2 33.0 -1.14 
C-8 41.0 41.3 0.29 
C-9 50.1 50.4 0.29 
C-10 37.1 36.8 -0.38 
C-11 20.9 20.9 -0.03 
C-12 25.7 25.9 0.21 
C-13 35.3 35.3 -0.01 
C-14 43.4 43.9 0.49 
C-15 27.5 26.9 -0.59 
C-16 34.9 34.1 -0.80 
C-17 46.0 45.6 -0.42 
C-18 52.9 52.5 -0.36 
C-19 155.0 154.8 -0.22 
C-20 29.1 29.6 0.54 
C-21 120.4 121.9 1.46 
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C-22 45.3 45.4 0.12 
C-23 28.0 27.3 -0.66 
C-24 15.4 15.1 -0.23 
C-25 16.0 16.2 0.25 
C-26 16.0 14.8 -1.20 
C-27 14.4 12.6 -1.82 
C-28 19.1 19.0 -0.14 
C-29 22.6 22.7 0.16 
C-30 22.3 22.8 0.50 
average deviation 
rms deviation 
-0.16 
0.67 
 
Table 4.4. Comparison of the observed and calculated 1H chemical shifts for 13. 
 
1H atom Obs δ Calc δ 
∆ 
Calc δ - Obs δ 
H-1a 0.95 0.93 -0.02 
H-2b 1.69 1.67 -0.02 
H-2a 1.63 1.62 -0.02 
H-2b 1.59 1.54 -0.04 
H-3a 3.20 3.18 -0.02 
H-5a 0.71 0.76 0.05 
H-6a 1.53 1.47 -0.06 
H-6b 1.40 1.41 0.01 
H-7a 1.39 1.41 0.02 
H-7b 1.39 1.30 -0.09 
H-9a 1.37 1.51 0.14 
H-11a 1.51 1.48 -0.03 
H-11b 1.34 1.41 0.07 
H-12a 1.35 1.47 0.12 
H-12b 1.95 1.96 0.01 
H-13a 1.98 2.08 0.11 
H-15a 1.01 0.91 -0.10 
H-15b 1.73 1.74 0.01 
H-16a 1.61 1.62 0.01 
H-16b 1.47 1.45 -0.02 
H-18 2.15 2.38 0.23 
H-20 2.39 2.45 0.06 
H-21 5.33 5.35 0.02 
H-22a 1.82 1.92 0.10 
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H-22b 1.82 1.85 0.03 
H-23 0.98 0.99 0.01 
H-24 0.77 0.74 -0.03 
H-25 0.85 0.78 -0.07 
H-26 1.05 0.99 -0.06 
H-27 0.98 0.97 -0.01 
H-28 0.82 0.85 0.03 
H-29 0.99 0.99 0.00 
H-30 1.01 1.00 -0.01 
average deviation 
rms deviation 
0.01 
0.069 
 
4.4 Discussion 
 
4.4.1 Phylogenetic Relationship between Nematocyphol Synthase and other OSCs 
from Asterids 
 
Relative to various characterized asterid OSCs, L. perennis nematocyphol synthase 
exhibits the highest amino acid sequence identity to the mixed amyrin synthases and the 
dammarenediol synthases (72%) as shown in Table 4.5. The phylogenetic tree in Figure 
4.6 suggests that these cyclases are closer to nematocyphol synthase than the lupeol 
synthases, which show a lower sequence identity. Moreover, the lupeol synthases show 
several distinctive active site residues that are not found in NEM, the mixed amyrin 
synthases, and dammarenediol synthases, as shown in the active site alignment in Figure 
4.7.  
Although this limited analysis suggests distant phylogeny between NEM and the 
lupeol synthases, both groups make 6-6-6-6-5 products, unlike the other OSCs in Table 4.5. 
The following mechanistic analysis sheds light on these seemingly paradoxical 
observations.  
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Table 4.5. Comparison of various characterized asterid OSCs with nematocyphol synthase. 
 
AA Sequence 
Identity to 
NEM 
 
OSC 
 
GeneBank ID 
 
Family 
 
Species 
 
Major Product 
 
Reference 
       
57% OEW AB025343 Asterids Olea europea Lupeol 4 
57% TRW BAA86932 Asterids 
Taraxacum 
officinale 
Lupeol 4 
57% BAS EU330197 Asterids Artemisia annua β-amyrin 49 
59% PNY1 AB009030 Asterids Panax ginseng β-amyrin 50 
58% PNY2 AB014057 Asterids Panax ginseng β-amyrin 51 
72% CrAS AFJ19235 Asterids 
Catharanthus 
roseus 
Mixed amyrin 52 
72% OEA AB291240 Asterids Olea europaea Mixed amyrin 53 
72% PNA AB265170 Asterids Panax ginseng Dammarenediol 54 
  AEO27862     
72% PnDS AGS79229 Asterids Panax notoginseng Dammarenediol 55 
72% PqDS AED99864 Asterids 
Panax 
quinquefolius 
Dammarenediol 56 
68%  SHS1 AB609123 Asterids Aster tataricus Shionone 57 
--- NEM DW077158 Asterids Lactuca perennis Nematocyphol --- 
 
 
 
Figure 4.6. Active-site alignments of L. perennis nematocyphol synthase (DW0077158) 
and related plant OSCs from the Asterids family. 
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Figures 4.7. Phylogenetic tree of characterized oxidosqualene cyclases from the Asterids 
clade. The tree was constructed by maximum likelihood using MEGA version 6. Multiple 
sequence alignments were generated in MegAlign from amino acid sequences with Clustal 
W using default parameters. 
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4.4.2 Products of L. perennis Nematocyphol Synthase (NEM) and their Mechanism 
of Formation 
 
The product profile of nematocyphol synthase was obtained from the combination 
of in vivo and in vitro experiments involving several purification techniques and a variety 
of analytical methods. Due to the high number of triterpene products that this cyclase can 
make, peak overlap was the major impediment in quantifying the many nematocyphol 
synthase products. However, HSQC analysis of EHY41 or RYX6 products enabled 
identification of minor NEM metabolites at a level of ~0.05% of total products due to the 
signal distribution along two axes.58,60 The HSQC experiments demonstrated that besides 
nematocyphol (1), this cyclase makes at least 37 other products that account for 45% of the 
product profile.  
The mechanism of formation and product profile are detailed in Scheme 4.1, 
Scheme 4.2 and Table 4.2. As shown in Scheme 4.1, 87.5% of the material goes through 
cation V, either in the 17H intermediate Va or its 17H epimer Vb. As suggested below, 
Va retains the 6-6-6-6-5 pentacyclic structure en route to lupane type rearranged products 
(71.6%), while Vb undergoes E-ring expansion toward the formation of ursanes and 
oleananes (total 16%), all of them made in less than 3% yield, except for isoursenol (2, 
8.7%). Ursanes and oleananes (16%) are formed by E-ring expansion of V by C18 
migration to form the germanicyl cation XII or by C18 migration to form a secondary 
cation en route to the C18 ursanyl cation XIV.  
Analysis of the mechanism in Schemes 4.1 and 4.2 implies that en route to the 
formation of nematocyphol ~30% is lost to the formation of dammaranes, lupanes, 
oleananes and ursanes. Of this ~30%, 12% is dedicated to tetracycles and the rest undergoes 
formation of ursanes with a minor loss to oleananes. 
Formation of nematocyphol 1 (55%) and a variety of lupeol derivatives is believed 
to arise from rearrangement and deprotonation of nepehinyl cation Va and account for the 
remaining 71.6% of material. Direct deprotonation without rearrangement of Vb provides 
lupeol 12 (1%), while water addition to C20 forms lupanediol 18 (0.4%). After a series of 
1,2-shifts and deprotonation at different positions this enzyme makes 18-lup-18-en-3β-ol 
17 (0.5%), neolup-13(18)-enol 25 (0.2%), DB-friedo-lup-5-en-3β-ol 19 (0.4%), neolupenol 
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7 (2.2%), tarolupenol 6 (3.5%), tylolupenol A 3 (7.6%), nematocyphol 1 (55%) and lup-
19(21)-en-3β-ol 13 (0.8%), a previously unknown product.  Once the rearrangement gets 
to the carbocationic intermediates Va and Vb, a series of rearrangements to X will cause 
the loss of 16.6% of the material en route to the formation of 1.  
Determination of the product profile of a cyclase allows it to be compared in 
accuracy with other OSCs by the standard measures P1/P2 and P1/∑Pi.14 Nematocyphol 
synthase has a value of P1/P2 of 6.35 and P1/∑Pi is 0.5. The analysis of the product profile 
of nematocyphol synthase and the values of P1, P2 and Pi shows that this enzyme can be 
placed in the range of moderately product-specific OSCs, as described by Lodeiro et al.16  
NEM is capable of performing the series of 1,2-shifts necessary to form 
nematocyphol and 9 other products, and also is able to undergo ring expansion to make 
ursanes and oleananes. Cationic intermediate V is shown in Scheme 4.2 with an ambiguous 
stereochemistry at the C19 position. Evidence from molecular mechanics calculations and 
organic synthesis suggest that the lupanyl cation is not the only possible intermediate that 
could eventually lead to the formation of the lupane-type rearranged products. 
 
 
 
Scheme 4.3. Suggested mechanism for the formation of nematocyphol and rearranged 
lupane type compounds. 
  
Hui Shan, Matias Kinzurik and Dorianne A. Castillo60 performed a series of triflic 
acid isomerizations using as starting material either normal lupane-3β,20-diol (17H) or 
its C17 epimer 17H-lupane-3β,20-diol, which is here referred to as nepehine-3β,20-
diol..When normal lupane-3β,20-diol was used, the product profile of this reaction was 
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primarily comprised of ring expansion products and rearranged lupenols were almost 
undetectable (<<1%). In contrast, when nepehine-3β,20-diol was used, they observed 
mainly rearranged lupenols, including several NEM products and ~30% ursanes and 
oleananes. 
Preliminary results from QM calculations performed by William K. Wilson present 
a possible explanation for the lupanyl cation to perform ring expansion and nepehinyl 
cation to do rearrangements. This hypothesis involves the understanding of the reactivity 
of horizontal and vertical cations (Scheme 4.4). 
 
 
 
Scheme 4.4. Illustration of vertical and horizontal cations. Thick bonds in red denote 
hyperconjugation with the cation. The relevant hyperconjugation for the vertical cation is 
with the C19-H19 bond, but the C17-C28 bond is shown in red for convenience.    
 
In vertical carbocations, orientation of the 2p orbital leads to hyperconjugation with 
axial substituents instead of a ring bond. The elongated bonds of axial hyperconjugation 
(vertical cation) readily undergo 1,2-shifts. When the carbocationic intermediate is 
horizontally oriented and hyperconjugated to a C-C ring bond, , the 1,2-shift will result in 
ring enlargement.61 Analysis of the vertical nepehinyl cation shows that H19 bond length 
(C19-H19) is 1.12 A, whereas the other axial C-H bonds in the molecule are generally less 
or equal to 1.10 A. Similarly, in the horizontal cation of the 17H epimer, the C19-C21 
bond is elongated to 1.63 A vs. ~1.55 A of other C-C bonds. The 17H and 17H epimers 
shown in Scheme 4.4 both contain an equilibrium mixture of vertical and horizontal cations, 
but the vertical cations predominate in the 17H epimer and are extremely minor in the 
usual 17H epimers.  
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QM calculations suggest that activation energy to convert the nepehinyl cation from 
to vertical is only 5 kcal/mol versus the 12 kcal/mol when the lupanyl cation undergoes the 
same transition. This means that lupanyl cation has to overcome a higher energy barrier to 
go from vertical (rearrangement) to horizontal (ring expansion), thus explaining why 
Castillo, D. A. and Shan, H. found «1% rearranged products when lupanyl cation was 
involved. On the other hand, the nepehinyl cation has better access to the unfavored 
orientation, which accounts for the products of ring expansion found in acid isomerization 
of nepehine-3β,20-diol.  
Nematocyphol synthase from L. perennis is the first OSC ever reported to 
synthesize nematocyphol 1 or any other rearranged lupenols in significant amounts (>5%). 
NEM is fairly good at controlling rearrangement with deprotonation to make a 7 bond. 
Nematocyphol has also been reported as a minor product of AthPEN6,59 parallel to my 
present observation of 1 in AlyPEN6. In both cases, only the  7 rearranged lupenol 1 is 
detected.  
Thus, nematocyphol is known to be part of the product profile of at least two other 
organisms from the Brasicaceae family, A. thaliana and A. lyrata. In both cases, 
nematocyphol is among the minor products of AlyPEN6 and AthPEN6, both of them being 
seco-amyrin synthases. In a previous study by Shibuya et al.,3  it was proposed that in order 
to perform the Grob fragmentation that permits the formation of seco amyrins, the enzyme 
needs to have an enlarged active site cavity, which permits the proper alignment of the C13 
empty orbital with the C8-C14 bond that is broken during this reaction. This alignment will 
be possible by allowing the enzyme to accommodate and bend the DE rings slightly 
upwards, thus favoring Grob fragmentation over elimination to β-amyrin formation.  
The suggestion of a slightly enlarged active site cavity around the DE-ring supports 
the hypothesis previously discussed for the formation of rearranged lupane type products. 
Formation of the nepehinyl intermediate is thought to be favored in NEM, thus preventing 
the steric problems that are encountered by rearrangement of lupanyl cation. An enlarged 
active site cavity, like the one described for A. thaliana PEN6 will have enough room to 
maintain the isopropyl group of the carbocationic intermediate in the correct position 
(isopropyl group up) in order to start the rearrangement. Consistent with the reasoning that 
a high ceiling over rings DE is needed for both lupanyl cation rearrangements and seco-
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amyrin-type Grob fragmentation, NEM makes a trace of seco--amyrin, just as PEN6 
makes a small amount of nematocyphol. The shape of the high ceiling evidently controls 
whether seco-amyrins or rearranged lupenol products predominate. 
 
4.5 Final remarks 
 
Throughout this chapter it is demonstrated that EST mining approaches are useful 
tools for the discovery of novel OSCs when the genome of an organism is not available; 
however, this strategy does not provide a complete picture of the variety of triterpenes or 
number of OSCs in the Lactuca family. 
Heterologous gene expression used to study L. perennis nematocyphol synthase is 
still a reliable methodology for the analysis of putative OSCs. This work shows the 
importance of a good approach for OSCs expression, product isolation and characterization 
in order to get a reliable triterpene product profile. With 38 products that range from 55% 
to <1%, it is important to have a reliable methods of quantification which in this case were 
NMR and GC-MS techniques. 
Finally, elucidating such a complex product profile provided insights into triterpene 
biosynthesis in other plant families. OSCs are phylogenetically quite different between 
Arabidopsis and Lactuca, but still both organisms have managed to share most of the 
known triterpene alcohols found in other plants.  
The next chapter will discuss strategies for identifying OSCs in Lactuca when 
genomic sequences as well as ESTs are available. Several characterized OSCs from L. 
sativa and L. serriola will be analyzed by genome mining strategies  
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CHAPTER 5 
 
Genome and EST Mining Approaches to Elucidate Triterpene Biosynthesis in Lettuce 
 
This chapter describes my work towards the analysis and characterization of novel 
oxidosqualene cyclases in lettuce. The many lettuce species from the Lactuca genus, which 
is a member of the Asteraceae (or Compositae) family, are asterids. The increasing 
availability of the Lactuca sativa genome during this project helped to give a more 
complete picture of triterpene biosynthesis in lettuce.  Lactuca sativa is the first plant from 
this family to have its genome available and can be used as a model organism for studying 
triterpene biosynthesis in Compositae.  
In this chapter, I present the product profiles of five oxidosqualene cyclases from 
Lactuca sativa and Lactuca serriola (Table 5.1). Although these OSCs were previously 
reported by Gia Fazio,1 a vast improvement in our laboratory’s analytical methodologies 
helped me to expand our knowledge about the product profiles of these cyclases, hence the 
possibility to expand our understanding of OSC catalysis in Compositae.   
 
Table 5.1. Summary of the Lactuca OSCs expressed for this study. 
 
Plasmid GeneBank ID Major Product Species 
pGCF14.3 BU000828 tirucalla-8,24-dien-3-ol L. serriola 
pGCF15.3 BQ869693 -amyrin L. sativa 
pGCF16.9 BQ997802 taraxasterol L. serriola 
pGCF17.6 BU003435 lupeol L. serriola 
pMMG11.2 BU003176 [nematocyphol]*  L. serriola 
pGCF19.6 BU008606 cycloartenol L. serriola 
    * No product was observed from EHY41[pMMG11.2] or RXY6[pMMG11.2] 
 
Product numbering for this chapter, as in chapter 3, is assigned in descending order 
of amount, starting with 1 for the major product of each enzyme. Thus, the same triterpene 
structure may have different numbers in different sections of this chapter. Another set of 
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numbers is used for the plant extracts. Additional information, sequences and spectral data 
can be found in the Appendix. 
 
5.1 Background and Previous Work  
 
The Compositae or Asteraceae family, where Lactuca is a member genus, is one of 
the largest and most diverse families of flowering plants, comprising almost one-tenth of 
all known Angiosperm species.2 The Compositae family contains over 40 economically 
important species like lettuce, which generates over 1.5 billion dollars in revenue as a 
group.3  
In the Cichorieae (or Lactuceae) tribe of Asteraceae, Lactuca has historically been 
the best genetically characterized genus.4 Disease is an important factor in lettuce 
production and has motivated studies of genetic variance at disease resistance loci.5  
Diverse secondary metabolites can contribute resistance to herbivores in plant systems. 
The defense role of triterpenes, which are abundant in lettuce, is mostly unexplored.  
Sequencing of the Lactuca sativa genome was announced in 2013,6a and the 
analysis tools were made accessible in the Lettuce Genome Resource where several 
versions of the data were displayed in GBrowse and could be used to compare with other 
plant genomes. In addition, lettuce genes were assigned a KEGG (Kyoto Encyclopedia of 
Genes and Genomes) metabolic pathway, which made my search for putative OSCs easier 
within the published genomic contigs.7 Now genomes of other Compositae species, 
including horseweed, sunflower, and globe artichoke, are at various stages of release.6b 
Investigation into OSCs in the Lactuca species began in the Matsuda Laboratory 
around 2005 with the analysis of ESTs by Gia Fazio.1 Large collections of ESTs have long 
been available for five Lactuca species and other Cichorieae.4b However, the ESTs-only 
approach does not establish how many putative OSCs Lactuca has. As expected, most 
Lactuca OSCs besides cycloartenol synthase (L. serriola BU008606) have no close 
counterparts in the Arabidopsis thaliana genome. 
Previous work of heterologous expression of these cyclases in the Matsuda 
Research group was done mainly by Gia Fazio; followed by experiments on the various 
cyclases by Carl Onak, Caroline V. McNeil, Aparna Bhaduri, Jazmin Godoy and Matias 
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Kinzurik. These experiments were afflicted by yeast strain problems and low quality NMR 
and GC-MS analysis. In the following sections, I will present a more complete product 
profile of each of the cyclases mentioned above, and I will discuss the implications of 
genome mining for the discovery of OSCs that seem characteristic of the Lactuca family. 
 
5.2 Experimental Procedures 
 
5.2.1 Phylogenetic Analysis of Lactuca sativa Genome 
 
Genomic DNA sequences and computer spliced sequences were downloaded from 
the Lettuce Genome Resource7,8 using the enzyme commission number (EC number) 
search provided by the database. The sequence of EC 5.4.99.8 (cycloartenol synthase) from 
A. thaliana was used to look for a match in the genomic sequences and/or computer spliced 
sequences deposited in the Lettuce Genome Resource.  Forty pieces of genomic sequence 
of various lengths were downloaded and assembled using SeqMan,9 these sequences were 
assembled in 19 different contigs and manually spliced using as references ESTs from 
different Lactuca species that were available in the NCBI Bio Systems database,10 and 
available sequences from Gia Fazio’s Lactuca OSCs.1  
Phylogenetic and molecular evolutionary analyses were conducted using MEGA 
version 6.11 Multiple alignments of nucleotide sequences were generated from amino acid 
sequence with Clustal W Method using default parameters. Maximum likelihood trees 
were constructed using MEGA version 6.11 
 
5.2.2 Plasmids and Yeast Strain Construction 
 
5.2.2.1 PCR-Mutagenesis of pGCF18.5: Construction of pMMG11.2 
 
Plasmid pGCF18.5 contains the putative OSC BU003176 from Lactuca serriola, 
and it was described by Gia Fazio1 as a pseudogene because her clone had two nucleotides 
(TC) at position 1834 missing that will create an early truncation upon expression, resulting 
in a putative OSC without the C-terminus. Since the genome of Lactuca serriola is not 
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available, I looked into the genomic sequence to see if these missing nucleotides were the 
product of evolution or a PCR mistake during the creation of the clone BU003176.   
Alignment of BU003176 with its close homologs (Figure 5.1) from Lactuca sativa 
and Lactuca perennis suggested that the absence of these nucleotides could be the product 
of a PCR mistake, since both closest homologs do have the missing nucleotides in the 
conflict region and, when they are inserted in BU003176, its amino acid sequence has a 
high percentage similarity to the homologs in L. sativa and L. perennis (nematocyphol 
synthase).  
 
 
 
Figure 5.1. Table of amino acid percentage identity values for corrected sequence of 
pGCF18.5 compared with its homologs. Green corresponds to L. serriola BU003176, 
orange to L. sativa homologs and yellow to L. perennis nematocyphol synthase. 
 
The original BU003176 clone was obtained from Arizona Genome Institute AGI 
(www.genome.arizona.edu) and sequenced with pertinent primers to confirm the ~2.3 kbp 
cDNA sequence. Sal I and Not I restriction sites were added by PCR amplification, and the 
amplicon was subcloned into the pGEM-T vector system.  
DNA mutagenesis of BU003176 was conducted as described in Chapter 2. It was 
done using the following primers: (1) a forward primer (5’- 
CCCGTCGACAAAATGTGGGAGTTAAAG-3’) that starts amplification at the ATG 
start site, (2) a reverse primer (5’-
CCCGATATCGTATTCCACTCAAAATTGAAAGTTC-3’) that introduced the TC 
nucleotides missing for this clone and (3) an EcoRV restriction site that allowed substitution 
with the piece with the point mutation into the BU003176 pGEMT-vector predigested 
plasmid using the restriction site alignment.  
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The correct construct (with the TC nucleotides added) was then digested with SalI 
and NotI restriction enzymes and gel purified, and cloned into the yeast expression vector 
pRS426GAL carrying the URA3 markers.  The resultant plasmid containing the ~2.3 kbp 
gene was named pMMG11.2 and it was used to transform the EHY41 and RXY6 yeast 
strains; however, it did not show any sign of cyclase expression in either strain. This result 
shows some similarities to the case of AlyPEN8, but in the case of pGCF18.5 there is 
evidence (in the form of ESTs) of the presence of this OSC in the plant. Other possibilities 
for lack of expression in yeast could be that this particular OSC is susceptible to yeast 
proteases. At this point, efforts were abandoned to express pGCF18.5 from L. serriola 
(pMMG11.2). Instead, plasmid pMMG12.3 was constructed from an EST (DW077158) of 
L. perennis to      
 
5.2.2.2 Yeast Strain Construction for the Plasmids pGCF14.3, pGCF15.3,  
pGCF16.9, pGCF17.6 and pGCF19.6 
 
The plasmids listed below in Table 5.2 were used to transform Saccharomyces 
cerevisiae strain RXY6. RXY6 transformants were selected on synthetic complete medium 
lacking uracil, solidified with 1.5% agar, and supplemented with 2% glucose, 13 mg/L 
hemin chloride, 20 mg/L ergosterol, and 5 g/L Tween 80.  
In vitro expression of pGCF14.3 (tirucalla-8,24-dien-3-ol synthase) proved to be 
challenging; it was repeated numerous times, at various pH and scales, but it never 
produced meaningful amounts of products. The effort of providing a product profile using 
in vitro expression was abandoned and instead I present my joint work with Matias 
Kinzurik in an effort to elucidate the product profile of this particular enzyme. 
Yeast transformation of pGCF14.3 was done by Matias Kinzurik in the strain 
EHY41 using the lithium acetate method. Further purification and analysis was done either 
under my guidance or directly by me.  
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5.2.3 In vitro and in vivo Experiments of Putative Lactuca OSCs 
 
Cyclases shown in Table 5.2 (except A and E), were previously reported by Gia 
Fazio. 1 Nevertheless, improved analytical techniques allowed me to present in this work 
an improved picture and understanding of the product profile for each one of these cyclases, 
which is important for the overall analysis of the metabolic triterpene capability of the 
Lactuca family. GC-MS data presented in Figures 5.2 to 5.4 follow the compound 
numbering presented in the results section of this chapter (Table 5.7 to 5.12). 
 
Table 5.2. Plasmids and Yeast Strains corresponding to the six expressed Lactuca OSCs 
expressed. 
 
 Plasmid 
Expression 
vector 
Yeast 
Strain 
Reported major 
products 
Organism 
A pGCF14.3 pRS426GAL EHY41 tirucalla-8,24-dien-3-ol L. serriola 
B pGCF15.3 pRS426GAL RXY6 mixed amyrin L. sativa 
C pGCF16.9 pRS426GAL RXY6 mixed taraxasterol L. serriola 
D pGCF17.6 pRS426GAL RXY6 lupeol L. serriola 
E pMMG11.2 pRS426GAL RXY6 nematocyphol  L. perennis 
F pGCF19.6 pRS426GAL RXY6 cycloartenol L. serriola 
 
Table 5.3. In vitro and in vivo experiments of Lactuca OSCs. 
 
 
Yeast Strain 
Constructs 
Culture size  pH* Cell pellet g 
Crude 
mg 
A EHY41[pGCF14.3] 4 L NA 80 200 
B RXY6[pGCF15.3] 2 L 6.2 26.3  208  
C RXY6[pGCF16.9] 2 L 7 23.74  163 
D RXY6[pGCF17.6] 4 L 6.4 53  177 
E RXY6[pMMG11.2] 2 L 7 --- --- 
F RXY6[pGCF19.6] 2 L 7 26  240 
* NA non applicable 
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Figure 5.2. A: GC-MS chromatograms of the crude extract of the 4 L EHY41[pGCF14.3] 
experiments. B: GC-MS chromatograms of the crude extract of the 2 L RXY6[pGCF15.3] 
experiments. C: GC-MS chromatograms of the crude extract of the 2 L RXY6[pGCF16.9] 
experiments. 
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Figure 5.3. D: GC-MS chromatograms of the crude extract of the 2 L RXY6[pGCF17.6] 
experiments. E: GC-MS chromatograms of the crude extract of the 2 L RXY6[pGCF19.6] 
experiments. 
 
The samples were purified by SPE (solid phase extraction). Each crude was 
dissolved in 2 mL of hexanes, and loaded onto a 5g SiO2 gel SPE column (Phenomenex). 
60 x 8 mL fractions were collected using diethyl ether (Et2O)/ hexanes gradient shown in 
Table 5.4. 
Fractions containing the triterpene alcohols and triterpene diols (usually but not 
limited to fractions 19 to 33 for triterpene alcohols and fractions 45 to 50 for triterpene 
diols) were combined to yield a combine sample of triterpene alcohols and one of triterpene 
diols (Table 5.5). These samples were used for GC-MS and NMR analysis. Proton NMR 
and HSQC spectra, were collected for these samples.  
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Combined fractions containing triterpene alcohols were subjected to small scale 
saponification to eliminate triglycerides and other impurities in order to obtain cleaner 
NMR spectra.  
 
Table 5.4. SPE elution gradient of Lactuca in vitro experiments. 
 
Fraction  
% Et2O in 
Hexanes 
Fraction  
% Et2O in 
Hexanes 
1-2 0 27-32 10% 
3-6 1% 33-38 20% 
7-12 2% 39-46 30% 
13-18 3% 47-54 50% 
19-26 5% 55-60 100% 
 
Table 5.5. Condensed analysis of Lactuca OSCs.  
 
 
Yeast Strain 
Constructs 
SPE Fx 
triterpene 
alcohols 
Weight 
mg 
SPE Fx 
triterpene 
diols 
Weight 
mg 
Saponification 
of triterpene 
alcohols Fx 
A EHY41[pGCF14.3] 22-28 10 --- --- --- 
B RXY6[pGCF15.3]  21-33 7 43-51 ~ 2 ● 
C RXY6[pGCF16.9]  22-32 5.5 
44-47 
50-51 
~ 2 
● 
D RXY6[pGCF17.6] 21-32  3.5 42-45 ~ 2 ● 
E RXY6[pMMG11.2] --- --- --- --- --- 
F RXY6[pGCF19.6] 20-33 18.8 --- --- ● 
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5.2.4 Extraction and Characterization of Lettuce Plant Tissue 
 
Lettuce tissue was harvested from two Lactuca sativa plants donated by a goat farm 
in the Houston area. In addition to this material, seeds from Lactuca sativa were purchased 
from Amazon.com in order to complete the analysis of all parts of this organism.  
The plant tissue was divided into the following categories: flowers, roots, leaves, 
stem and seeds. Each part was weighted and extracted according to Shan, H. et al.12  
Table 5.6 illustrates the final weight of fresh tissue for each part of the plant, NLSs 
after extraction, the weight of the final crude and the amount that was taken for further 
analysis, including GC-MS and NMR.   
Plant tissue was crushed using a mortar and pestle and soaked in 10 mL of 1:1 
methylene chloride/ methanol per gram of tissue for a day with gentle stirring. The 
methylene chloride in the samples was removed by rotatory evaporation, leaving behind a 
crude extract.  
After centrifugation, the methanolic extracts were saponified with 10% KOH (w/v) 
in 80% EtOH (v/v). Following saponification, the supernatant was decanted, and the 
methanol was removed by rotatory evaporation. The aqueous layer was then extracted with 
8 x 50 mL hexanes. The combined hexanes layers were concentrated to dryness by rotatory 
evaporation in a round-bottomed flask, then transferred to pre-weighted scintillation vials 
and evaporated under nitrogen. The crude non-saponifiable lipids (NSLs) were weighed 
and analyzed by GC-MS and NMR spectroscopy. Further purification was done following 
the procedures outlined in Chapter 2. 
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Figure 5.4. GC-MS chromatograms presented in this figure are those of the NSLs of 
Flowers, Roots and Leaves crude extracts from Lettuce (Lactuca sativa). 
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Figure 5.5. GC-MS chromatograms presented in this figure are those of the NSLs of Stem 
and Seeds crude extracts after saponification from Lettuce (Lactuca sativa). 
 
Table 5.6. Condensed information from plant tissue experiments.   
 
Plant part  Weight (g) 
Crude of NSLs 
(mg)  
NMR sample (mg) 
Flower 26  608  7 
Roots 65  148 12 
Leaf 66  1036 11 
Stem 120  1032 8 
Seeds 10  500 30 
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5.2.5 Extraction of Curcurbitadienol as a Standard from Watermelon Seeds 24 
 
Eight grams of watermelon seeds (Citrullus lanatus var. lanatus) were crushed with 
mortar and pestle and soaked in 100 mL of hexanes for two days with gentle stirring. The 
hexanes in the sample was removed by rotatory evaporation, leaving behind ~5 g of crude 
extract.  
8 mL of water, 32 mL of MeOH and 4 g of KOH was added to the sample (10% 
KOH (w/v) in 80% EtOH) and incubated at 70 ˚C for 3 h. Following saponification, the 
excess ethanol was removed by rotatory evaporation. The aqueous layer was then extracted 
6 x 50 mL with hexanes. The combined hexanes layers were concentrated to dryness by 
rotatory evaporation in a round-bottomed flask before being transferred to a pre-weighed 
scintillation vial and evaporated under nitrogen. The crude NSLs weighed 184 mg, and 
were analyzed by GC-MS (Figure 5.6). 
 
 
 
Figure 5.6. GC-MS chromatogram presented in this figure is of the NSLs of Watermelon 
seed crude extracts after saponification. 
 
The crude NSLs were subsequently dissolved in 2 mL of hexanes, and loaded onto 
a 5g SiO2 gel SPE column (Phenomenex). 60 x 8 mL fractions were collected using diethyl 
ether (Et2O)/ hexanes gradient (0%, 1%, 2%, 3%, 5%, 10%, 20%, 30%, 50%, and 100% 
diethyl ether). 
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Fractions containing the triterpene alcohols (Fx 25 to 31) and triterpene diols (Fx 
45 to 51) were combined to yield 4 mg of triterpene products, this sample was used for 
GC-MS and NMR analysis in order to establish the product profile of triterpene alcohols 
minor products in watermelon seeds. 
Fractions 21 to 24 were combined to get good GC-MS and NMR data for 
curcurbitadienol since that product was the major component of those fractions. 
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5.3 Results  
 
5.3.1 Manual Splicing of Genomic Sequence from Lactuca sativa: Phylogenetic     
Relationship of Lactuca sativa OSCs 
 
 
 
 
Figure 5.7. Phylogenetic tree of L. sativa OSCs derived from the initial manual splicing of 
the genome. The tree was constructed by maximum likelihood using MEGA version 6.11 
Multiple sequence alignments were generated in MegAlign from amino acid sequences 
with Clustal W Method using default parameters. After experimental analysis, the gene in 
blue turned out to be a mixed amyrin synthase.  
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Extensive analysis of genomic sequence from the Lactuca sativa genome generated 
17 putative OSCs. As explained in the experimental section of Chapter 5, each cyclase was 
manually spliced using as a guide either available ESTs from Lettuce 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi), or Lactuca serriola OSCs sequences that were 
assembled by Fazio.1 
After manual splicing, each putative OSC was analyzed by comparing a protein 
query versus translated sequence (tBLASTn). This search was performed against 
nucleotide collections, “Asterids” database, each query was covered 99%.  
Figures 5.7 and 5.8 show the phylogenetic results and the active site sequence 
alignment for the various putative OSCs of L.sativa. 
 
 
 
Figure 5.8. Comparison of active-site residues in human LAS42 and corresponding residues 
of Lactuca sativa OSCs.  
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5.3.2 In vivo and in vitro Product Profile of Lactuca OSCs from Lactuca sativa and 
Lactuca serriola 
 
5.3.2.1 In vivo Product Profile of Tirucalla-8,24-dien-3-ol Synthase  
 
Tirucalla-8,24-dien-3-ol synthase (BU000828) from L. serriola was named after 
its major product (1).  This gene was cloned by Gia Fazio; Caroline V. McNeil and Jazmin 
Godoy performed heterologous expression of this cyclase, so they provided a preliminary 
product profile from which the foundation presented in this document comes from. 
In this work, I present preliminary results of the in vivo product profile of this 
enzyme. Tirucalla-8,24-dien-3-ol account for 70% of the total of products that this 
enzyme can make.  In addition to tirucalla-8,24-dien-3-ol (1), this cyclase makes at least 
3 other triterpene alcohols, and 8% of other minor products.  
The enzyme mechanism and product profile are presented in Scheme 5.1 and a 
summary of its products is presented in Table 5.7. 
Product profiles of triterpene alcohols were determined as described by Castillo et 
al.56 Ratios for the triterpene-monoalcohols were determined using HSQC spectrum of 
EHY41[pMMG14.3] Fractions 22-28.  
 
Table 5.7. Summary of analytical evidence for tirucalla-8,24-dien-3-ol synthase products 
identified in the 4 L in vivo experiment.  
 
Product Product # GC-MS*  
NMR 
Evidence 
Reference 
tirucalla-8,24-dien-3-ol 1 A HSQC, 1D 13 
tirucalla-7,24-dien-3-ol 2 A HSQC, 1D 14 
isotirucallol 3 A HSQC, 1D 15 
20S-dammara-12,24-dienol  4 A HSQC, 1D 16 
* 
GC-MS evidence using Method A, Chapter 2.
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Scheme 5.1. Mechanism of the formation of L. serriola tirucalla-8,24-dien-3-ol synthase 
products.  
 
5.3.2.2 In vitro Product Profile of Mixed Amyrin Synthase  
 
L. sativa mixed amyrin synthase (BQ869693) was cloned by Gia Fazio.1 This 
cyclase was inadvertently reported as giving a 3:1 ratio of β-amyrin to α-amyrin, along 
with 7 minor products. In this work, I report that this enzyme makes a 3:1 ratio of α-amyrin 
to β-amyrin as well as 19 minor products. The product profile of this enzyme has a variety 
of tetra and pentacycles that include dammarenes, lupanes, ursanes and oleananes; however, 
it clearly favors the mechanistic pathway to ursanes.   
The enzyme mechanism and product profile are presented in Table 5.8 and Scheme 
5.2. As with all cyclases in this work, product profiles were determined as described in 
Chapter 3. Ratios for the triterpene-monoalcohols and diols were determined using an 
HSQC spectrum of RXY6[pGCF15.3] Fractions 21-33.  
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Table 5.8. Summary of analytical evidence for L. sativa mixed amyrin synthase products 
identified in the 2 L in vitro experiment.  
 
Product Product # GC-MS*  
NMR 
Evidence 
Reference 
α-amyrin 1 A HSQC, 1D 17 
β-amyrin 2 A HSQC, 1D 18 
dammara-20,24-dienol 3 A HSQC, 1D 19 
ψ-taraxasterol 4 A HSQC, 1D 20 
tirucalla-7,24-dien-3-ol 5 A HSQC, 1D 14 
(20S)-dammarenediol 6 A HSQC, 1D 21 
butyrospermol 7 A HSQC, 1D 19 
taraxasterol 8 A HSQC, 1D 20 
(20R)-dammarenediol 9 A HSQC, 1D 21 
lupeol 10 A HSQC, 1D 22 
δ-amyrin 11 A HSQC, 1D 23 
isoursenol 12 A HSQC, 1D 24 
nematocyphol 13 A HSQC, 1D 25 
isobauerenol 14 A HSQC, 1D 26 
bauerenol 15 A HSQC, 1D 27 
isotirucallol 16 A HSQC, 1D 15 
taraxerol 17 A HSQC, 1D 28 
germanicol 18 A HSQC, 1D 29 
lupane-3,20-diol 19 A HSQC, 1D 30 
(20R/S) -taraxastanediol 20 A HSQC, 1D 31 
multiflorenol  21 A HSQC, 1D 32 
* GC-MS evidence using Method A, Chapter 2. 
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Scheme 5.2. Mechanism of the formation of L. sativa mixed amyrin synthase products. 
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5.3.2.3 In vitro Product Profile of Mixed Taraxasterol Synthase  
 
L. serriola mixed taraxasterol synthase (BQ997802) was cloned by Gia Fazio,1 but 
the product profile has not been previously reported. This enzyme makes roughly a 1:1 
ratio of taraxasterol to ψ-taraxasterol and at least 15 other minor products. The mechanism 
for this enzyme and product profile ratios are presented in Table 5.9 and Scheme 5.3. 
Product profiles were determined as described in Chapter 3. Ratios for the triterpene-
monoalcohols and diols were determined using an HSQC spectrum of RXY6[pGCF16.9] 
Fractions 22-32.  
 
Table 5.9. Table summary of analytical evidence for L. serriola mixed taraxasterol 
synthase products identified in the 2 L in vitro experiment. 
 
Product Product # GC-MS*  
NMR 
Evidence 
Reference 
taraxasterol 1 A HSQC, 1D 20 
ψ-taraxasterol 2 A HSQC, 1D 20 
(20S)-dammarenediol 3 A HSQC, 1D 21 
β-amyrin 4 A HSQC, 1D 18 
α-amyrin 5 A HSQC, 1D 17 
butyrospermol 6 A HSQC, 1D 19 
(20R)-dammarenediol 7 A HSQC, 1D 21 
lupeol 8 A HSQC, 1D 22 
tirucalla-7,24-dien-3-ol 9 A HSQC, 1D 14 
δ-amyrin 10 A HSQC, 1D 23 
lupane-3,20-diol 11 A HSQC, 1D 30 
nematocyphol 12 A HSQC, 1D 25 
bauerenol 13 A HSQC, 1D 27 
isotirucallol 14 A HSQC, 1D 15 
isoursenol 15 A HSQC, 1D 24 
isobauerenol 16 A HSQC, 1D 26 
dammara-20,24-dienol 17 A HSQC, 1D 19 
* GC-MS evidence using Method A, Chapter 2. 
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Scheme 5.3. Mechanism of the formation of L. serriola mixed taraxasterol synthase 
products. 
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5.3.2.4 In vitro Product Profile of Lupeol Synthase  
 
L. serriola lupeol synthase (BU003435) is 92% identical to the Taraxacum lupeol 
synthase. Gia Fazio1 was the first one to clone this enzyme and reported its product profile. 
She reported 6 compounds including lupeol (93%), -amyrin (4.8%), butyrospermol 
(0.8%), and taraxasterol (0.1%). My new analysis of the product profile revealed a total of 
ten compounds including germanicol, lupane-3β,20-diol, tirucalla-8,24-dien-3-ol, 
tirucalla-7,24-dien-3-ol and nematocyphol.  
The product profile ratios and mechanism of formation are presented in Table 5.10 
and Scheme 5.4. Product profiles were determined as described in Chapter 3. Ratios for 
the triterpene monoalcohols and diols were determined using the HSQC spectrum of 
RXY6[pGCF17.6] Fractions 21-32.  
 
Table 5.10. Table summary of analytical evidence for L. serriola lupeol synthase products 
identified in the 2 L in vitro experiment.  
 
Product Product # GC-MS*  
NMR 
Evidence 
Ref 
lupeol 1 A HSQC, 1D 22 
lupane-3,20-diol 2 A HSQC, 1D 30 
butyrospermol 3 A HSQC, 1D 19 
β-amyrin 4 A HSQC, 1D 18 
germanicol 5 A HSQC, 1D 29 
tirucalla-8,24-dien-3-ol 6 A HSQC, 1D 13 
tirucalla-7,24-dien-3-ol 7 A HSQC, 1D 14 
nematocyphol 8 A HSQC, 1D 25 
dammara-20,24-dienol 9 A HSQC, 1D 19 
taraxasterol 10 A HSQC, 1D 20 
* GC-MS evidence using Method A, Chapter 2. 
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Scheme 5.4. Mechanism of the formation of L. serriola lupeol synthase products. 
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5.3.2.5 In vitro Product Profile of Cycloartenol Synthase  
 
L. serriola cycloartenol synthase (BU008606) was first characterized by Gia 
Fazio.1 Within the product profile described in her thesis, she reported as major product 
cycloartenol (87.8%) and parkeol (12.2%). Although this enzyme is in fact a cycloartenol 
synthase, the product profile reported previously was inaccurate. Table 5.11 and  Scheme 
5.5 show that cycloartenol accounts for 98.7% of the total of triterpene alcohols that this 
enzyme can make, followed by 1% parkeol, 0.2% lanosterol and lastly <0.1% 
curcurbitadienol.  
Product profiles were determined as described in Chapter 3. Ratios for the 
triterpene-monoalcohols were determined using HSQC spectrum of RXY6[pGCF19.6] 
Fractions 20-33. 
 
 
 
Scheme 5.5. Mechanism of the formation of L. serriola cycloartenol synthase products. 
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Table 5.11. Summary of analytical evidence for L. serriola cycloartenol synthase products 
identified in the 2 L in vitro experiment.  
 
Product Product # GC-MS*  
NMR 
Evidence 
Ref 
cycloartenol 1 A HSQC, 1D 33 
parkeol 2 A HSQC, 1D 34 
lanosterol 3 A HSQC, 1D 35 
curcurbitadienol 4 A HSQC, 1D 36 
* GC-MS evidence using Method A, Chapter 2. 
 
5.3.2.6 Lactuca Plant Extracts Analysis and Curcurbitadienol from Watermelon 
Seeds Extracts 
 
Table 5.12 and Scheme 5.6 have a detailed summary of the triterpene alcohols 
found in L. sativa. Figure 5.9 gives details for the GC-MS and NMR information used to 
characterize curcurbitadienol that helped to identify this compound as a minor product of 
L. serriola cycloartenol synthase (BU008606).   
 
Table 5.12. Table summaries of names, numbering and analytical evidence for compounds 
found in lettuce plant extracts.  
 
Product Product # GC-MS*  
NMR 
Evidence 
Ref 
taraxasterol 1 A HSQC 20 
germanicol 2 A HSQC, 1D 29 
lupeol 3 A HSQC, 1D 22 
β-amyrin 4 A HSQC, 1D 18 
ψ-taraxasterol 5 A HSQC, 1D 20 
α-amyrin 6 A HSQC, 1D 17 
bauerenol 7 A HSQC, 1D 27 
butyrospermol 8 A HSQC, 1D 19 
tirucalla-7,24-dien-3-ol 9 A HSQC, 1D 14 
lupane-3β,20-diol 10 A HSQC, 1D 30 
δ-amyrin 11 A HSQC, 1D 23 
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cycloartenol 12 A HSQC, 1D 33 
multiflorenol  13 A HSQC, 1D 32 
nematocyphol 14 A HSQC, 1D 25 
(20R/S) -taraxastanediol 15 A HSQC, 1D 31 
cucurbitadielnol 16 A HSQC, 1D 36 
isoursenol 17 A HSQC, 1D 24 
parkeol 18 A HSQC, 1D 34 
taraxerol 19 A HSQC, 1D 28 
euphol 20 A HSQC, 1D 37 
tarolupenol 21 A HSQC, 1D 38 
boeticol 22 A HSQC, 1D 39 
∆8(26)-polypodatetraenol-9βH 23 A HSQC, 1D 40 
achilleol A 24 A HSQC, 1D 41 
* GC-MS evidence using Method A, Chapter 2. 
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Scheme 5.6. Summary of the products found in the plant extracts of the various parts of 
lettuce.  
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Figure 5.11 Analytical evidence of curcurbitadienol in watermelon seeds.  
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5.4 Discussion 
 
 
 
Figure 5.12. Molecular phylogenetic tree of Lactuca sativa OSCs found by manual 
splicing of the genome. Genes within the β-amyrin, germanicol synthase clade and 
dammarenediol synthase are considered putative. The tree was constructed by maximum 
likelihood using MEGA version 6.11 Multiple sequence alignments were generated in 
MegAlign from amino acid sequences with Clustal W Method using default parameters. 
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5.4.1 CAS Clade 
 
L. sativa seems to have two putative cycloartenol synthases (Figure 5.8, Figure 
5.12), Lsa038838 and Lsa002193. Lsa038838 is not only 99% identical to L. serriola 
cycloartenol synthase  (BU008606) but the putative active site sequence alignment is 100% 
conserved, which means that this is the possible ortholog of the cycloartenol synthase 
studied in this chapter.  
On the other hand, Lsa002193 is only 90% similar to L. serriola CAS1 and the 
active site residues show two substitutions (Leu98Tyr and Leu702Ile) with respect to L. 
serriola cycloartenol synthase. Both amino acids are located near the B ring, where the C-
9 cationic intermediate could be potentially deprotonated to cycloartenol, parkeol, 
lanosterol or curcurbitadienol. 
In an article published in May of 2015, Kushiro and co-workers43 described how a 
single point mutation (Leu125Tyr) of curcurbitadienol synthase (CBS) from Cucurbita 
pepo, converted the cyclase into a parkeol synthase. The Leu to Tyr mutation seems to 
prevent the formation of the cyclopropyl ring characteristic of cycloartenol due to possible 
steric hindrance from the large amino acid side chain of Tyr; it also seems to be involved 
in the prevention of further rearrangement to yield curcurbitadienol, instead it prefers 
deprotonation to yield the ∆9(11) double bond characteristic of parkeol. 
Alignment of curcurbitadienol synthase from Cucurbita pepo and Lsa002193 from 
Lactuca sativa revealed that Leu98Tyr corresponds to Leu125Tyr from Takase et. al.43, 
thus showing that Lsa002193 could be a putative parkeol synthase from L. sativa. Further 
evidence for the presence of a putative parkeol synthase among the OSCs in L. sativa is 
provided by the unusual amount of parkeol in the lettuce plant extracts (Scheme 5.6). 
Parkeol is one of the minor products of the cycloartenol synthase (BU008606) from L. 
serriola, however the amount of parkeol made by this enzyme does not account for the 
amounts of parkeol that are reported in the different lettuce plant extracts. Parkeol is often 
isolated as a minor cyclization product in cycloartenol and lanosterol synthases; 16 however, 
sea cucumbers further metabolize this compound to saponins.44 Saponins are known to 
confer protection against microbes and other predators.45 Even though the role of parkeol 
is unknown in lettuce, it may be involved in plant defense against external factors.  
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5.4.2 Lanosterol Synthase 
 
Lsa015654 is an OSC from L. sativa that could encode for a putative lanosterol 
synthase. The analysis of the amino acids of the active site, and the overall sequence 
identity with respect to A. thaliana LSS146 and A. lyrata LSS1 revealed that Lsa015654 
has an almost identical active site alignment, except for position 233 in where Lsa015654 
has a Thr instead of Cys characteristic of the Arabidopsis genus. The overall amino acid 
sequence identity when compared to two lanosterol synthases from the rosids clade 
(AlyLSS and AthLSS) is 66%. Although this is low identity in comparison with other pairs 
of orthologs in this work, enzymes like lanosterol synthases across species have overall 
low sequence identity and still make lanosterol as the major product.16 
Lanosterol biosynthesis in plants seems to be part of the biosynthesis of polar 
metabolites that are involved in signaling and defense.48 In Euphorbia species, lanosterol 
and lanosterol oligosaccharides have been detected in low amounts; it is speculated that the 
role of lanosterol synthase in plants is related to the biosynthesis of phytosterols, which 
provide assistance in plant growth and development.49 
 
5.4.3 β-amyrin Synthase Clade and Putative Germanicol Synthase 
 
The phylogenetic tree in Figure 5.12 groups seven putative OSCs from Lactuca 
sativa. Due to the high sequence identity of these OSCs to β-amyrin synthases from asterids, 
this clade is called: β-amyrin clade.  
Out of these seven genes, Lsa072965 is the best candidate to be a β-amyrin synthase 
since it shares 90% sequence identity to β-amyrin synthases from Olea europea, 
Taraxacum officinale and Artemisia annua. 50 On the other hand, Lsa042272, Lsa004879, 
Lsa04880 and Lsa022126 identities are only in the high 60s to low 70s, making it more 
difficult to hypothesize which type of cyclases this group could encode.  
Results from plant extracts show that butyrospermol is a compound well distributed 
among lettuce plant parts; however it is present in high amounts (27% of triterpenes) in 
seeds (as shown in Scheme 5.6 and Table 5.12), suggesting a possible butyrospermol 
synthase among the OSCs whose product profiles have not been determined. 
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Lastly, Lsa004866 and Lsa004866b are genes that seem to have arisen from gene 
duplication within the genome (paralogs). DNA analysis and blast searching revealed that 
these genes are 92% identical, and their active site sequences differ only at positions 236 
and 337. They are within the clade that has the lowest amount of characterized cyclases 
(orthologs or otherwise) and they are the pair that has highest sequence identity to the 
known germanicol synthase from Rhizophora stylosa 51 (75% for Lsa004866b and 77% for 
Lsa004866). Further evidence that Lactuca sativa might have one or two germanicol 
synthases is that germanicol is the second major compound (bes -amyrin) 
accumulating widely in different parts of the lettuce plant (Scheme 5.7). 
 
5.4.4 Putative Dammarenediol Synthase and Nematocyphol Synthase Orthology 
 
Lsa001562 (BQ869693) is a mixed amyrin synthase whose product profile and 
phylogeny will be discussed in more depth later on. The rest of the cyclases in this clade 
have been expressed and characterized by Fazio and by myself in the closest 
organism L. serriola (Figure 5.14 and Figure 5.15).  
Each pair of orthologs shows a 99% sequence identity, as well as 100% active site 
sequence identity. This high level of homology could be explained by the fact that 
cultivated Lactuca species are highly inbred,52 in order to retain certain traits like tastes 
and pathogen resistance from L. serriola.53 
The only two genes from this clade that are not characterized in either L. sativa or 
L. serriola are Lsa001068 and Lsa005683.  
Lsa031918 and Lsa001068 are grouped as putative nematocyphol synthases 
(Figure 5.12, Figure 5.13), Lsa031918 has higher sequence homology (95%) than 
Lsa001068 (83%) to the L. perennis nematocyphol synthase from Chapter 4. It is more 
likely that Lsa031918 is the nematocyphol synthase ortholog in L. sativa. 
Lsa005683 might be a dammarenediol synthase since its closest homolog of 
Lsa005683 within the asterids clade is Panax notoginseng dammarenediol synthase (77% 
sequence indentity).54 
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Figure 5.13. Comparison of active site residues of NEM putative orthologs. 
 
 
 
Figure 5.14. Comparison of active-site residues in human LSS42 and corresponding 
residues of Lactuca OSCs from L. sativa, L. serriola and L. perennis.  
 
145 
 
 
 
Figure 5.15. Molecular phylogenetic tree of Lactuca OSCs. Expressed OSCs from the 
Lactuca family (L.sativa or L. serriola) are the ones preceded by the name in black. The 
tree was constructed by maximum likelihood using MEGA version 6.11 Multiple sequence 
alignments were generated in MegAlign from amino acid sequences with Clustal W 
Method using default parameters. 
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5.4.5 Tirucalla-8,24-dien-3-ol Synthase from Lactuca serriola 
 
Tirucalla-8,24-dien-3-ol synthase from Lactuca serriola is 99.7% identical to its 
ortholog in Lactuca sativa, and the active site amino acids are the same. Phylogenetic 
comparison of this pair of these orthologs indicates that L. sativa also has a tirucalla-8,24-
dien-3-ol synthase, with a very similar product profile. 
Within the asterids clade, this is the first ever described tirucalla-8,24-dien-3-ol 
synthase. Early work from Jazmin Godoy and Caroline McNeil supports the product profile 
described in the results section of Chapter 5. This OSC was the only enzyme that did not 
performed well during in vitro expression, for this reason only preliminary in vivo results 
are presented in this work. 
The product profile for this enzyme includes tirucalla-8,24-dien-3-ol 1 (70%), 
tirucalla-7,24-dien-3-ol 2 (15%), isotirucallol 3 (5%), (20S)-dammara-12,24-dienol 4 
(2%) and a mixture of unknown minor products that account for the remaning 8% of total 
products. All the products made by this enzyme are 20S tetracyclic epimers that arise from 
II with the side chain syn to C-16 when 17α-H migrates or side chain anti to C-16 when 
17β-H migrates.55 
The other known characterized enzyme that makes predominantly 20S dammaranes 
is AthLUP5, whose major product is tirucalla-7,24-dien-3-ol.16,56 Classification of 
product accuracy (Figure 5.16) for tirucalla-8,24-dien-3-ol synthase places this enzyme 
in the moderately accurate category (P1/P2: 4.5 / P1/∑Pi: 0.7), whereas A. thaliana LUP5 is 
a non-product-specific cyclase (P1/P2: 1.1/ P1/∑Pi: 0.36) or multifunctional cyclase.16 The 
sequence identity between these two enzymes from distant clades is only 53%, and several 
active site residues are different. Analysis of the plant extracts does not show any tirucalla-
8,24-dien-3-ol present in the plant, so the specific role of this cyclase in Lactuca is 
unknown.  
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Figure 5.16. Classification of the characterize OSC from Lactuca genus by its accuracy. 
P1/∑Pi is the ratio of the major product to the total amount of products; P1/P2 is the ratio of 
the major product to the second most abundant product. 
 
5.4.6 Mixed Amyrin Synthase from Lactuca sativa 
 
This mixed amyrin synthase (BQ869693) was previously reported by Gia Fazio, 
and it is the only cyclase from the L. sativa family for which the product profile has been 
characterized. While Gia Fazio1 reported a 3:1 ratio β-amyrin to α-amyrin and seven other 
minor products, a decade of improvement in our analytical techniques provided a more 
detailed product profile: 3:1 ratio of α-amyrin to β-amyrin (~80% of total products), with 
minor compounds that include dammaranes, lupanes, ursanes and oleanes.  
Cyclization starts by converting OS into the dammarenyl cationic intermediate II. 
Cation quenching by water at C20 yields (20S)-dammarenediol 6 (2.3%), (20R)-
dammarenediol 9 (0.7%). Direct deprotonation of II without rearrangement gives 
dammara-20,24-dienol 3 (5.3%). The remaining 91.7% of the material undergoes a series 
of hydrogen and methyl 1,2-shifts (III and IV) followed by hydride elimination to yield 
isotirucallol 16 (0.1%), tirucalla-7,24-dien-3-ol 5 (2.8%) and butyrospermol 7 (0.8%).  
Then the remaining 88% of the material undergoes D-ring expansion followed by 
E-ring closure to give the lupanyl cation V. Direct deprotonation of V without 
rearrangement provides lupeol 10 (0.6%), and water quenching of the C20 cation forms 
lupane-3β,20-diol 18 (<0.1%). After a series of 1,2-shifts, deprotonation from V generates 
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nematocyphol  13 (0.2%). The material that is lost en route to the formation of lupane 
skeletons is less than 1% of the total.  
This enzyme favors formation of oleanes and ursanes; 87.1% of the material will 
convert from V to the cationic intermediate VII by E-ring expansion. Direct deprotonation 
of germanicyl cation VII yields germanicol 18 (<1%), and 19.7% of the material undergoes 
a series of 1,2-shifts followed by deprotonation to generate δ-amyrin 11 (0.6%), 
multiflorenol 21 (<0.1%), taraxerol 17 (<0.1%) and β-amyrin 2 (19.1%). 
En route to the formation of ursane type compounds, 5.1% of the material will 
rearrange from the germanicyl cation VII to XII. Proton elimination from the newly 
formed taraxastyl cation XII yields taraxasterol 8, ψ–taraxasterol 4 and 3β(20)R/S-
taraxastanediol 20, which are made in 0.7%, 4.2% and <1% amounts, respectively.  
    On the other hand, when VII rearranges to the ursanyl cation XIII, a series of 
1,2-shift and proton eliminations give the major product α-amyrin 1 (61.7%), isoursenol 
12 (0.2%), baurenol 15 (0.1%) and isobauerenol 14 (0.1%). The ursane type compounds 
that derived from XIII, account for 62.1% of the total products. En route to 1, little material 
is lost to due to formation of  minor products, which suggests that once the enzyme makes 
the taraxasteryl cation, it is good at controlling formation of 1 without a significant lost to 
minor “mistakes”. 
A refined product profile of this enzyme allows placing it in the accuracy 
continuum shown in Figure 5.16. The values for accuracy classification are P1/P2: 3.22 and 
P1/∑Pi: 0.61; classification following Paul Bodager16 places this enzyme close to the 
moderately product-specific category.   
Analysis of extracts of different parts of lettuce (Scheme 5.6) shows that in L. sativa, 
β-amyrin is present in a higher level than α-amyrin, approximately in a 2:1 ratio. Clearly 
other cyclases are responsible for the abundance of β-amyrin in lettuce. In the results 
section it was suggested that lettuce could have a cyclase that makes β-amyrin as a major 
product; this would explain in part the ratio discrepancy between enzymatic product profile 
and plant extracts results or -amyrin could be metabolize by the plant. 
Even though this might be the first example of an asterid OSC that makes 
predominantly amyrin products, there is only one other characterized mixed amyrin 
synthase from the rosids clade. Pisum sativum cyclase makes a 3:2 ratio of α-amyrin to β-
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amyrin,57 accompanied by several other minor byproducts. However, sequence identity 
with our cyclase is only 60%. This cyclase is a nice example of parallel evolution of mixed 
amyrin synthases in distant clades.   
 
5.4.7 Mixed Taraxasterol Synthase from Lactuca serriola 
 
Taraxasterol and ψ-taraxasterol20 are known compounds that are present as minor 
products in A. thaliana. Mixed taraxasterol synthase (BQ997802) from L. serriola is the 
first example of an enzyme that synthesizes this compound in a 1:1 ratio and as major 
products. The complete profile includes 15 minor products. The phylogenetic tree shows 
that this cyclase shares a common ancestor with NEM, mixed amyrin synthase and 
tirucallol synthase; it is grouped in a separate branch along with its homolog in L. sativa 
(Figure 5.12 and 5.15). Mixed taraxasterol synthase from L. sativa and the expressed clone 
from L. serriola are 99.6% identical and have the same amino acid sequence for the active 
site.  
Plant extracts show that both compounds are predominant in all the parts of the 
lettuce plant and the ratios are quite close to the ones found in this cyclase, discrepancies 
could be accounted for by contributions of minor amounts of taraxasterols from other OSCs.  
The mechanism of formation of the product profile of this multifunctional cyclase 
(Table 5.9 and Scheme 5.3) starts by cyclization of oxidosqualene to the 6-6-6-5 
dammarenyl cation II. Twenty percent of the material is lost to the formation of (20S)-
dammarenediol 3 (19.5%), (20R)-dammarenediol 7 (1.3%) and dammara-20,24-dienol 17 
(<0.1%); these pathways involve addition of a hydroxyl group at C20 or direct 
deprotonation of II without rearrangement.  
Around 2.5% of the total is converted to tetracyclic products following a series of 
hydride and methyl 1,2-shifts via III and IV to form isotirucallol (14), tirucalla-7,24-dien-
3-ol (9) and butyrospermol (6) at levels of 0.1%, 1.3% and 1.1%. The remaining 77.7% 
goes into D-ring expansion followed by E-ring closure and gives the lupanyl cation V.  
En route to the formation of taraxastane, ursane and oleane skeletons, only 0.6% of 
the material is converted to lupanes via rearrangement or water addition to the C20 of V. 
The results are lupeol 8 (0.2%), lupane-3β,20-diol 11 (0.2%) and nematocyphol 12 (0.2%).  
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Germanicyl cation VII (77.1%) arises from E-ring expansion of V; less than one 
third of the material rearranges to form the oleanyl cation VIII, the rest forming X (59.4%) 
in route to the major product 1 or to VIII, which will rearrange to β-amyrin 4 (15.4%) and 
δ-amyrin 10 (0.1%). 
Deprotonation of the taraxastyl cation X (59.4%) yields taraxasterol 1 (30%) and 
ψ–taraxasterol 2 (27.4%). A small portion of X (2.2%) undergoes three 1,2-hydride shifts 
via XI to form the ursanyl cation XII, which is either directly deprotonated to α-amyrin 5 
(2%) or undergoes further rearrangement to isoursenol 15 (<0.1%), baurenol 13 (0.2%) and 
isobauerenol 16 (0.1%).  P1/P2 and P1/∑Pi values place this enzyme in the non- product-
specific category. The four structurally diverse major products, Taraxasterol, -
taraxasterol, (20S)-dammarenediol, and -amyrin (30:27:20:15 ratio) comprise 92% of 
total products. The diverse structures might provide some kind of shotgun defense;  
taraxasterol has anti-inflamatory properties in human cell culture.58 
 
5.4.8 Lupeol Synthase from Lactuca serriola 
 
Lupeol synthase from L. serriola was previously described by Gia Fazio1, who 
identified six products and four unknowns. This work identifies the minor unknowns and 
also analyzes the phylogenetic relationship of this cyclase within the L. sativa genome. 
This OSC is 99.5% identical to the L. sativa putative lupeol synthase ortholog. Alignment 
of the amino acids that are believed to be involved in catalysis shows that their active site 
is 100% identical. This high level of homology suggests very similar product profiles.   
Lupeol synthase (BU003435) falls within the category of accurate lupeol synthases 
(P1/P2: 47.3 P1/∑Pi: 0.95) and is 92% identical to another accurate lupeol synthase59 from 
Taraxacum officinale (Asteraceae family). Other accurate lupeol synthases in asterids 
isolated from Olea europaea59 and Betula platyphylla60 also show ≥76% identity with 
BU003435. No OSC in A. thaliana makes more than ca. 20% lupeol, although the 
literature55 might suggest higher amounts.  
Lupeol has been shown to be the dominant component of the epicuticular wax of 
the castor bean Ricinus communis.61 In animal tests lupeol shows anti-cancer62 and anti-
malarial63 capabilities as well as activity as a hepatoprotectant,64 and oxidized forms of 
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lupeol can have potent bioactivities. The role of lupeol or its metabolites in Lactuca 
remains to be explored. 
As shown in Scheme 5.4, BU003435 cyclizes oxidosqualene to the dammarenyl 
cation II, 2% of which will form tetracycles: dammara-20,24-dienol 9 (0.1%), tirucalla-
8,24-dien-3-ol 6 (0.2%), tirucalla-7,24-dien-3-ol 7 (0.2%) and butyrospermol (1.5%) 3. 
The remaining 98% undergoes D-ring expansion and E-ring closure to give the lupanyl 
cation V, which is mainly deprotonated to lupeol 1 (95%). Rearrangement of V by 1,2-
shifts gives nematocyphol 7 (0.1%), and water addition to V gives lupane-3β,20-diol 2 
(1.6%).  The remainder of V (<2%) undergoes E-ring expansion and 1,2-shifts to give 
mainly β-amyrin 4 (0.9%), taraxasterol 10 (<0.1%) and germanicol 5 (0.3%). 
 
5.4.9 Cycloartenol Synthase from Lactuca serriola 
 
The last cyclase to be discussed in this work is involved in plant primary 
metabolism. As shown in Scheme 5.5, L. serriola cycloartenol synthase (BU008606) 
cyclizes oxidosqualene to cycloartenol 1 (98.7%), and other 3 minor products originating 
from the protostery cation I.  
Cation I arises from oxidosqualene cyclization via chair-boat-chair intermediates, 
instead of the chair-chair-chair cations of secondary metabolism). Then a cascade of 1,2-
hydride and methyl shifts generates the lanosteryl cation III, from which C9 deprotonation 
gives lanosterol 3 (0.2%). Another hydride shift gives cation IV, which is deprotonated at 
C11 to parkeol 2 (1%) or cyclized with deprotonation to cycloartenol 1 (98.7%). A trace 
of IV undergoes further 1,2-shifts to cation V, which is deprotonated to curcurbitadienol 4 
(<0.1%).   
L. serriola cycloartenol synthase is 99.7% identical to its L. sativa ortholog and 
they share the same active site alignment. The cycloartenol synthase from A. thaliana, is 
only ~80% identical to the Lactuca cycloartenol synthases, however the active site is 100% 
identical.  
Paul Bodager,16 performed an extensive analysis on OSCs from primary 
metabolism, and while he found as a minor product curcurbitadienol in human lanosterol 
synthase and cow lanosterol synthase. He did not find any curcurbitadienol from A. 
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thaliana cycloartenol synthase, the only plant OSC that he analyzed but did identify 
curcurbitadienol as a minor product of other OSCs. He also showed that primary 
metabolism in plant, animals and fungi can tolerate OSCs that make up to around 1% total 
byproducts, while maintaining efficient production of essential sterol precursors.  
 
5.5 Genome Mining to Elucidate the Triterpene Biosynthetic Capability of the 
Lactuca Clade  
 
The availability of the genome of an organism presents the opportunity to obtain a 
complete picture of the genes involved in secondary metabolism. In the study of OSCs, the 
accessibility of other plant genomes opens up the possibility to explore differences and 
similarities in triterpene biosynthesis across species.  A. thaliana has given a general insight 
of OSCs evolution and has provided the foundation for detailed characterization of plant 
genes.65 
The analysis of OSCs in Lactuca was significantly more challenging than the 
analysis of A. lyrata in Chapter 3. Although the experimental analysis was similar to what 
was done with Arabidopsis, the approach had to be modified as L. sativa itself might 
possibly be viewed as the model organism of the Compositae family.66,67 There was no 
previous reference work about OSCs in Lactuca beyond that carried out by Gia Fazio. 
In Chapter 5 it was shown that the L. sativa genome encodes 17 OSCs, six of which 
have characterized orthologs from the closely related organisms L. serriola and L. perennis. 
Within the Lactuca clade, differences between cyclases (both active site and sequence 
alignment) are minimal, which implies a higher level of orthology than, for example, the 
OSCs within the Brasicaceae family (Chapter 3). 
Upon sequence analysis, the Arabidopsis and Compositae clades have only one 
OSC in common, cycloartenol synthase, which is involved in primary metabolism. The rest 
of the OSCs appear to be unique to each clade even though most of the triterpene skeletons 
that have been characterized within the Rosids clade are present in Asterids clade. This is 
an example of convergent evolution in organisms that are distantly related. They 
independently evolved oxidosqualene cyclases capable of synthesizing a comparable 
triterpene product profile.  
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While enzymes in both Arabidopsis and Lactuca display the majority of the known 
triterpene skeletons as part of their product profile, it appears that the chemical solution to 
common problems is often dissimilar in different plant linages (different sets of OSCs). 
This idea is supported by the low level of orthology observed among OSCs from Rosids 
and Asterids.68 Lactuca does have a characteristic set of triterpene compounds (lupane type 
rearranged products) that have not been detected in A. thaliana. Even though the function 
of these compounds is not yet known, this unique set of secondary metabolites may be 
related to the mechanism of adaptation and defense that Lactuca developed along its 
evolution pathway.   
The analysis of OSCs in Lactuca shows that the study of OSCs in distant organisms 
still depends upon heterologous yeast expression and plant extracts. In spite of the fact that 
orthology across species seems to be conserved in enzymes involved in primary 
metabolism, this does not simply translate to secondary metabolites. The prediction of the 
existence of orthologs for secondary metabolites across species or, in particular, the 
product profile of OSCs, is more complicated than it was previously thought.  
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CHAPTER 6 
Concluding Remarks 
 
The metabolic diversity of natural products in higher plants appears to be driven 
out of their necessity to adapt and survive in different ecological environments. Among the 
vast amount of natural products found in nature, triterpenes are widely distributed across 
the plant kingdom. Triterpenes serve as precursors of essential membrane sterols in primary 
metabolism and have diverse roles in secondary metabolism, including defense and 
regulation. 
The primary route used in this work for the study of triterpene biosynthesis and the 
discovery of novel OSCs uses genome mining strategies, where the availability of plant 
genomes and cDNA libraries allows identifying and isolating putative OSCs. 
In this thesis, I have explored the differences and similarities in triterpene 
biosynthesis across species from the Brasicaceae and Astereaceae families using genome 
mining. A key component of this study was the knowledge that Arabidopsis thaliana, the 
model organism for the Brasicaceae, can provide in terms of OSC evolution, giving a 
foundation for detailed characterization of plant genes.1 
Other powerful tools in the study of OSCs were the analytical methods developed 
in the course of the studying A. thaliana. Methods like GC-MS, 1H NMR and 2D NMR 
gave this study a reliable process for quantification and characterization of complex 
mixtures.2,3 
In Chapter 3 I described the role of the model organism A. thaliana in studying 
triterpene biosynthesis in the closely related species A. lyrata. The OSC analysis of A. 
lyrata was significantly easier than for A. thaliana because of the precedent established 
over the past decades in studying OSCs.4 
Genomic DNA analysis, active site comparisons and protein expression were 
applied to determine the number of cyclases present and their possible product profile. At 
the end, nine OSCs were proposed to be functional A. lyrata. Due to the high level of 
orthology with A. thaliana OSCs, it was predicted that seven of them would likely make 
the same major products as their A. thaliana counterpart. This highly reduced the need for 
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protein expression. In the case where the cyclase was unique to A. lyrata (AlyPEN9), 
protein expression was required. 
In Chapter 4, I applied the same core phylogenetic analysis and analytical 
techniques that were utilized throughout this thesis. However, the techniques used in 
studying L. perennis nematocyphol synthase (NEM) had to be adapted to suit EST mining 
strategies. With 40 products that ranged from 55% to <1%, NEM turned out to be one of 
the most product-diverse OSCs characterized by heterologous yeast expression. 
Nematocyphol, the major product, along with many minor NEM products, was found in 
the PEN6 product profiles of the Arabidopsis species described in Chapter 4. In addition, 
seven lupane type rearranged products were found for the first time to be part of the product 
profile of an OSC, including the novel compound lup-19(21)-en-3β-ol. 
Finally, Chapter 5 presented an analysis of OSCs in the genome of L. sativa and 
product profiles of several Lactuca OSCs. Several genomes from the Asteraceae family 
have been studied, but only those from lettuce, horseweed, sunflower and globe artichoke 
are available, yet not completely annotated.5 Thus the analysis of the genome in 
the Lactuca species was more challenging than in A. lyrata. The study of secondary 
metabolites by genome mining is limited in the Compositae family6 due to the lack of 
available orthologs for the cyclases present in this family. This in turn complicated the 
prediction of the putative OSCs product profiles. 
Gia Fazio6 and the work presented in this thesis utilized EST mining to characterize 
six OSCs from L.sativa, L. serriola and L. perennis. The work done in these cyclases 
showed for the first time orthology between OSCs in the Lactuca family; moreover, it 
showed that OSC orthology is much higher in Lactuca than in Arabidopsis. 
Genome mining in Arabidopsis and the Lactuca clade gave some insight into the 
similarities and differences in triterpene biosynthesis in distant organisms. The first 
variation highlighted by this study is the difference in orthology within genera. A. 
thaliana and A. lyrata, which diverged approximately 10 million years ago,7 conserved 
their primary metabolism OSC (CAS) with high sequence similarity (98%) and identical 
active site. Orthology for the rest of the OSCs that have an ortholog is in the low 90s, thus 
making product profile prediction somehow less certain than in Lactuca. In addition, the 
number of OSCs differs between species. A. thaliana has 13 characterized OSCs,4 while A. 
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lyrata only has 9 putatively functional OSCs, three of which (AlyPEN4, AlyPEN6 
and AlyPEN9) I characterized by heterologous expression in yeast. 
 The genomes of these species also show significant differences. The genome of A. 
thaliana (125-Mb) is smaller than the one for A. lyrata (207-Mb); this downsizing of the 
large ancestral polyploidal genome mirrors a persistent selection for a smaller genome in 
Brasicaceae.10 While the Arabidopsis genus displays significant sequence variation among 
OSC its orthologs, the Lactuca genus has a high level of orthology. Each pair of Lactuca 
orthologs shows a 99% sequence identity, as well as 100% active site sequence identity. 
This higher level of homology can be attributed to the younger age of Lactuca and to the 
high level of inbreeding8 of cultivated Lactuca species in order to retain certain traits like 
taste and pathogen resistance from L. serriola.9 Even with the high level of homology 
among Lactuca OSCs from different species, the analysis of OSCs and their product profile 
is still dependent on the availability of orthologous genes that were previously expressed 
(see Chapter 5). 
Finally, the idea behind this work was to investigate whether the phylogenetic 
analysis of OSCs will be sufficient to predict the catalytic outcome of an OSC. To a certain 
extent, it is safe to say that if the cyclase has an ortholog and the active site is identical then 
it is possible to predict the major product and to expect a similar product profile. Even 
when an ortholog is not available, heterologous expression is still a powerful tool for 
studying novel OSCs. Comparison between triterpene biosynthesis in different organisms 
showed that Arabidopsis and Lactuca do share a high identity in terms of triterpene 
structures made by their OSCs. However, apart from primary metabolism (CAS), they do 
not have orthologs; thus, we still depend upon heterologous protein expression to predict 
product profiles of OSCs from species to species, even with the presence of model 
organisms within the genus.  
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Appendix A 
 
A1. Triterpene Structures and Atom Numbering 
 
 
Figure A.1. Carbon atom numbering scheme used for triterpene structures. This atom 
numbering was used to describe the skeleton groups reported in this work.  
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A2. List of Abbreviations 
 
AlyPEN4 thalianol synthase 
AlyPEN6 seco--amyrin 
AlyPEN9 -amyrin synthase 
Amp ampicillin 
BLAST Basic Local Alignment Search Tool 
BSTFA N,O-bis(trimethylsilyl)trifluoroacetamide 
CAS  cycloartenol synthase 
CDCl3 chloroform  
cDNA complementary deoxyribonucleic acid 
COSYDEC F1 decoupled 1H-1H correlation spectroscopy 
DCM dichloromethane, methylene chloride 
DEPT distortionless enhancement by polarization transfer 
DEX dextrose 
DMAPP dimethylallyl pyrophosphate 
DNA deoxyribonucleic acid 
dNTP deoxyribonucleotide triphosphates 
EDTA ethylenediaminetetraacetic acid 
EI electron impact 
ERG1  squalene epoxidase 
ERG7  lanosterol synthase 
EST expressed sequence tag 
EtOH ethanol 
FPP farnesyl pyrophosphate 
GC gas chromatography, gas chromatograph 
GC-MS gas chromatography-mass spectrometry 
GCP Compositae Genome Project  
GGPP geranylgeranyl pyrophosphate 
GPP geranyl pyrophosphate 
GTAE Guanosine-Tris-acetate-EDTA 
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HMBC heteronuclear multiple bond correlation 
HPLC high performance liquid chromatography 
HSQC heteronuclear single-quantum coherence 
HSQC heteronuclear single quantum coherence 
Hsa ERG7 human lanosterol synthase 
IPA isopropanol 
IPP isopentenyl pyrophosphate 
KOH potassium hydroxide 
LB Luria-Bertani broth 
LSS lanosterol synthase 
LUP1 lupane-3β,20-diol synthase 
LUP2 b-amyrin synthase 
LUP3 camelliol C synthase 
LUP4 b-amyrin synthase 
LUP5 tirucalla-7,24-dienol 
MeOH methanol 
MS mass spectroscopy, mass spectrometer 
MSD mass selective detector 
NaOH sodium hydroxide 
NCBI National Center for Biotechnology Information 
NEM L. perennis nematocyphol synthase 
NMR nuclear magnetic resonance spectroscopy 
NOESY Nuclear Overhauser effect spectroscopy 
NSL non-saponifiable lipid 
OD600 optical density at 600 nanometers 
ORF open reading frame 
OS  2,3-oxidosqualene 
OSC oxidosqualene cyclase 
OSCs oxidosqualene cyclases 
PCR polymerase chain reaction  
PEN1 arabidiol synthase 
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PEN2 baruol synthase 
PEN3 tirucalla-7,24-dienol 
PEN4 thalianol synthase 
PEN5 marneral synthase 
PEN6 seco--amyrin synthase 
PMMA polymethylmethacrylate 
PTLC preparative TLC 
RNA ribonucleic acid 
RT room temperature 
SC synthetic complete 
SDS sodium dodecyl sulfate 
SOC Super Optimal Broth with Catabolite Repression 
SPE solid phase extraction 
SS DNA single stranded salmon sperm deoxyribonucleic acid 
TAE 40 mM tris base, 20 mM acetic acid, 1 mM EDTA 
TE8 10 mM Tris-HCl, pH8.0, 0.1 mM EDTA 
TIC total ion chromatogram 
TLC thin-layer chromatography 
T-MAS testicular meiosis activating sterol, 4,4-dimethylzymosterol 
TMS tetramethylsilane (NMR), trimethylsilyl (GC-MS) 
UV ultra-violet 
YP yeast extract + peptone 
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Appendix B 
 
B1. Arabidopsis lyrata growth conditions 
 
 
                 
 
Figure B1.1 Seeds germinated after 7 days on PNS plates. After 20 days in PNS plates, 
seedlings were transplanted into soil following standard Arabidopsis growth procedures.  
 
 
 
 
Figure B1.2. Two week’s old rosettes from the time that seedlings were move to soil. 
Rosettes ready for vernalization at 4 ºC for four weeks.  
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Figure B1.3. Fifteen days into verbalization of rosettes. The twenty day old seedlings were 
left in soil in the plant rooms for two weeks before the vernalization process started, so the 
plants could get use to the soil transplant.  
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Figure B1.4. Rosettes ready for bolting in the Arabidopsis plant rooms after four weeks in 
vernalization.   
 
 
                         
                                           
 
Figure B1.5. Plants starts to grow stem after 10 days in the Arabidopsis plant room. Three 
days after, the plants reach ~ 10 cm and start to produce flowers. 
 
171 
 
         
 
 
Figure B1.6. After two weeks from the time of bolting, flowers were collected for 
extraction. Flowers were collected daily for one week (cDNA extraction and plant extracts). 
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Figure B1.7. Four months old plants were harvested for RNA extraction and organic 
solvent extractions.  
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Appendix C 
 
C1. Primers 
 
C1.1 List of primers for RNA amplification of AlyPEN8. 
 
PEN8cDNARTPCR TTACGGACGCAGAGCTTGAG 
 
C1.2 List of primers for sequencing of DW017758 L. perennis nematocyphol synthase. 
 
T3 ATTAACCCTCACTAAAGGGA 
T7 TAATACGACTCACTATAGGG 
SP6 ATTTAGGTGACACTATAG 
426GALF AATATACCTCTATACTTTAACGTC 
DW58Rint GTAGACACATTAGTGCTTCAGCTGTAC 
 
C1.3 List of primers for sequencing and PCR amplification of L. perennis nematocyphol 
synthase. 
 
T3 ATTAACCCTCACTAAAGGGA 
T7 TAATACGACTCACTATAGGG 
426GALF AATATACCTCTATACTTTAACGTC 
pGCF18.5TCF/SalI CCCGTCGACAAAAATGTGGGAGTTAAAG 
pGCF18.5TCR CCCGATATCGTATTCCACTCAAAATTGAAAGTTC 
pGCF18.5NotI CCCGATATCGTATTCCACTCAAAATTGAAAGTTC 
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C2. Sequences 
 
C2.1 Arabidopsis lyrata putative OSCs. 
 
Expressed sequences (AlyPEN4, AlyPEN6 and AlyPEN9) contain two restriction sites, a 
poly-A, and an additional stop codon. NCBI protein reference sequence name is provided, 
however online sequences are not proofreader; sequences provided in this document are. 
 
C2.1.1 DNA sequence of XP_002883756 A. lyrata cycloartenol synthase (CAS).  
ATGTGGAAACTGAAGATCGCGGAAGGAGGTAGTCCATGGCTTAGAACCACCAATAATCACGT
CGGAAGACAGTTTTGGGAGTTCGATCCGAATCTCGGTACTCCTGAGGATCTCGCCGCCGTCG
AGGAAGCTAGGAAGTCTTTTTCAGATAACCGATTCTTGCAGAAACATAGCTCCGATCTGCTT
ATGCGCCTTCAGTTTTCAAGAGAAAATTTGATTAGCCCAGTTTTACCTCAAGTCAAAATCGA
AGATACTGATGATGTTACAGAGGAGATGGTGGAAAACACGTTAAAGAGGGGTGTAGATTTCT
ATTCAACAATACAGGCGCACGACGGGCACTGGCCAGGTGATTATGGTGGTCCTATGTTTCTT
CTCCCAGGACTGATAATTACACTCTCCATAACTGGAGCACTGAATACAGTATTGTCGGAACA
ACATAAACAAGAAATGCGCCGTTATCTCTTTAATCACCAGAATGAGGACGGAGGTTGGGGTT
TACATATTGAGGGCCCTAGCACCATGTTTGGGTCTGTGTTGAACTATGTTACTCTAAGGTTG
CTTGGAGAAGGACCTAACGATGGAGATGGAGCTATGGAGAAAGGGCGAGACTGGATACTAAA
TCATGGTGGTGCTACCAATATCACATCTTGGGGGAAAATGTGGCTATCGGTACTTGGAGCTT
TTGAATGGTCTGGAAATAACCCACTGCCACCTGAGATATGGCTTCTTCCATATTTCCTGCCA
ATTCATCCAGGAAGGATGTGGTGCCATTGTCGGATGGTGTACTTGCCGATGTCGTATTTGTA
TGGAAAAAGGTTTGTGGGTCCCATAACGTCCACTGTTTTATCACTGAGAAAGGAGCTTTTCA
CTGTACCATATCATGAAGTCAACTGGAATGAAGCACGCAACCTTTGCGCAAAGGAGGATTTA
TACTACCCACACCCACTTGTGCAAGATATTCTTTGGGCATCACTTCATAAGATTGTTGAGCC
TGTTCTGATGCGATGGCCTGGTGCAAATTTGAGAGAAAAGGCTATAAGAACCGCAATAGAAC
ATATTCATTATGAAGATGAGAATACTAGGTACATCTGCATAGGTCCCGTGAACAAGGTATTA
AATATGCTTTGCTGTTGGGTAGAGGACCCAAACTCAGAGGCTTTCAAGTTGCACCTACCAAG
AATCCATGACTTTCTCTGGCTAGCTGAAGATGGAATGAAGATGCAGGGTTATAACGGAAGTC
AGCTATGGGATACAGGTTTTGCTATTCAAGCGATTTTGGCAACTAACCTTGTCGAAGAATAT
GGGCCCGTTTTGAAAAAAGCACATTCATTTGTCAAGAATTCTCAGGTGTTAGAAGACTGTCC
TGGAGATCTGAATTACTGGTACCGCCACATTTCTAAAGGGGCTTGGCCTTTCTCAACTGCAG
ATCACGGTTGGCCCATCTCCGACTGCACCGCAGAAGGACTGAAAGCTGCTCTTTTGTTATCC
AAAGTTCCCAAAGAGATTGTTGGTGAACCAATAGATGCAAAACGGTTATATGATGCTGTTAA
TGTTATCATTTCATTACAGAATGCAGATGGAGGCCTCGCAACATATGAGCTCACCAGGTCAT
ACCCTTGGTTGGAGCTAATCAACCCAGCAGAAACCTTTGGCGATATTGTTATAGATTATCCT
TACGTAGAATGTACATCAGCTGCTATCCAAGCTTTGATATCATTCCGAAAGCTGTATCCTGG
TCATCGGAAGAAGGAAGTAGATGAGTGCATTGAGAAGGCGGTTAAGTTCATTGAATCTATTC
AAGCAGCAGATGGCTCATGGTATGGATCATGGGCTGTTTGCTTCACATATGGTACGTGGTTT
GGAGTGAAAGGGCTGGTAGCTGTTGGAAAGACATTGAAAAACTCTTCACATGTTGCCAAAGC
TTGCGAATTTCTATTGTCTAAACAACAACCTTCGGGCGGATGGGGAGAAAGCTATCTTTCAT
GTCAAGACAAGGTATATTCAAACCTTGAAGGCAACAGGTCTCATGTCGTGAATACAGCATGG
GCTATGCTCGCACTCATTGGTGCTGGGCAAGCTGAGGTAGATCAAAAACCACTAGACCGGGC
TGCAAGATACTTGATTAATGCTCAGATGGAGAATGGTGATTTTCCACAACAGGAAATAATGG
GAGTCTTCAATAGGAACTGCATGATAACATATGCTGCGTATCGAAACATTTTTCCGATATGG
GCATTGGGGGAGTACCGTTGCCAGGTATTATTGCAACAAGGAGAATGA 
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C2.1.2 DNA sequence of XP_002877385 A. lyrata lanosterol synthase (LSS). 
ATGTGGAGGTTAAAGTTATCGGAAGGAGACGAAGAGAGTGTGAATCAACATGTTGGAAGACA
GTTTTGGGAGTATGATAACCAATTTGGAACCTCTGAAGAGAGACATCACATCGCCGATCTTC
GGGGCAACTTTACTCTCAATCGGTTTTCTTCTAAGCATAGTTCTGATCTTCTCTACCGTTTT
CAGTGTTGGAAAGAGGAAGGAAAAGGAAAGGAGAGGCTTCCACAAGTGAAAGTAAAAGAGGG
GGGAGAAGGAGAGATAAATGAAGAAGTGGTGAATGTAACATTAAGAAGAAGTTTGAGATTCT
ACTCAACACTTCAATCACAAGATGGGTTTTGGCCTGGTGATTATGGTGGCCCTTTGTTTCTC
TCGCCTGCTCTGGTGATCAGCTTATATGTGACAGAAGTTTTAGACGCAACTTTAACTGCTCA
ACATCAAATGGAGATTCGTCGTTATCTCTATAACCATCAGAACAAGGATGGAGGATGGGGAC
TACACATAGAAGGGAGTAGCACCATGTTCTGTACGGCTCTCTCATACGTAGCACTAAGGCTC
ATGGGGGAAGAAATGGACGGTGGAGATGGAGCCATGGAATCAGCTAGACTTTGGATTCACCA
CCGTGGTGGTGCCACCTTTGTTCCCTCTTGGGGCAAGTTCTGGCTCTCCGTTCTTGGAGCTT
ATGAATGGAGTGGCAACAATCCTTTACCTCCAGAGCTATGGCTCCTTCCTTATAGTCTTCCA
TTTCATCCAGGCCGAATGTGGTGCCATTGTAGGATGGTTTATCTTCCAATGTCATATCTATA
CGGAAGAAGATTTGTTTGTCGCACTAATGGAACTATTTTGTCCCTTCGACGAGAGCTTTACA
CTGTTCCTTATCATCATATCGATTGGGACACGGCTCGTAATCAATGTGCCAAGGAGGACTTG
TACTATCCACATCCAAAGATTCAAGACGTTCTTTGGAGTTGTCTGAATAAATTTGGAGAGCC
TCTTCTTGAAAGATGGCCATTGAATAAGCTAAGAAGCCGGGCTCTTCAGACAGTGATGCAAC
ATATTCAATATGAAGACCAAAACAGCCACTATATTTGTATCGGTCCTGTCAATAAAGTCTTG
AATCTTCTTTGTTGTTGGGTTGATTCCTCGAATTCCGAGGCATTTAAATCTCACCTCTCGCG
TATTAAAGACTATTTATGGGTGGCTGAGGATGGAATGAAAATGCAGGGATACAACGGATCTC
AGCTGTGGGACGTGACTTTAGCGGTCCAAGCAATCTTGGCTACGAATTTGGTTGATGAGTAT
GATTTGATGCTTAAGAGAGCGCATAACTACATCAAGAACACTCAAATAAGGAAAGACACTTG
TGGAGATCCGGGGTTGTGGTACCGACACCCGTGCAAGGGAGGATGGGGTTTCTCCACCGCAG
ACAATCCATGGCCTGTTTCTGACTGTACTGCTGAAGCCTTGAAGGCGTCGTTGTTATTGTCA
CAGATACCAGTTGATTTGGTTGGAGAAGCCATGCCTGAAGAGCATTTATTTGATGCTGTTGA
CTTTATCTTATCATTACAGAACAACAATGGGGGATTTGCGTCATACGAGCTAACTAGATCAT
ATCCCGCGCTAGAGGTGATCAATCCATCAGAGACTTTTGGGGATATCATCATAGATTATCAA
TACGTAGAATGTACGTCAGCTGCAATCCAAGGTCTTGCGTTATTCACAACGATCAATCCAAC
ATACAAGAGGAAAGAGATACTAATATGCATTAACAAAGCAGTTGAGTTTATTGAAAAAACAC
AACTTCCGGATGGTTCATGGTACGGCTCGTGGGGAGTGTGTTTCACCTATGCGACATGGTTT
GGTATTAAAGGGATGTTAGCTGCTGGCAAAACATATGAGACCAGTCTTTGTATTAGAAAAGC
TTGTGGTTTCTTGCTCTCCAAACAACTTTGTTGTGGTGGGTGGGGAGAGAGCTACCTTTCTT
GCCAAAACAAAGTATACACCAATCTTCCAGGGAACAAATCGCATATCGTGAACACATCATGG
GCAGTTTTGGCTCTCATTGAAGCAGGACAAGCTAATAGAGACCTGATGCCATTGCATCGCGG
GGCAAAATCGCTGATCAACTCGCAGATGGAAGACGGAGATTACCCTCAACAGGAGATATTGG
GAGTCTTTAATCGGAATTGTATGATCAGCTACTCAGCTTATAGAAACATATTCCCTATTTGG
GCTCTAGG 
 
C2.1.3 DNA sequence of XP_ 002887764 A. lyrata lupeol synthase (LUP1). 
ATGTGGAAGTTGAAGATAGGAAAGGGAAATGGTGAGGAACCGCATTTATTCAGTAGCAATAA
TTTCGTCGGACGTCAAACATGGGAGTTTGATCACCAAGCCGGCTCACCAGAGGAAAGAGCTT
CCGTCGAAGAAGCTCGCCGAAGTTTCTTGATCAACCGTTCTCGTGTTAAAGGTTGCAGTGAT
CTCTTATGGCGAATGCAATTTCTAAGAGAGAAGAAATTCGAACAAGGCATACCGAAACCTAC
TAAAATAAAGGAGGAAATAACGTATGAAACAACGACAAATGCATTACGAAGAGGCGTTCGTT
ACTTCTCAGCTTTGCAAGCCTCCGACGGCCATTGGCCTGGAGAAATCACTGGTCCGCTTTTC
TTCCTTCCTCCTCTCATATTTTGTTTGTACATTACCGGACATCTGGAGGAAGTATTCGATGC
TGAACATCGCAAAGAGATGCTACGGCATATCTATTGTCATCAGAACGAAGATGGTGGATGGG
GATCACATATCGAAAGCAAGAGTGTTATGTTCTGCACCGTGTTGAATTACATATGTTTTCGT
ATGCTTGGAGAAAATCCTGAACAAGACGCGTGCAAACGAGCTAGACAATGGATTCTTGACCG
TGGTGGTGTGATTTTTATTCCTTCTTGGGGGAAATTTTGGCTCTCGATACTCGGAGTTTATG
176 
 
AATGGTCTGGAACTAATCCGACGCCACCAGAAATCTTGATGCTGCCTTCTTTTCTTCCAATA
CATCCTGGGAGAACTTTGTGTTATAGCCGGATGGTTAGTATACCTATGTCTTACCTATATGG
GAAGAGGTTTGTTGGTCCAATAACACCTCTTATTTTGCTCTTGCGCGGGGAACTTTACTTGG
AATCTTATGAAGAAATCAGTTGGAATAAAACTCGACGTCTATATGCAAAAGAAGACATGTAT
TATCCTCATCCTTTGGTTCAAGATTTGATATCTGACACTCTTCACAACTTTGTGGAGCCTTT
TCTTACACGTTGGCCATTGAACAAGCTTGTGAGGGAAAAAGCTCTTCAGCTGACTATGAAAC
ACATACATTATGAAGACGAAAATAGCCATTACATAACCATTGGATGTGTTGAGAAGGTACTG
TGCATGCTAGCTTGTTGGGTCGAAAATCCTAATGGAGACTACTTCAAGAAGCATCTGGCTAG
AATTCCAGATTACATGTGGGTCGCTGAAGATGGAATGAAAATGCAGAGCTTTGGATGTCAAC
TGTGGGATACCGGATTTGCTATTCAAGCTTTACTTGCAAGTAATCTCCCTGATGAAACTGAT
GATGCATTAAGGAGAGGACATAATTACATCAAGACATCTCAGGTTAGAGAAAACCCTTCAGG
TGATTTTAAGAGCATGTACCGCCACATTTCGAAAGGAGCATGGACATTTTCTGATCGAGATC
ATGGATGGCAAGTTTCAGATTGTACAGCTGAAGCTTTAAAGTGTTGCCTACTTCTTTCCATG
ATGCCAGCTGATATCGTTGGCCAGATAATAGATGATGAACAATTATATGATTCTGTTAATCT
CTTGCTATCTTTACAGAGCGGAAATGGAGGTGTCAATGCGTGGGAGCCTACCCGTGCATATG
AATGGATGGAACTGCTCAATCCTACAGAATTCATGGCTAATACCATGGTCGAGCGGAAGTTT
GTGGAATGCACCTCATCTGTTATACAAGCACTTGATCTATTTAGAAAGTTGTATCCAGATCA
CAGGACAAAAGAGATCAACAAGTCCATCAAAAAAGCTGTGCAATTTATACAAGGCAAACAAA
CAGCAGACGGTTCATGGTACGGAAATTGGGGTGTTTGCTTCATTTACGCTACTTGGTTTGCT
CTTGGAGGTCTAGCAGCAGCTGGTGAAACTTACAACGATTGTTTAGCTATGCGCAAAGGTGT
CCACTTTTTGCTCACTACACAAAGAGATGATGGAGGTTGGGGTGAAAGCTATTTATCATGCT
CCGAACAGAGATACATACCATTAGAAGGAGAAAGATCAAACATTGTGCAAACATCATGGGCT
ATGATGGCTCTAATTCATACGGGACAGGCTGAGAGAGATTTGATTCCTCTTCATCGTGCTGC
CAAACTAATCATCAATTCACAACTTGAAAACGGGGATTTTCCTCAACAGGAAATAGTAGGAG
CGTTCATGAATACATGCATGCTACACTATGCTACATACCGAAACACCTTCCCCTTATGGGCA
CTCGCGGAATACCGAAAAGTAATTTTAATTAATTAATCATCATTTACTTATTTATGTAATTT
T  
 
C2.1.4 DNA sequence of XP_ 00288776 A. lyrata -amyrin synthase (LUP2). 
ATGTGGAAGTTGAAGATAGGAGAGGGAAATGGAGAAGACCCTTACTTATTCAGCAGCAACAA
CTTCGTCGGACGTCAAACATGGGAATTTGATCCCAAAGCCGGCACACCAGAGGAACGAGCCG
CCGTCGAAGAAGCTCGCCGGAAATTTTTAGACAACCGTTCCCGTGTTAAAGGTTGCAGTGAT
CTCTTGTGGCGAATGCAAGTGATTTTTGAAAGAGGCGAAATTCGAGCAAGTGATCCCGCCGG
TGAAGATCGACGACGGCGACGCCATAACTTACGAAAACGCGACGAATGCGCTACGGAGAGCA
GTTTCTTTCTTCTCGGCTTTGCCTCCGATGGCCACTGGCCGGCGGAAATCGCAGGAACTCTC
TTCTTCCTCCCTCCATTGGTTTTTTGTTTGTATATCACAGGACACCTCGAGAAGATATTCGA
TGCGGAACATCGCAGCGAGATGCTTCGGCATATCTATTGTCACCAGAACGAAGACGGTGGAT
GGGGATTACATGTTGAGGGAAACAGCGTTATGTTTTGCACCGCACTGAATTACATATGCTTG
CGTATGCTCGGAGAAGGTCCCAACGGAGGGCGAGATAACTCCTGCAAACGGGCCAGGCAATG
GATTCTTGACCATGGTGGTGTGACTTATATTCCTTCTTGGGGAAAATTTTGGCTCTCGATAC
TCGGAATCTATGATTGGTCTGGAACCAACCCAATGCCTCCCGAGATTTGGTTGCTGCCTTCT
TTCATTCCAATACACTTAGGAAAAACTTTGTGTTATACTCGAATGGTTTATATGCCCATGTC
TTATCTGTATGGGAAACGATTTGTTGGTCCTCTTACACCTCTTATCATGCTATTGCGCAAAG
AACTCCACTTACAACCTTATGAGGAAATCAATTGGAACAAAGCGCGCCGTCTATGTGCAAAA
GAAGACATGATTTATCCTCATCCTCTGGTTCAAGATTTGTTATGGGACACTCTTCACAATTT
TGTGGAGCCTTTCCTTACAAGTTGGCCGTTAAAAAAACTTGTACGGGAAAAGGCTCTTCGAG
TGGCAATGGAACACATACATTATGAGGACGAAAATAGCCATTATATTACCATCGGATGTGTT
GAGAAGGTTCTGTGCATGCTTGCTTGCTGGATCGAGAATCCTAATGGAGATCACTTTAAGAA
ACATCTCGCTAGAATTCCGGACTTCATGTGGGTTGCTGAAGACGGACTGAAAATGCAGAGCT
TTGGAAGTCAACTATGGGACACAGGGTTTGCGATTCAAGCTTTACTTGCTTGTGACCTTTCT
GACGAAACTGATGATGTACTCAGGAAAGGACACAATTTCATAAAAAATTCTCAGGTTAGAGA
AAACCCTTCAGGTGACTTTAAGAGCATGTATCGCCATATTTCCAAAGGAGCCTGGACTTTGT
177 
 
CTGATCGAGATCATGGATGGCAAGTGTCAGATTGCACAGCTGAAGCTTTGAAGTGTTGCATG
CTGCTCTCCTTGATGCCAGCTGAGGTCGTTGGCCAGAGAATAGATCCTGAACAACTATACGA
TTCTGTTAATCTCTTGTTATCGTTGCAGGGTGAAAAAGGAGGTTTGACTGCATGGGAGCCTG
TCCGTGCACAAGAATGGTTGGAATTACTCAATCCCACAGATTTTTTTACTAGTGTTATGGCT
GAACGCGAGTATGTAGAATGTACCTCAGCTGTTATTCAAGCTTTGGTTCTATTCAAACAACT
TTATCCGGATCACAGAACGAAAGAGATCATCAAGTCGATTGAGAAAGGGGTGCAATTCATAG
AAAGCAAGCAAACGCCTGATGGTTCATGGTATGGAAATTGGGGTATCTGTTTTATCTACGCG
ACATGGTTTGCTCTGAGCGGGCTAGCAGCTGCTGGTAAAACTTACAAAAGTTGTCTGGCGAT
GCGCAAAGGTGTAGATTTCCTGCTTACGATACAAGAAGAAGATGGAGGTTGGGGCGAAAGCC
ATCTGTCATGCCCTGAGCAGAGATACATACCATTAGAAGGGAACAGATCAAACCTAGTGCAA
ACTGCTTGGGCTATGATGGGTTTGATTCATGCCGGACAGGCCGAGAGAGATCCTACACCTCT
TCATCGTGCTGCGAAACTTATCATCACTTCGCAACTTGAAAATGGGGACTTTCCGCAACAGG
AAATATTAGGAGTATTCATGAATACATGCATGCTACACTATGCTACATACAGAAACACCTTC
CCCTTATGGGCACTCGCGGAATATCGAAAAGCTGCCTTCTTAACTCATCAAGATCTATAG  
 
C2.1.5 DNA sequence of XP_ 002889222 A. lyrata camelliol synthase (LUP3). 
ATGTGGAAGTTGAAGATAGCAAATGGAAACAAAGAAGAGCCCTACTTGTTCAGCACCAACAA
CTTCCTCGGAAGACAGACATGGGAGTTTGATCCGGACGCCGGCATAGCAGAGGAACTAGCTG
CCGTCGAAGAAGCTCGTCGGAAATATTTTGATGATCGTTTTCAGGTTAAAGCTAGCAGCGAT
CTCATATGGCGTATGCAGTTTTTAAAAGAGAAGAAATTCGAGCAAGTTATACCTCCGGTAAA
AGTTGAAGATGCCAACAAGATCACGAGCGAAATAGCTACAAATGCGTTAAGGAGAGGGGTCA
ATTTCTTATCGGCATTGCAGGCCACTGATGGACACTGGCCTGCAGAAAATGCTGGTCCTTTA
TTCTTCCTTCCTCCATTGGTTTTCTGTCTATTTGTCACTGGACATCTCCATGAGATATTCAC
TCAAGAGCATCGTCGAGAGATCCTCAGATACATCTACTGTCACCAGAATGAAGATGGTGGCT
GGGGATTACACATAGAAGGAGACAGCACCATGTTCTGCACCACACTAAACTATATTTGCATG
CGCATACTTGGAGAATCTCCTTTTGGAGGACCAGGAAACGCGTGCAGACGGGCCAGGGATTG
GATTCTTGACCATGGGGGTGCAACATACATACCCTCTTGGGGCAAAACTTGGCTTTCTATAC
TTGGTGTCTTTGATTGGTCAGGAAGCAACCCCATGCCTCCAGAGTTTTGGATCCTACCTTCG
TTTCTTCCAATACATCCAGCGAAAATGTGGTGTTACTGCCGGTTGGTTTACATGCCAATGTC
TTATCTTTACGGGAAGAGATTTGTTGGTCCAATAAGTCCTCTTATTCTGCAACTACGCGAAG
AAATTTACTTGCAGCCTTATGCAAAAATAAACTGGAACAGAGCACGCCATCTATGTGCAAAG
GAAGACGCGTACTGTCCTCATCCACAAATTCAAGATGTTATATGGGACTGTCTTTACATCTT
CACTGAGCCGTTTCTTACATGTTGGCCATTTAATAAGCTGCTTAGGGAAAAAGCTCTTGGGG
TGGCAATGAAACACATACATTATGAAGACGAAAATAGCCGTTATATTACCATTGGATGTGTT
GAAAAGGCATTATGCATGCTTGCCTGTTGGGTTGAGGATCCTAACGGAAGTCATTTCAAGAA
GCATCTTTTGAGGATTTCTGATTACTTGTGGATTGCAGAAGATGGGATGAAAATGCAGAGCT
TTGGAAGTCAATTATGGGATTCAGGATTTGCCCTCCAAGCTTTAGTTGCAAGTGATCTCGCG
AACGAAATCCCAGATGTACTCAGGAGAGGATATGACTTTTTAAAAAATTCTCAGGTTAGGGA
GAACCCTTCGGGTGACTTTACGAACATGTTCCGTCACATCTCTAAAGGGTCGTGGACTTTCT
CTGATCGAGACCATGGATGGCAAGCTTCCGACTGCACAGCCGAAGGGTTTAAGTGTTGCCTT
TTGCTTTCGATGATGCCACCTGACATTGTTGGCCCGAAAATGGATCCCGAACAGTTATATGA
GGCTGTTACTATCTTACTGTCTCTACAGAGTAAAAATGGAGGTGTAACTGCTTGGGAGCCTG
CCCGTGGACAAGAATGGTTGGAATTGCTAAATCCTACTGAAGTTTTTGCTGACATTGTGGTT
GAGCACGAGTACAATGAGTGTACTTCATCAGCAATCCAAGCTTTGATTCTGTTCAAGCAACT
ATATCCGAATCACAGGACAGCAGAGATCAACACTTCCATCAAGAAAGCCGTGCAATATATAG
AGAGCATACAAATGCATGATGGTTCATGGTACGGAAGCTGGGGAGTTTGCTTCACATACAGT
ACATGGTTTGGTCTGGGAGGCCTCGCAGCTGCTGGAAAGACGTACAACAACTGTTTGGCTAT
GCGTAAAGGCGTTCATTTCCTTCTCACAACTCAAAAAGATAATGGAGGTTGGGGTGAAAGCT
ACTTGTCATGTCCTAAAAAGAGATACATTCCAAGTGAAGGGGATAGATCAAACTTGGTGCAA
ACCTCTTGGGCAATGATGGGTCTACTTCATGCTGGACAGGCAGAGCGAGATCCGGCTCCTCT
TCACCGTGCTGCGAAGCTCTTAATCAACTCTCAACTGGAGAATGGCGATTTTCCTCAGCAGG
AGATAACTGGAGCTTTCATGAAGAACTGCTTGTTACACTATGCAGCATACAGAAACATCTTC
178 
 
CCCGTGTGGGCACTCGCAGAGTATAGGAGACGAGTTCCGTTGCCATATGAAAACCTTGAACA
GAGAGAAGAAGTAAGATCCATCATAACGTCTCAACAGTCACAGGTCATTGACCATGATGTAG
GATCATAA  
 
C2.1.6 DNA sequence of XP_ 002868209 A. lyrata baruol synthase (PEN2). 
ATGTGGAGACTGAGAATTGGTGCTAAGGCCAGAGACGATACTCATTTGTTCACCACCAATAA
CTACGTTGGGAGGCAGATTTGGGAGTTTGATGCCGACGTAGGCTCTCCCGAGGAACTTTCCG
AGGTCGAGGAGGCTCGTCGGAATTTCTCCAACAACAGGTCGCGTTTCAAGGCTAGTGCTGAT
CTTCTATGGCGGATGCAGTTTCTTAGGGAGAAGAAGTTCGAACAGAAGATTCCTGGAGTGAG
AGTAGAGGATGCAGAGAAAATAACGTATGAAGATGCAAAGACTGCATTAAGAAGAGGATTAC
TCTATTTCACGGCCTTGCAAGCTGATGATGGACATTGGCCTGCTGAAAATGCTGGTTCCATA
TTCTTCAATGCCCCTTTTGTTATATGTCTTTACATCACTGGACATCTTGAGAAAATCTTCAC
TCACGAGCATCGTATAGAGTTACTTCGTTACATGTACAACCATCAGAACGAAGATGGTGGGT
GGGGATTACACGTAGAAAGCCCCAGCAATATGTTCTGCACAGTCATTAACTACGTATGTTTG
CGGATCTTGGGAGTAGAAGCTGGTCATGATGACCAAGGAAGCGCTTGTGCAAGGGCTCGTAA
GTGGATCCTCGACCATGGTGGTGCTACCTACTCGCCCTTAATAGGAAAAACTTGGCTTTCGG
TTCTTGGAGTGTATGATTGGTCTGGCTGCAAACCTATACCCCCTGAGTTCTGGTTCCTTCCT
TCTTGTTTCCCTGTTAATGGAGGGACTCTCTGGATTTATTTACGGGATATTTTTATGGGGTT
GTCATACTTGTATGGTAAAAAGTTTGTTGCTACCTCAACACCTCTCATTCTCCAGCTCCGAG
AAGAAATTTATCCCGAGCCTTACACAAAAATCGATTGGAAGCAAGCACGAAACCGATGTGCA
AAGGAAGATCTCTACTATCCACAATCATTTTTACAAGATTTATTTTGGAAAGGTGTTCACAT
ATTCTCAGAAAATATCCTAAATCGATGGCCTTTCAACAATACCATAAGACAAAGAGCTCTTC
GAACTACTATGGATCTCGTTCACTATCATGATGAAGCCACCAGATACATTACAGGCGGATCT
GTGCCGAAGGCCTTTCATATGCTTGCATGTTGGGTAGAAGACCCAGATAGTGACTATTTTAA
GAAACATCTTGCTCGAGTCCCTGATTTCATATGGATTGGCGAGGATGGTCTTAAAATTCAGT
CTTTTGGAAGCCAGTTGTGGGATACAGCCTTGTCGCTACATGTCCTTATAGACGGTTTCGAT
GATGATGTTGATGACGAAATTAGGTTAACGCTCTTTAAAGGATACGAGTATTTGAAGGAATC
TCAAGTTACAGAGAACCCTCCTGGCGATCACATGAAAATGTTCCGTCACATGGCGAAAGGTG
GATGGACATTTTCGGACCAAGATCAAGGATGGCCAGTTTCAGATTGTACTGCTGAGAGTTTA
GAGTGCTGTCTATTCTTCGAGAGCATGCCATCAGAGTTTATTGGCAAAAAAATGGCTGTGGA
GAAACTCTATGAAGCCGTTGATTTCCTTCTCTATTTGCAGAGTGATAATGGAGGTATAACGG
CATGGCAACCAGCGGATGGGAAAACTTGGTTAGAGTGGCTTAGTCCAGTGGAGTTTATTGAA
GACGCGGTTGTCGAGCATGAGTATGTAGAATGTACGGGGTCAGCAATTGCAGCATTGGCTAA
GTTCAATAAACAGTTTCCAGGATACAAAAAGGAAGAGGTTGAACGGTTTATAACCAAGGGGG
TGAAGTACATTGAGGACTTTCAAATGGTGGATGGTTCATGGTACGGAAATTGGGGAGTGTGT
TTCATCTATGGAACCTTCTTTGCGGTAAGAGGTCTTGTGGCTGCAGGGAAGTGTTACAATAA
CTGTGAGGCAATTCGTAGAGCAGTTCGTTTCATTCTAGACACACAAAACCTGGAGGGTGGCT
GGGGAGAAAGCTATCTCTCTTGTCCAACCAAGAAATATACTCCTTTGATAGGAAACAAGACA
AATGTGGTGAATACAGGACAAGCACTTATGGTTCTAATTGCGAGTGATCAAATGGAGAGAGA
TCCTTTGCCGGTTCATCGCGCTGCCAAAGTGTTGATTAATTCACAGTTGGATAATGGTGATT
TCCCGCAACAGGAAATAATGGGAGTTTTCAAGATGAATGTGATGCTCCATTTTCCTACCTAT
AGGAACATGTTCACTCTTTGGGCTCTCACACATTACACCAAGGCTCTGCGAGGGCTTTGA  
 
C2.1.7 DNA sequence of XP_ 002863840 A. lyrata thalianol synthase (PEN4). 
GTCGACAAAAATGTGGAGATTGAGATTGGGTCCTAAGGCAGGTGAAGATACACACTTGTTTA
CTACTAATAACTATGCTGGTAGACAAATATGGGAATTTGATGCCAATGCTGGTTCCCCAGAA
GAATTAGCCGAAGTTGAAGACGCTAGACAAAACTTCTCTAACAACAGATCAAGATTCAAAAC
TAGTGCTGATTTGTTATGGAGAATGCAATTCTTGAGAGAAAAGAAATTCGAACAAAAGATTC
CTAGAGTAATAGTCGAAGATGCAAGAAAAATTAAGTATGAAGACGCCAAAACTGCTTTAAGA
AGAGGTTTGTTATACTTTACAGCATTGCAAGCCGATGACGGTCATTGGCCAGCCGAAAATTC
179 
 
AGGTCCTAACTTTTATGCTCCACCTTTCTTAATCTGTTTGTACATCACCGGTAATTTGGAAA
AGATTTTTACTCCAGAACATGTTAAGGAATTGTTGAGACACATCTATAACATGCAAAACGAA
GATGGTGGTTGGGGTTTACATGTAGAATCCCACAGTGTCATGTTCTGTACTGTTATCAATTA
CATCTGCTTGAGAATAGTTGGTGAAGAAGCTTCTCATGATGACCAGGGTAACGGTTGTGCAA
AAGCCCATAAGTGGATTATGGATCACGGTGGTGCAACCTATACTCCATTGATCGGTAAAGCC
TTGTTGTCTGTTTTGGGTGTATACGATTGGTCAGGTTGCAATCCTATACCACCTGAATTTTG
GTTGTTACCATCTTCATTCCCTGTAAACGGTGGTACATTGTGGATCTATTTGAGAGATACCT
TTATGGGTTTGTCTTATTTGTACGGTAAAAAGTTCGTCGCTGCACCAACACCTTTGATATTG
AAGTTGAGAGAAGAATTGTATCCAGAACCTTACGCCAAGATAAATTGGACACAAACCAGAAA
CAGATGTGCTAAGGAAGATTTGTACTACCCAAGATCCTTTTTACAAGACTTGTTCTGGAAGA
GTGTTCATATGTTCTCTGAATCAATCTTGGATAGATGGCCTTTGAATAAGTTGATCAGAGAA
AGAGCTTTGAGATCTACTATGTCATTGATCCATTATCACGATGAATCTACTAGATACATCAC
AGGTGGTTGTTTACCAAAGGCATTTCATATGTTGGCCTGCTGGATAGAAGATCCTAAGTCAG
ACTACTTCAAAAAGCACTTGGCAAGAGTTAGAGAATACATATGGATCGGTGAAGATGGTTTG
AAGATCCAATCCTTCGGTAGTCAATTGTGGGACACATCCTTGAGTTTGCATGTATTGTTGGA
TGGTATAGACGAACACGATGTTGATGAAATCAGAACTACATTGGTTAAGGGTTACGATTACT
TGAAAAAGTCCCAAATCACCGAAAATCCAAGAGGTGACCATTTCCAAATGTTCAGACACATA
ACAAAGGGTGGTTGGACCTTCTCAGATCAAGACCAAGGTTGGCCAGTTTCCGATTGTACAGC
TGAAAGTTTGGAATGTTGCTTGTTTTTCGAATCTTTGCCTTCAGAATTGATCGGTAAAAAGA
TGGATGTTGGTAAATTGTACGATGCTGTAGACTATTTGTTGTACTTGCAATCTGATAACGGT
GGTATTGCCGCTTGGCAACCAGTTGATGGTAAAGCATGGTTAGAATGGTTGTCTCCTGTTGA
ATTCTTGGAAGATGCAGTTGTAGAATATGAATACGTAGAATGCACTGGTTCAGCCATTGTCG
CTTTGGCAAAGTTTAATAAGCAATTCCCAGAATACAAAAAGGCTGAAGTTAAGCAATTCATT
ACCAAAGGTGCAAAGTACATCGAAGATATGCAAACTGTTGACGGTTCATGGTATGGTAATTG
GGGTGTATGTTTCATCTATGGTACATTTTTCGCTGTCAGAGGTTTAGTTGCAGCCGGTAAAA
CCTATGGTAACTGCGAAGCTATCAGAAAGGCAGTTAGATTTTTGTTGGATACTCAAAATTTG
GAAGGTGGTTGGGGTGAATCCTTCTTGAGTTGTCCAAACAAAATCTATACACCTTTGAAGGG
TAACTCTACTAACGTCGTTCAAACAGGTCAAGCTTTGATCGTTTTGATCATGGCAGATCAAA
TGGAAAGAGACCCATTGCCTGTACATAGAGCTGCAAAGGTCTTGATTAATTCTCAATTGGAT
AACGGTGACTTTCCACAACAAGAAATCATGGGTACCTTTATGAGAACTGTTATGTTGCATTT
CCCTACATATAGAAATACTGAGCGGCCGC  
 
C2.1.8 DNA sequence of XP_ 002887743 A. lyrata seco--amyrin synthase (PEN6). 
GTCGACAAAAATGTGGAGGCTGAAGATCGGAGCTAAGGGCGGAGATGAGACTCACTTGTTCA
CCACCAACAACTACACCGGAAGACAAACTTGGGAGTTTGATGCCGATGCCTGCTCCCCAGAG
GAACTCGCTGAGGTCAATGAAGCTCGGCAGAATTTCTTCATAAACCGGTCACGTTTCAAGAT
CAGTGCTGATCTCCTTTGGCGAATGCAGTTTCTAAGGGAGAAGAAGTTCGAGCAGAAGATTC
CGAGAGTGGAAATAGGAGATGCGGAAAAGATAACGTACAAAGACGCAAAGTCGGCACTGAGA
AGAGGGATACTATATTTCAAGGCATTGCAAGCTGAGGATGGACATTGGCCTGCTGAAAACTC
TGGTTCCTTGTTCTTCGAAGCTCCCTTTGTCATATGCTTGTACATTACTGGACATCTGGAGA
AAATCTTCAGTTTGGAACATCGCAAGGAACTATTGCGCTACATGTACAACCATCAGAACGAA
GATGGTGGGTGGGGACTACACGTGGAAGGCCAAAGTGCTATGTTCTGCACGGTCATCAACTA
CATTTGCCTACGGATTTTTGGAGTAGAAGCAGATCATGATGATATTAAAGGAAGTGGTTGTG
CAAGGGCTCGTAAGTGGATCCTTGATCACGGTGGTGCTACATATACGCCCTTGATCGGAAAA
GTTTGGCTATCGGTCCTTGGAGTGTATGATTGGTCCGGTTGCAAACCCATACCGCCTGAGGT
GTGGATGCTCCCTTCTTTTTCGCCCTTCAACGGAGGTACTCTATGGATTTATTTCCGGGAGA
TTTTCATGGGCGTGTCATACTTGTATGGTAAGAAATTTGTAGCTACACCAACACCTCTCATT
TTACAGCTTCGGGAAGAGCTTTATCCTCAACCTTATGACAAAATCCTATGGAGTCAAGCTCG
GAATATGTGCGCAAAGGAAGATCTCTACTATCCACAGTCATTTTTACAAGAAATGTTTTGGA
AAGGTGTTCATACATTGTCAGAGACTATCCTGAGTCGATGGCCTTTCAACAAGCTCATAAGG
CAAAAAGCTCTTCGAACCACAATGGAGCTCCTACATTATCACGATGAAGCGAGCCGATACTT
TACCGGTGGATGTGTGCCAAAGCCGTTTCATATGCTTGCTTGTTGGGTAGAAGACCCCGACG
180 
 
GTGATTATTTTAAGAAACATCTTGCTCGAGTCCCCGATTATATATGGATTGGAGAGGATGGT
CTGAAAATCCAATCTTTTGGTAGCCAATTGTGGGATACAGCATTCTCACTTCAAGTCATGTT
AGCTTATCAAGATGTTGATGCCGATGATAATGATATTGGATCAACGTTAATGAAAGGATACA
ATTTCTTGAATAAATCTCAGCTTACACAAAATCCTCCTGGTGACCATAGGAAAATGTTTAAA
GACATTGTGAAAGGAGGATGGACATTTTCGGACCAAGACCAAGGATGGCCTGTTTCCGATTG
TACTGCTGAGAGTTTAGAGTGTTGCCTTGTCTTTGGAAGCATGCCATCGGAGTTGATTGGCG
AGAAAATGGATGTGGAGAGGCTCTATGATGCCGTTAACTTACTTCTCTATTTTCAGAGCAAA
AATGGAGGCATAGCAGTGTGGGAGGCAGCTCGTGGAAGAACCTGGCTAGAGTGGCTTAGTCC
GGTGGAGTTTATGGAAGACACAATCGTCGAGCATGAGTATTTAGAATGCACGGGGTCTGCGA
TAGTGGCATTGGCACGGTTCTTGAAAGAGTATCCGGAGCACAGAAAGGAAGAGGTTGAAAGG
TTTATCAAGAGTGCTGTCAAATACATAGAAAGCTTTCAAATGCCCGATGGTTCGTGGTATGG
AAACTGGGGTGTCTGTTTCATGTATGGAACCTTTTTCGCGGTAAGAGGTCTAGTGGCTGCAG
GCAAGACGTACCAGAACTGTGAGCCGATTCGTAGAGCGGTTCAGTTCCTTCTGGAGACACAA
AACGTTCAAGGCGGTTGGGGTGAGAGTTATCTATCTTGCCCCAGGAAGAGATATACACCTCT
AGAGGGAAACAGAACCAATGTGGTGAATACGGGACAAGCAATGATGGTTTTGATTATGTGTG
GTCAGATGGAGAGAGACCCTTTGCCTGTTCATCGCGCAGCTAAAGTGTTGATCAATTCCCAG
ATGGATAATGGCGATTTTCCGCAAGAGGAAATAATGGGAGTGTTCAAGATGAATGTGATGAT
CAATTATCCAAACTATAGTGAGCGGCCGC  
 
C2.1.9 DNA sequence of A. lyrata -amyrin synthase (PEN9). 
GTCGACAAAAATGTGGAGATTGAGAATAGCTGCAGAAGCTGAAGACAAGACTCATTTGTTTA
CTACAAACAACTACGCAGGTAGACAAATCTGGGAATTCGATGCCAACACATGTTCTCCAGAA
GAATTGGCTGAAGTCAATAAGGTTAGACAAAACTTCTCTTCAAACCCATCTAGATTCAAGCC
TTCAGCAGATTTGTTATGGAGAATGCAATTCTTGAGAGAAAAGAAATTCGAACAAAAGATTC
CTAGAGTTATTATCGAAGACGCCCAAAAGATTACCTATGAAGATGCCAAGACTGCTTTAAGA
AGAGGTATTTTGTACTTTGCCGCTTTACAAGCAGATGACGGTCATTGGCCAGCCGAAAACTC
CGGTAGTTTGTTTTTCGAAGCACCTTTCGTTATCTCCTTGTACATCACTGGTCATTTGGATA
AGATTTTCAGTTTGGAACACAGAAAGGAATTGTTGAGATATTTGTACAACCATCAAAACGAT
GACGGTGGTTGGGGTATACACGTAGAATCTCAATCAGTCATGTTCTGTACAGTTATTAATTA
CATCTGCTTAAGAATCTTCGGTATTGAACCAGATCATGACGGTCAAGAATCAGTTTGTGCAA
GAGCCAGAAAATGGATTTTGGATCACGGTGGTGCTACATATACCCCATTAATAGGTAAAATC
TGGTTGTCCGTATTAGGTGTCTACGATTGGAGTGGTTGCAAGCCTATTCCACCTGAATTTTG
GATGTTGCCAGGTTCCAGTCCTATAAATGCAGGTACTTTGTGGATCTATTTCAGAGATATTT
TCATGGCCTTGTCTTATTTGTACGGTAAAAAGTTCGTTGCTTCACCAACACCTTTGATAGCA
CAATTGAGAGAAGAATTGTACCCACAACCTTACAATAAGATTAATTGGTCCCAAGCCAGACA
ATTATGTGCTAAGGAAGACTTGTATTACCCACAAAGTTTCGTTCAAGATTTGTTCTGGAAGT
CCGTTTACATGTTCAGTGAAAACGTATTGAACCAATGGCCTTTTAATAAGTTGATCAGACAA
AGAGCATTGAGAAAGGCCATGGAATTAATCCATTATCACGATGAAGCAACCAGATACATTAC
TGGTGGTTGTGTACAAAAACCATTTCATATGTTGGCTTGCTGGGTCGAAGATCCTGACGGTG
ACTATTTCAAAAAGCACTTAGCAAGAGTTCCAGACTACATTTGGGTTGGTGAAGATGGTTTG
AAGATCCAATCTTTCGGTTCACAATTATGGGACACTTCCTTGAGTTTACAAGTTATGTTGGC
AGCCGTTGCTGATGTAGATGACGAAGTCATTAGATCTACATTGGTTAAGGGTTACAAGTTCT
TGGAAAAATCACAATTAACCCAAAATCCACCTGGTGACCATATGAAGATGTTCAGACACATA
ACAAAGGGTGGTTGGACCTTCTCCGACCAAGATCAAGGTTGGCCAGTATCTGATTGTACTGC
AGAATCATTGGAATGTTGCTTGATCTTCGAATCTATGTCTTCAGAAATCATAGGTGAAAAGA
TGGACATTGAAAGATTGTACGATGCTGTTAACTTCTTGTTGTACTTACAATCCAAAAATGGT
GGTATAAGTGCTTGGGAACCAGCATTGGGTAAAACTTGGTTGGAATGGTTATCTCCTGTTGA
ATTCATGGAAAACACCACTATCGAACATGAATACGTAGAATGCACAGGTTCAGCTATAATCG
CTTTAGCAAGATTCAAACAACAATTCCCAAGACACAGAACTGAAGAAGTCGAAAGATTCATT
ACAAAGGGTGTTAAGTACATCGAATCTTTCCAAATGCCTGATGGTTCATGGTATGGTAACTA
CGGTGTCTGTTTTATGTATGGTACCTTTTTCGCCGTCAGAGGTTTGGTTGCTGCAGGTAAAA
CTTACTGCAATTCTGAACCAATCCATAGAGCTGTTCAATTCTTGTTAGAAACCCAAAACATT
181 
 
GAAGGTGGTTGGGGTGAATCCTATTTGAGTTGTCCAAATAAGAAATACACACCTTTGGAAGG
TAATAAGACTAACGTTGTAAACACATCACAAGCTTTGATGGGTTTAATTATGGGTGGTCAAA
TGAAAAGAGATCCATTACCTGTACATAGAGCCGCTAAGGTCTTGATAAACTCTCAATTAGAC
AATGGTGACTTTCCACAAGAAGAAATCAGAGGTGTATTCAAAATGAACGTCTTGTTGCATTA
CCCTACATACAGAAACATTAATGAGCGGCCGC  
 
C2.2 DNA sequence of DW017758 L. perennis nematocyphol synthase. 
 
The following sequence contains the L. perennis nematocyphol synthase gene, two 
restriction sites, a poly-A, and an additional stop codon: 
 
GTCGACAAAAATGTGGGAGTTAAAGATAGCCGAAGAGGATGGTCCCTATTTGTATAGTACTA
ACAACTTTGTTGGTAGACAATTCTGGAAATTTAATCCTGATGCTGGAACTCCAAAAGAGAAA
GAAGAAATTGAACAGGTTCGGCAAAACTTCAAAGATAATCGGAAAAATGGTGGACAACATGC
TTGTGGCGATCTCTTGATGCGGATGCAGCTTATGAAGGAAAATCAAATTGATCTTATGGACA
TAGCTCCAATAAGACTAAATGATGATGAACAAGTCACTTTTGAATCTGTAACAACTGCAGTG
AAGAAAGCGGTCCGACTAAACCGTGCAATCCAAGCAAAAGATGGTCACTGGCCTGCTGAAAA
TGCTGGCCCCTTGTTCTTCACTCCTCCACTTTTAATTGCTTTATACATAAGTGGTACCATTA
ATACAATCTTGAATGAAGAACACCACAAAGAGATGATACGGTATTTCTACAATCATCAGAAT
GAAGACGGGGGATGGGGGTTTTTTATCGAAGGCAAAAGTACGATGATTGGATCTGCATTAGT
CTATGTAGCCCTGCGTATACTAGGAGAAGGAAAAAATGGAGGAGATGGTGCAATGGACCGAG
GCCGCAAGTGGATACTTGACCATGGAGGTGCAACCTCCATTCCCTCCTGGGGAAAGCTCTAT
CTTTCGGTGCTTGGAGTGTATGATTGGGAGGGCTGTAACCCATTGCCACCAGAATTCTGGAT
TTTGCCATCATCATTTCCTTTTCATCCCGCTGAGATGTGGTGCTATTGTCGGACAACCTACA
TGCCTATGTCATATTTATATGGGAAAAGATTCCAAGGACCCATCACACCTCTTGTTTCATCA
TTGCGAAAAGAAATCTACCCCACCCCTTTTGAGCATATTAACTGGAATAAACAAAGGAATAA
TTGTTGTAAGGAGGACTGGTATTATCCGCATTCATTTCTTCAAGATGTTTTGTGGCATACCC
TTCACTACATTACTGAGCCTGTCCTTAAATATTGGCCATTTTCCAAACTACGTGGGAGATCG
CTTGATAGAGTTGTCGAGCTAATGCGCTATGAATCACAAGAGACTAGATACATGACCATAGG
ATGCATTGAAAAAAGTCTACAAATGATGTGTTGGTGGGCAGAGAATCCAAAAGGTGATGAGT
TCAAATATCACTTAGCCAGAGTTCCAGACTATTTATGGATTGCAGAAGATGGAATGACAATG
CATAGCTTTGGCAGTCAAGTGTGGGATTGTGTTTTTGCAACTCAAGCAATTATTGCAAGTAA
CATGACTGAAGAATACGGTGATTGTCTCAAAAAGGCACACTTTTATTTAAGAGAATCTCAGA
TAAAAGAAAATCCTTCAGGAGATTTCACTCGAATGTATCGACATATAACTAAAGGAGCATGG
GCCTTCTCCGATCAAGATCATGGATGGGCTGTCTCTGATTGTACAGCTGAAGCACTAATGTG
TCTACTTTTACTATCAAACATGCCGAAAGAAATTGTTGGAGAGAAAGTTGACAATGCCCGAC
TATACGAGGCAGTGAATCTTCTTCTTTACCTACAAAGTCCTATAAGCGGAGGATTTGCTATT
TGGGAGCCACCGATTCCAAAACCATTTCTACAGCTTCTTAATCCTTCAGAGATGTTTGCAGA
TATAGTTGTTGAGAAAGAGCATCTGGAACCCTCAGCTTGCATTATTGTAGCTCTGGTAGAGT
TCAACCGTGTCCATCCAAGACACAGAAAGAAAGAAATAGAACTTTCAATTTCGAATGGGATA
CGATATCTGGAGGAAACGCAATGGCATGATGGTTCATGGTATGGTTACTGGGGAATATGCTT
CCTATATGGAACATTCTTTGCATTAAGGGCTTTAAGTGCTGCTGGAAAGACATATGACAATA
ACGAAGCAGTCTGTAAAGGTGTCAAATTCTTACTTTCCAAACAGAATGAAGAGGGGGGTTGG
GGAGAGAGTCGCCTATCTTGTCCTACTGAGGTGTATACACCGTTGGATGGAAACCGAACAAA
TTTGGTGCAGACATCATGGGCTATGCTTGGTCTTATGTCCTGTGGGCAGGTGGAGAGAGATG
TGACGCCCTTAGATAAAGCAGCAAAGCTGTTGATTAACGCTCAAATGGATAACGGAGATTTT
CCTCAACAGGAAATTACTGGAGCCTGGATGAGGAATTGCACTYTGCACTATGCACAATACAG
GAATATTTTCCCACTCTGGGCACTTGGGGAGTACCGAAAACGTGTTTGGTGAGCGGCCGC 
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C2.3 DNA sequences of expressed Lactuca OSCs. 
 
The following sequences contain each the Lactuca gene, two restriction sites, a poly-A, 
and an additional stop codon. 
 
C2.3.1 DNA sequence of BU000828 L. serriola tirucalla-8, 24-dienol synthase. 
GTCGACAAAAATGTGGAAGTTAAAGATAGCAGAAGGTAACGATCCTTACTTATTTAGCACTA
ACAACTTTGTTGGACGCCAAATTTGGGAGTTTGATCCCGATGCTGGAACTCCTGAAGAGCAC
CAAGAAGTCGAAAACGCTCGTCAACTTTTCCTTAACCGTCAAAAGGAAGGTTTTCAAGCATC
AGGCGATTTACTCATGCGGATACAGTTAATCAAGGAGAATGAAATTGATATATTAAGCATAC
CACCAGCAAGGTTAGGGGAAAATGAGGAAGCGAATCAAGAAGCGGTAACAACCACGATAAGA
AAAGCAGTCAGATTTAATCGTGCCATCCAAACAAAAGATGGTCATTGGGCTACTGAACATGG
TGGCCCTTTATTTTTCACTCCTCCACTTATTATTATCTTATACATTAGTGGAGCCATCGATA
CACATTTAACAAAGGAGCACAAGAAAGAGATGAAACGCTTTATCTACAATCATCAAAATGAA
GATGGAGGATGGGGATTTCACATTGAAGGACATAGCACTATGTTTGTGTCCGTGTTAAGCTA
CATATCCCTACGACTTCTAGGGGAAGAAAAAGATGACAAAAATGTTGCACTTACTCGAGCAA
GAAAATGGATACTTGACCATGGTGGTGCAACCTATGTACCATCTTGGGGAAAACTTTATCTT
TCGGTGCTTGGTGTATATGAATGGGAAGGATGCAACCCAATACCACCAGAATTTTGGATTTT
CCCCGAGTTTCTACCCTTTCATCCAGGAAAAATGTGGTGTTATTGTCGAACGGCCTATATGC
CCATGTCATACTTGTACGGAAGAAAATTCCATGGCCCAATCACTGATCTTGTTCTTCAACTG
AGGCAAGAGATTTATCTTACCCCATACGATGAGATAAATTGGAATAAACAACGCCATAAATG
TTGTAAGGAAGATCTCTATTACCCTCACACAATAGTCCAAGATTTGATATGGGATGGTCTTT
ATTACTTAAGTGAGCCACTCTTCAAGTACTGGCCTTTTACAAAACTAAGAGAAAAAGCTCTC
AAAAGAACAATTGAGTTAACTCGTTATAACGCTGAAGAAAGCAGGTACATTACCATGGCAAG
TATTGAAAAGGGTTTTCAAATGATGTGTTGGTGGGCGGAGAACCCAAACGGGAATGAATTCA
AGCACCACCTTGCTAGATTACCGGATTACTTGTGGCTAGCAGAAGATGGAATGAAGTCGCAA
ACATTTGGTAGTCAATTATGGTGTAGTGCATTTGCAACTCAAGCAATAATCGCAAGTAATAT
GCCTGAAGAATATGGGGATTCTCTTAAAAAGGCCCATTTCTTTATCAAAGAATCTCAGGTTA
AGCAAAACCCAAAAGGAGATTTCACTAAAATGTGTCGACAGTTTAGTAAAGGATCATGGACA
TTCACAGATCAAGATCATGGATGGCCTGTCTCGGATTGCACAGGAGAAGCATTGAAATGCCT
ACTTTTATTATCCCAAATGCCCGAAGAAATTTCTGGAGAAAATGTAGATAACCAGCGACTGT
ATGATGCTGTTAACTTCCTTCTTTATGTACAAAGCCCTACAACAGGAGGTTTTGCTGTTTGG
GAAAAACCAATCCCACATCCATATTTACAGACGTTGAATCCTTCAGAAATGTTCGCCGACAT
TGTTGTTGAAAGAGAGCATGTTGAGTGCACAACTTCAGTGATGCAAGCTCTCATAGAGTTCA
AACACTTCCACCCCGGGCATCGGGAAAAAGAAATAGAAAAGGCTGTGGCAAATGCAGTGCGT
TATCTAGAGGATATACAATGGGAAGATGGTTCATGGTATGGTTATTGGGGGATATGTTTCAT
ATGTGGCACATTCTTTTCGTTAGGAGGCTTAGAATCAGCTGGAAAAACATATAATGATTGTG
AAGCAGTTCGCAAAGGAGCCAAGTTTTTACTCTCGATACAAAATGAAGAAGGTGGTTGGGGA
GAAAGCTACAAATCTTGCCCTAGTGAAGTCTACACACCACTAGATGGAAATAGAACTAATAT
AGTTCAAACAGCATGGGCTATGCTAGGTCTCATGTCATCTGGACAGGCTGAAAGAGATCCAA
CACCATTACACAAAGCAGCAAAGATCTTGATCAATGCACAGATGGATGATGGAGATTTTCCA
CAACAGGAGATGACTGGAACTGCAATGAGGAACTGCATTCTACATTATCCGTTATATAGGAA
TATATTCCCGTTATTGGCACTTTCGAAATATCGCAATATATTTTGGGCTACATAATGAGCGG
CCGC  
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C2.3.2 DNA sequence of BQ869693 L. sativa mixed amyrin synthase. 
GTCGACAAAAATGTGGAAGTTAAAGATAGCAGAAGGAAATGATCATTATTTGTATTCCACCA
ACAATTTTGTTGGCCGGCAAATTTGGGAATTTGACCCCGATGCTGGAACTCCGGTAGAGCGA
CAAGAAGTTGAAGATGCACGTCAGTATTTTAGAGACAATCGAAGGGAAGGTGTTCATCCATG
TGGCGATCTGCTTATGCGGATGCAGTTGATCAAAGAAAACGGAATTGATTTATTTAGCATAC
CACCAAGAAGATTGGGAGTGAATGAGGAAGTAAATTATGATGCAGTGACAACATCAGTTAAA
AAAGCACTCCGATTAAACCGTGCAATTCAAGCAAAAGATGGTCATTGGCCTGCAGAAAATGC
GGGCCCTATGTTTTTCACTCCTCCACTCCTTATTGCTATGTACATCAGTGGAGCCATAGATA
CGCATTTAACCAAAGAACACAAGGAAGAAATGATACGTTATATCTACAACCACCAAAATGAA
GATGGAGGGTGGGGATTTTATATAGAAGGACACAGCACCATGATTGGATCTGCTTTAAGCTA
TGTAGCCCTACGGTTACTAGGAGAAGGACCCGATGATGGGAACGGTGCAGTGAGCCGAGCAA
GGGAGTGGATACTCGAACATGGCGGTGCAATGTCGATTCCTTCTTGGGGCAAAACTTATCTA
TCGGTACTTGGGGTGTATGAATGGGATGGATGCAATCCACTTCCGCCAGAATTTTGGCTTTT
CCCAGAAACTTTACCATATCATCCAGCAAAAATGTGGTGCTATTGTCGGACAACTTATATGC
CCATGTCATACTTGTATGGGAGAAAATTCCATGGTCCAATCACTGATCTTGTTTTGCAACTT
CGACAAGAAATTCATCCGATCCCATATGATAACATAAATTGGAATAAACAACGCCACAACTG
TTGCAAGGAAGATCTCTACTACCCTCATTCAACACTTCAAGATTTGTTGTGGGATAGTCTTA
ACTACTTCAGCGAGCCACTTCTTAAGCATTGGCCTTTTAAGAAATTAAGAGAAAAAGGTCTC
AAAAGAGCAGTTGAATTAATGCGATATAGTGCTGAAGAGAGTAGATATATCACTATCGGATG
TGTTGAAAAGAGCTTGCAAATGATGTGTTGGTGGGCAGAGAATCCAAACGGGGATGAATTCA
AGCATCATCTTGCTAGGGTTCCGGATTACTTATGGCTAGCAGAAGATGGAATGAAGATGCAA
AGTTTCGGGAGCCAAGTATGGGATTGTACACTTGCAACTCAAGCAATAATCGCTAGTGATAT
GGTTGAAGAATATGGGGATTCCCTTAAAAAAGCCCATTTTTATATAAAAGAATCCCAAATAA
AACAAAACCCATCTGGAGATTTTAGTAAAATGTGTCGACAGTTTACTAAAGGAGCATGGACT
TTCTCTGACCAAGATCAAGGTTGGGTTGTCTCAGATTGCACAGCTGAAGCACTTAAGTGTCT
TTTATTACTATCCCAAATGCCAGAGGAAATTTCAGGAGAAAAGGCTGATAATGAAAGATTAT
ATGAGGCTGTTAATGTCCTTCTTTACTTACAAAGTCCTATAAGTGGAGGTTTTGCTATTTGG
GAGCCACCTGTCCCTCAACCATATTTACAGATGTTGAATCCTTCGGAGATTTTTGCAGACAT
TGTTGTTGAGAAAGAGCATGTTGAGTGCACATCATCAATTATTCAAGCCCTTTTAGCCTTCA
AAAGATTGCACCCAGGTCATAGGGAGAAAGAAATTGAAATTTCTGTGGCAAAAGCAGTTGGT
TTTTTGGAGGAAAAACAATGGCATGATGGTTCTTGGTATGGTTATTGGGGAATATGTTTCCT
ATATGGCACATTTTTTACAATAGGAGGCTTAATTTCAGCTGGAAAAACATATAACAATAGTG
AATCGGTTCGTAAAGCAGTAAATTTTTTCCTTTCAACACAAAATGAAGAGGGAGGATGGGGA
GAAAGCATACAGTCTTGCCCTAGTGAAGTATACACACCACTGGATGGAAGTCGAACAAATTT
AGTTCAAACATCATGGGCTATGCTTGGCCTTATGTTATGTGGACAGGCTGAAAGAGATCCAA
CACCCTTGCATAAAGCAGCAAAGATATTGATTAATGCACAAATGGATAATGGAGATTTTCCT
CAACAGGAGATTACTGGAGTCTACATGAAGAATTGCATGCTGCATTATGCAGAGTACAGGAA
CATTTTCCCACTTTGGGCACTTGGGGAATATCGCAAACGTGTTTGGGTCAATTAATGAGCGG
CCGC  
 
C2.3.3 DNA sequence of BQ997802 L. serriola mixed taraxasterol synthase. 
GTCGACAAAAATGTGGAAGCTCAAAATAGGTGAAAAGAATGGGAAATTCAACATCGGTGATG
GAAATGGTGATGAATATTTATATAGCACCAATAACTTTGTGGGGAGACAAACTTGGGAGTTC
GACCCTGATGCAGGCACGCAGGAAGAACGTGAACAAGTTGAAAAGTTTCGAGAACAATTTTT
GATTAATAAGAAGAAGCTTGACATCAGTTGTTGTGCAGATCTGCTCATGCGAAATCAGCTTA
TTAAGGAAAGCGGGATCGATCTTCTGAGCGAACCTCCGGTGAGACTTGGAGAGGAGGAGGAT
GTGAACTTTGAAGCGGTGACAACCGCAGTTAAAAAGGCAGTTCGATTAAACCGTGCAATCCA
AGCTTGGGATGGTCATTGGCCGGCTGAAAATGCGGGTCCGCTCTTCTTCACTCCTCCCCTGA
TAATTGCCCTGTACATAAGTGGTACATTGGATACAATCCTAACAGAAGAACACAAGAAAGAG
ATGATCCGTTATATGTACATCCATCAAAATGAAGATGGAGGATGGGGATTCTATATATCAGG
CAGAAGTACAATGATAGGGAGTGTCTTGAACTATGTGGGTCTAAGACTTCTTGGAGAAACTT
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CATCACCCAATGACAATGGTGATGGTGCGCTTGCTAAAGGCCGTAAATGGATACTTGATCAC
GGTGGCGCTACTTCGATTCCTTCGTGGGGCAAGGTGTATCTCTCGGCGCTTGGAGTGTATGA
ATGGGCAGGCTGCAACCCTCTTCCTCCAGAATTCTGGCTTTTCCCTTCCTTTTTGCCTTATC
ATCCTGCAAAAATGTGGTGTTACTGCAGAACCACATACATGCCAATGTCATACTTGTATGGT
AGAAGCTTTCATGGGCCTATTACAGACCTTGTTATATCATTGAGAGACGAGATTCATGTCAT
TCCTTACCACCAGATTAATTGGAACAAACAACGACATAATTGTTGCAAGGAGGATCTGTACT
ACCCCCACACCTACATCCAAGATCTCTTATGGGATGGTCTTCATTATTTTAGCGAGCCACTT
ATCACAAAATGGCCCTTTAAGAAGTTAAGAGAGAAGGGTCTCCAAAGAGTTTTGGAGCTAAT
GCAATATAACGCTGAGGAAGGACGTTACATAACCATGGGTTGCGTGGAAAAGGCTTTACAGA
TGATGTGTTTCTTTGCCCTAGATCCAAATGGAATTGACTTCAAACGACACCTTGCTAGACTG
CCGGATTACTTATGGATGGCGGAGGATGGTATGAAGATGCAAAGTTTTGGTAGCCAGTTATG
GGATTGCACTCTTGTGACTCAAGCAATTCTCTCGAGTGATATGGTTGACGAGTATGGAGATT
CACTAAAAAAAGCTCACTTTTACTTGAAAGAATCACAGATAAAAGAGAACCCAAAAGGAGAT
TTCGCAAATATGTGTCGCCAATTTACAAAAGGGGCATGGACTTTCTCCGATCAAGATCAAGG
TTGGGTCGTCTCAGATTGCACTGCCGAAGCTTTGAAGTGTTTAATGGCGTTGTCGCAAATGC
CACAAGAAATTGTCGGAGAAAAGGCTGAAGTGGAGCAATTATATGATGCTGTGAATGTCCTT
CTTTACCTACAAAGTCCACAAAGTGGTGGTTTTGCAATTTGGGAGGCACCAGTCCCAAAACC
ATATTTAGAGAAATTAAACCCTTCAGAACTTTTTGCAGACATAGTGGTGGAAAGAGAGCATG
TTGAATGTACAGGCTCCATAATTCAGGCTCTACAAACGTTCAAAGATCTACATCCAGGGCAT
CGTGAGAAAGAAATCGAAGTTGCTATTGAAAAAGGCATACACTTTTTGGAAAACAGGCAACA
AGAAAATGGTTCATGGTATGGTTATTGGGGTATATGTTATCTCTATGGCACATATTTTGTGC
TTCAAGGATTAGTATCTTGTGGGAAAACATATGAAAATAGTGAAGCAGTTCGAAAAGCTGTC
AATTTTTTCCTCTCAACACAGAACTCAGAAGGTGGTTGGGGAGAGAACTTTGAGTCATGCCC
ACAAGAGAAATTTATACCTTTGGAGGGGAACCGAACAAATTTGGTGCAAACTTCATGGGCAT
TGCTCGGTCTTTTATGTGGTGGACAGGCTGAAAGGGATCAGACACCATTACACAAGGCAGCA
AAATTACTTATAAATGGGCAAATGGATGATGGAGATTTTCCTCAACAAGAAATAACGGGAGT
GTACATGAAGAATTGCATGTTACATTATGCAGAATATAGGAACACTTTTCCCCTATGGGCAC
TCGCTGAGTATCGAAAGCGTGTTTGGTTGCCAAAACAAGAAAACTAATGAGCGGCCGC  
 
C2.3.4 DNA sequence of BU003435 L. serriola lupeol synthase. 
GTCGACAAAAATGTGGAAGCTGAAAATAGCAGAAGGTGGTGATGATGAGTGGCTGACCACCA
CCAACAACCATGTTGGCCGCCAACACTGGGAGTTTGATCCGGATGCAGGAACCGAAGAGGAA
CGTACTGAGATCGAGAAGATGCGTCTTCACTTCAAACTTAATCGTTTTCAATTCAAACAAAG
TGCCGACTTGTTAATGCGTACTCAACTAAGAAAGGAGAATGCAATAGATGAAAATGAAATAC
CGAAAGCAATAAAATTGAATGAAACAGAAGAAGTATCAAATGACGCTGTTACAACTACACTC
CGAAGAGCCATTAGCTTCTACTCTACTATTCAAGCCCATGATGGCCATTGGCCTGCTGAGTC
TGCTGGGCCTTTGTTCTTCCTTCCTCCACTGGTGATAGCACTGTATGTGACTGGAGCCATGA
ATGATATTCTAACACCTGCACATCAGCTAGAAATCAAACGCTACATATACAATCATCAGAAT
GAAGATGGAGGCTGGGGATTACATATAGAGGGACACAGCACAATGTTTGGATCAGTACTTAG
TTACATTACATTGAGAATGCTTGGAGAAGAAGCCAACAGTGTTGCAGAGGACATGGCAGTGG
TTAAAGGCCGTAAATGGATCCTTGACCATGGTGGTGCAGTTGGGATTCCTTCGTGGGGAAAG
TTTTGGCTCACGATACTTGGAGTATATGAGTGGGGAGGCTGTAATCCCATGCCACCCGAATT
TTGGCTGCTCCCTAAGTTTTTCCCGGTTCATCCAGGCAAAATGTTGTGTTACTGTCGCTTAG
TGTACATGCCCATGTCGTACTTATATGGCAAAAGATTTGTGGGAAGAATAACAAAGTTGGTT
CACTCACTAAGGCAAGAGCTTTATACGAACCCTTATGATGAAATTAATTGGAATAAAGCACG
AAATACTTGTGCAAAGGAAGATCTGTATTATCCACACCCTTTTGTTCAAGATATGGTATGGG
CCACACTTCATAATGTTGTTGAACCTATCTTAACTCGTCGGCCATTTTCCACACTACGAGAA
AAGGCACAAAAAGTTGCAATGGAGCATGTTCACTATGAAGATAAGAGTAGTAGATATCTTTG
CATTGGATGTGTGGAAAAGGTATTATGCTTGATTGCAACATGGGTGGAAGATCCAAATAGTG
ATGCATATAAGCGTCATCTTGCAAGAATTCCTGATTACTTTTGGGTTGCTGAGGATGGGATG
AAGATGCAGAGTTTTGGATGTCAAATGTGGGATGCAGCCTTTGCTATTCAAGCCATTTTTTC
AAGTAATCTAGTAGAGGAGTACGGCCAGACTCTTAAAAAGGCACACGAGTTTGTAAAAGCAT
185 
 
CACAGGTTCGTGATAACCCCCCTGGAGATTTTAGTAAAATGTATAGACACACTTCTAAAGGT
GCATGGACGTTTTCCATACAAGACCATGGTTGGCAAGTTTCTGATTGTACAGCAGAAGGCTT
AAAGGTTGCACTTTTGTACTCCCAAATGAGCCCAGAACTTGTAGGCGAAAAACTTGAAACCG
AGCGTCTCTACGATGCTGTCAATGTTATTCTTTCATTACAGAGTGAAAATGGTGGATTTCCA
GCTTGGGAACCACAAAGGGCATATGCTTGGTTGGAGAAATTCAATCCGACTGAATTTTTTGA
AGATGTGTTGATTGAACGAGAGTATGTGGAATGCACTTCATCTGCAGTCCAAGGTTTGACAC
TCTTCAAGAAGTTGCACCCTGGACATAGAACCAAGGAGATCGAATATTGTATTTCAAAAGCA
GTGAAGTACGTCGAAGACATACAAGAAAGTGATGGCTCATGGTATGGTTGTTGGGGAATTTG
CTACACCTATGGGACATGGTTTGCAGTAGATGCACTAGTAGCTTGTGGGAAGAACTATCATA
ACAGTCCCACCCTTCAAAAAGCTTGCAAATTTCTCTTATCCAAACAACTTCCAGATGGTGGA
TGGGGAGAGAGTTATCTTTCAAGCTCAAACAAGGTGTATACGAATTTAGAGGGAAACCGGTC
GAATTTAGTACATACATCTTGGGCTTTGATATCACTTATTAAAGCTGGACAGGCTGAAATTG
ATCCTACACCAATAACTAATGGAATACGACTTCTCATCAATTCACAAATGGAAGAAGGAGAC
TTTCCTCAACAGGAAGTCACAGGAGTATTCATGAAGAACTGTAACCTCAATTATTCATCATA
TAGAAATATTTTCCCAATATGGGCACTTGGTGAGTATGGGCGTATTGTTCAAAATGTATGAT
GAGCGGCCGC  
 
C2.3.5 DNA sequence of BU003176 L. serriola nematocyphol synthase. 
GTCGACAAAAATGTGGGAGTTAAAGATAGCCGAAGGGGATGGACCCTATTTGTTTAGTACTA
ACAACTTTGTTGGTAGACAATTTTGGGAATTTAATCCTAATGTTTGCACAACAAAAGAGAAA
GAAGAGATTGAAAAGATTCGACAAAATTTCAAAGATAATCGAAAAAATGGAGGACAACATGC
TTGTGGCGATCTCCTGATGCGGATGCAGCTTATGAAGGAAAATCAAATTGACCTTATGGACA
TAGCTCCAATTAGACTAACCGATGATGAACAAGTTACTTTTGAAGCCGCAACAACTGCAGTG
AAGAAAGCAGTCCGACTAAACCGTGCAATCCAAGCAAAAGATGGTCACTGGCCTGCTGAAAG
TGCTGGCCCCTTGTTCTTCACTCCTCCACTTTTAATTGCTTTGTACATAAGTGGTACTATTA
ATACAATCTTGAATGAAGAACACCACAAAGAGATGATACGGTATTTCTACAATCATCAGAAT
GAAGATGGAGGATGGGGGTTTTTTATCGAAGGCAAAAGCACGATGATTGGATCTACATTGGT
CTATGTAGCCTTGCGTATGCTAGGAGAAGGAAAAAATGGAGGAGATGGTGCAATGGACAGAG
GCCGCAAGTGGATACTTGACCATGGTGGTGCAACCGCCATTCCCTCCTGGGGAAAGCTCTAT
CTATCGGTGTTGGGAGTGTATGATTGGGAGGGTTGCAACCCATTGCCACCAGAATTCTGGAT
TATCCCATCGGCATTTCCTTTTCATCCTGCTGAGATGTGGTGTTATTGTCGGACAACCTACA
TGCCTATGTCATATTTATATGGGAAAAGAGTCCAAGGACCCATCACACCTCTTGTTTCATCA
TTGCGAAAAGAAATCTACCCCACTGCTTTTGAGCATATAAATTGGAATAAGCAACGAAATAA
TTGTTGTAAGGAGGACTTGTACTATCCACATTCATTTCTTCAAGATGTTTTGTGGCATACCC
TTCACTACATTACTGAACCTATCCTTAAATATTGGCCATTTTCCAAACTACGAGGGAAATCG
CTTGATAGAGTTGTTGAGCTAATGCGCTATGAATCAGAAGAGACTAGATACATGACCATAGG
ATGCATCGAAAAAAGTCTACAAATGATGTGTTGGTGGGCAGAGAATCCAAATGGCGATGAGT
TTAAATATCACTTAGCAAGAGTTCCAGATTACTTATGGGTTGCAGAAGATGGAATGACAATG
CATAGTTTTGGTAGTCAAGTGTGGGATTGTGTTTTTACAACTCCAGCAATTATTGCAAGTAA
CATGACTGAAGAATATGCTGATTGTCTCAATAAGGCACACTTTTATTTAAGAGAATCTCAGA
TAAAACAAAATCCTTCAGGAGATTTCACTCGAATGTATCGACATATCACTAAAGGAGCATGG
GCCTTCTCTGATCAAGATCATGGATGGGCTGTCTCTGACTGTACAGCTGAAGCACTAATGTG
CCTACTCTTACTATCAAACATGCCGAAAGAAATTGTTGGAGAGAAAGTTGACAATGCCCGAC
TATATGAGGCAGTGAATTTTCTTCTTTACTTGCAAAGTCCGATAAGCGGAGGATTTGCTGTT
TGGGAGCCACCGATTCCAAAACCATTTCTACAGCTTCTTAATCCTTCAGAGATGTTTGCAGA
TATAGTTGTTGAGAAAGAGCATTTGGAACCCTCAGCTTGCATTATTGTAGCTTTGGTAGAGT
ACAACCGCGTCCATCCAAAACACAGAAAGAAAGAAATAGAACTTtcAATTTTGAGTGGAATA
CGATATCTAGAGGAAACACAATGGCATGATGGTTCATGGTATGGTTACTGGGGAATATGCTT
CTTATATGGAACATTCTTTGCCTTAAGGGCTTTAAGTGCTGCAGGAAAGACATACGACAATA
ATGAAGCAGTATGTAAAGGTGTCAAGTTCTTACTTTCCAAACAGAATGAAGAGGGGGGTTGG
GGAGAGAGCCACCTATCTTGTTCTACTATGGTGTATACGCCATTGGATGGAAACCGAACAAA
TTTGGTGCAAACATCATGGGCTATGCTTGGTCTTATGTTCTGTGGGCAGGTGGAGAGAGATA
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TAACGCCCTTAGATAAAGCAGCAAAACTGTTGATTAATGCTCAAATGGATAACGGAGATTTT
CCTCAACAGGAAATTACTGGAGCTTGGATGAGGAATTGCACTCTGCATTTTGCACAATACAG
GAGCATTTTCCCACTCTGGGCACTTGGGGAGTACCGTAAACGTGTTTGGTGATGAGCGGCCG
C  
 
C2.3.6 DNA sequence of BU008606 L. serriola cycloartenol synthase. 
GTCGACAAAAATGTGGAAACTGAAGATCGCAGAGGGAGGGAGTCCATGGCTGCGTTCGACAA
ACGATCACGTCGGCCGACAATTTTGGGAGTTTGATCCCACGCTAGGGTCCCTTGAGGAACTC
GCTGATATCGAGAAAGTTCGACAGACCTTTCATGAAAATCGGTTTGAGAAAAAACACAGTTC
AGATCTGCTTATGCGCAGTCAGTTTGCAAAAGAGAAGTCACTCTCTGTATTCCCACCTAGAG
TGAACATAAAAGATGCTGAAGATATCACAGAGGAGAAAGTAGCAAACGTCTTACGAAGAGCT
ATTGGTTTCCATTCAACCCTCCAGGCAGATGATGGGCATTGGCCAGGAGACTATGGAGGCCC
TATGTTTTTATTGCCTGGTTTGGTTATTACTCTAACTATTACTGGGGCACTGAATGCAGTCT
TATCTAAAGAGCATAAACGGGAGATGTGCCGTTACCTTTACAATCATCAGAATAGAGATGGT
GGATGGGGTCTACACATCGAGGGTCATAGCACCATGTTTGGTAGTGCCTTGAACTATGTCAC
TTTGAGATTGCTGGGTGAAGGAGCTAATGATGGAGAAGGGGGGGCGATGGAGAAGGGGCGGA
AGTGGATTTTGGATCATGGTGGTGCCACTTCAATAACATCTTGGGGAAAGTTTTGGCTTTCA
GTACTTGGGGTATTTGAGTGGTCTGGAAATAACCCGTTGCCCCCTGAGATGTGGGTCCTTCC
ATATTTCCTTCCCGTGCATCCAGGTAGGATGTGGTGTCACTGCCGGATGGTGTATCTGCCTA
TGTCATACTTATATGGGAAGAGGTTTGTTGGACCTATAACATCTACGGTTCTGGCCTTGAGA
AAGGAGCTGTTTACAGTCCCCTATCACGACATAGATTGGAATGATGCACGCAACCTCTGTGC
CAAGGAAGATCTTTACTACCCTCACCCACTCATCCAAGACATACTTTGGGCAACTCTTGACA
AGTTTGTGGAGCCTATACTGATGAGATGGCCTGGGAAGAAGCTGAGAGAGAAGGCTCTTCGC
ACTGCAATGGAACACATCCATTATGAGGATGATAATACTCGCTATATATGCATAGGGCCTGT
AAACAAGGTGTTAAATATGCTCTGCTGCTGGGCAGAAGATCCAAACTCAGAGGCTTTCAAGC
TACACCTCCCAAGGATACATGATTATCTTTGGCTTGCTGAAGATGGCATGAAAATGCAGGGT
TACAATGGTAGTCAACTTTGGGATACCGCATTCACCGTTCAAGCAATTATTTCTACAAACCT
CATCGAAGAGTTTGGTCCAACACTGAAAAAAGGACACATGTTCTTAAAGAAGTCACAGGTGT
TGGATAACTGCCCTGGcgATCTTGATTATTGGTATCGTCATATTTCAAAAGGTGCTTGGCCT
TTCTCAACAGCAGATCACGGATGGCCCATTTCAGATTGTACTGCAGAAGGGCTCAAGGCGGC
ACTCTTGCTTTCAAAATTGCCATCAAAAATCGTTGACGAGCCATTGGATGCAAAACGGCTGT
ATGATGCTGTCAATGTTATTTTATCTTTACAGAATTCTGATGGTAGTTTTGCAACATATGAA
CTTACAAGATCCTACAGCTGGTTGGAGTTGGTGAATCCTGCTGAAACCTTTGGTGACATTGT
TATTGACTACCCATATGTAGAGTGCACCTCGGCTGCGATTCAAGCTCTGGTGGCATTCAAGA
GATTGTACCCTGGGCATAGGCGAGAAGAGGTACAGCGTTGTATTGATAAATCTGCCTCCTTT
ATCGAAAAAATCCAAGCACCAGATGGTTCATGGTATGGTTCGTGGGCAGTTTGTTTCACGTA
TGGCACATGGTTTGGAGTGAAAGGCTTAGTGGCTGCTGGAAGGAACTTCTCTAACTGCTTTA
GCATTCGCAAGGCTTGTAACTTTTTGTTGTCCAAACAACTTGCTTCTGGGGGATGGGGGGAG
AGCTACCTCTCTTGTCAGAACAAGGTGTACACCAATCTTGAGGGAAATCGATCTCATGTGGT
AAACACAGGATGGGCTATGCTAGCTCTCATTGATGCTGAGCAGGCCAAGAGAGATCCAACAC
CATTGCATCGTGCAGCAAGAGTATTGATTAATTCTCAGATGGAAAATGGAGATTTTCCACAA
CAGGAGATCATGGGGGTTTTTAACAGGAATTGCATGATTACTTATGCTGCCTACAGAAACAT
CTTCCCTATTTGGGCATTAGGAGAATACAGATGTCGAGTACTTGAGGAGAAATCCATGCTAA
GCTAATGAGCGGCCGC  
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Appendix D 
 
D1. Additional Spectral Data 
 
 
Figure D1.1. Expanded portion of the GC-MS chromatogram of A.lyrata Flower-Folch 
Extraction-SPE Fraction I20, indicating the presence of 29-hydroxycamelliol.  
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Figure D1.2. HSQC spectra of lup-19(21)-en-3β-ol. 
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Appendix E 
 
E1. HSQC NMR Spectral Data 
E1.1 HSQC spectra of in vivo AlyPEN4 SPE Fractions 22-35. 
 
 
Figure E1.1. Upfield methyl region of the 800 MHz H and HSQC spectra of in vivo 
AlyPEN4 SPE Fractions 22-35. Thalianol (1) represents the major product. 
190 
 
E1.2 HSQC spectra of in vivo AlyPEN6 SPE Fractions 21-35. 
 
 
Figure E1.2. Upfield methyl region of the 800 MHz H and HSQC spectra of in vivo 
AlyPEN6 SPE Fractions 21-35. Seco -amyrin (1) represents the major product. 
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E1.3 HSQC spectra of in vivo AlyPEN9 SPE Fractions 23-30. 
 
 
Figure E1.3. Upfield methyl region of the 800 MHz H and HSQC spectra of in vivo 
AlyPEN9 SPE Fractions 23-30. -amyrin (1) represents the major product. 
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E1.4 HSQC spectra of in vivo L. perennis nematocyphol synthase SPE Fractions 18-34. 
 
 
Figure E1.4. Upfield methyl region of the 800 MHz H and HSQC spectra of in vivo L. 
perennis nematocyphol synthase SPE Fractions 18-34. Nematocyphol (1) represents the 
major product. 
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E1.5 HSQC spectra of in vitro L. sativa mixed amyrin synthase SPE Fractions 21-33. 
 
 
Figure E1.5. Upfield methyl region of the 800 MHz H and HSQC spectra of in vitro L. 
sativa -amyrin synthase SPE Fractions 21-33. -amyrin (1) and (2) -amyrin represent 
the two major product. 
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E1.6 HSQC spectra of in vitro L. serriola mixed taraxasterol synthase SPE Fractions 22-
32.  
 
 
Figure E1.6. Upfield methyl region of the 800 MHz H and HSQC spectra of in vitro L. 
serriola mixed taraxasterol synthase SPE Fractions 22-32. Taraxasterol (1) and (2) -
taraxasterol represent the two major product. 
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E1.7 HSQC spectra of in vitro L. serriola lupeol synthase SPE Fractions 21-32. 
 
 
Figure E1.7. Upfield methyl region of the 800 MHz H and HSQC spectra of in vitro L. 
serriola lupeol synthase SPE Fractions 21-32. Lupeol (1) represents the major product. 
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E1.8 HSQC spectra of in vitro L. serriola cycloartenol synthase SPE Fractions 21-32. 
 
 
Figure E1.8. Upfield methyl region of the 800 MHz H and HSQC spectra of in vitro L. 
serriola cycloartenol synthase SPE Fractions 21-32. Cycloartenol (1) represents the major 
product. 
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E1.9 HSQC spectra of in vivo L. serriola tirucalla-8,24-dien-3-ol. 
 
 
Figure E1.9. Upfield methyl region of the 800 MHz H and HSQC spectra of in vivo L. 
serriola tirucalla-8,24-dienol synthase SPE Fractions 4-9. Tirucalla-8,24-dien-3-ol (1) 
represents the major product. 
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E1.10 HSQC spectra of crude extract Lettuce flowers. 
 
 
Figure E1.10. Upfield methyl region of the 800 MHz H and HSQC spectra of the crude 
extract of Lettuce flowers. Taraxasterol (1), germanicol (2), lupeol (3), -amyrin (4), -
taraxasterol (5), -amyrin (6) represent the major products. 
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E1.11 HSQC spectra of crude extract Lettuce roots. 
 
 
Figure E1.11. Upfield methyl region of the 800 MHz H and HSQC spectra of the crude 
extract of Lettuce roots. Taraxasterol (1), germanicol (2), lupeol (3), -amyrin (4), -
taraxasterol (5), -amyrin (6) represent the major products. 
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E1.12 HSQC spectra of crude extract Lettuce leaves. 
 
 
Figure E1.12. Upfield methyl region of the 800 MHz H and HSQC spectra of  the crude 
extract of Lettuce leaves. Taraxasterol (1), germanicol (2), lupeol (3), -amyrin (4), -
taraxasterol (5), -amyrin (6) represent the major products. 
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E1.13 HSQC spectra of crude extract Lettuce stem. 
 
 
Figure E1.13. Upfield methyl region of the 800 MHz H and HSQC spectra of the crude 
extract of Lettuce stem. Taraxasterol (1), germanicol (2), lupeol (3), -amyrin (4), -
taraxasterol (5), -amyrin (6) represent the major products. 
 
 
202 
 
E1.14 HSQC spectra of crude extract Lettuce seeds. 
 
 
Figure E1.14. Upfield methyl region of the 800 MHz H and HSQC spectra of the crude 
extract of Lettuce seeds. Taraxasterol (1), germanicol (2), lupeol (3), -amyrin (4), -
taraxasterol (5), -amyrin (6) and butyrospermol (8) represent the major products. 
 
* Compound numbering for Figures E1.10 to E1.14 comes from Chapter 5 Table 5.12. 
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E1.15 HSQC spectra of crude extract Arabidopsis lyrata seeds. 
 
 
Figure E1.15. Upfield methyl region of the 800 MHz H and HSQC spectra of the crude 
extract of Arabidopsis lyrata seeds. Seco -amyrin (1) represents the major product. 
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Appendix F 
 
F1. GC-MS Spectral Data 
 
Table F1 letter code assigned to the OSCs or plant extract studied in this work. 
 
A. AlyPEN4 G. L. serriola mixed taraxasterol synthase 
B. AlyPEN6 H. L. serriola lupeol synthase 
C. AlyPEN9 I. L. serriola cycloartenol synthase 
D. A. lyrata seeds extract J. L. serriola tirucalla-8,24-dienol synthase 
E. L. perennis nematocyphol synthase K. Lettuce plant extract 
F. L. sativa mixed amyrin synthase 
 
 
Table F1. Summary of the triterpene alcohols found in this work. Numbers in red represent 
the number that was assigned to a specific compound when analyzing a particular OSC or 
plant extract.  
 
# Product name A B C D E F G H I J K 
F1.1 (20R)-dammar-24-ene-3,20-diol  19 10  32 9 7     
F1.1 (20S)-dammar-24-ene-3,20-diol 10 13 7 13 20 6 3     
F1.2 (20R/S)-taraxastane-3β,20-diol  40   35 20     35 
F1.3 ∆7-14-epithalianol 5 36          
F1.3 ∆7-thalianol 20 24   36       
F1.3 14-epithalianol 4 38          
F1.4 ∆8(26)-polypodatetraenol-9βH           23 
F1.5 ∆8(26)-seco-β-amyrin  7  7 38       
F.16 17-epilupeol     24       
F.17 18-lupane-3b-ol     17       
F1.8 
25-nor-9β-methylpodioda-5(10),17E,21-trien-
3-ol 
3           
F1.9 achilleol A  18         24 
F1.10 arabidiol 14           
F1.10 14-epiarabidiol 2           
F1.11 bauerenol  6  6 21 15 13    7 
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F1.12 butyrospermol  20 9  5 7 6 3   8 
F1.13 camelliol C 8 16          
F1.14 curcurbitadienol         4  16 
F1.15 cycloartenol         1  12 
F1.16 dammara-20(22)E,24-dien-3β-ol 18 23   34       
F1.17 dammara-20(22)Z,24-dien-3β-ol  29   37       
F1.18 dammara-20,24-dien-3β-ol 16 9 2 9 4 3 17 9    
F1.19 DB-friedo-lup-5-en-3β-ol     19       
F1.19 lup-19(21)-en-3β-ol     13       
F1.20 euphol    23       20 
F1.21 germanicol 21 31 6   18  5   2 
F1.22 glutinol  15  15        
F1.23 isobauerenol  37   11 14 16     
F1.24 isoeuphol  32   28       
F1.25 isotirucallol  33   29 16 14   3  
F1.26 isoursenol  17   2 12 15    17 
F1.27 lanosterol         3   
F1.27 parkeol         2  18 
F1.28 lupane-3β,20-diol  11  11 18 19 11 2   10 
F1.29 lupeol  2 3 2 12 10 8 1   3 
F1.30 multiflorenol  14  14  21     13 
F1.31 nematocyphol  22   1 13 12 8   14 
F1.32 neolup-13(18)-enol     25       
F1.33 neolupenol     7       
F1.34 polypoda-7,13E,17E,21-tetraen-3β-ol  3          
F1.35 seco-α-amyrin  12  12 10       
F1.36 seco-β-amyrin  1  1 31       
F1.37 taraxasterol 22 27 11  8 8 1 10   19 
F1.38 taraxerol  28   27 17     19 
F1.39 tarolupenol     6      21 
F1.40 thalianol 1           
F1.41 tirucalla-7,24-dien-3β-ol 20 35   15 5 9 7  2  
F1.42 tirucalla-8,24-dien-3β-ol 9    33   6  1  
F1.43 tylolupenol A     3       
F1.44 α-amyrin 24 4 4 4 14 1 5    6 
F1.45 β-amyrin 23 30 1  26  4 4   4 
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F1.46 γ-amyrin  34   16       
F1.47 δ-amyrin  8 8 8 22 11 10    11 
F1.48 ψ-taraxasterol 25 10 5 10 9 4 2    5 
** 13αH-malabarica-14(27)-trien-3b-ol 12           
** 13βH-malabarica-14(27)-trien-3b-ol 15 26          
** 13αH-malabarica-14E,17E,21-trien-3b-ol 7 25          
** 13αH-malabarica-14Z,17E,21-trien-3b-ol 6           
** 13βH-malabarica-14Z,17E,21-trien-3β-ol 27 21          
** 13βH-malabarica-14E,17E,21-trien-3b-ol 17           
** 20S-dammara-12,24-dienol          4  
** boeticol           22 
** friedelin  39          
** polypoda-8,13E,17E,21-tetraen-3-ol 13           
** 
9αH-polypoda-7,13E,17E,21-tetraen-3β-
ol 
11   3        
** 
9αH-polypoda-8(26),13E,17E,21-tetraen-
3β-ol 
19 5  5        
** rhoiptenol     30       
**Found by HSQC NMR. 
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Figure F1.1. GC-MS TIC and EI mass spectra of (20S/R)-dammar-24-ene-3,20-diol. 
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Figure F1.2. GC-MS TIC and EI mass spectra of (20R/S)-taraxastane-3β,20-diol. 
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Figure F1.3. GC-MS TIC and EI mass spectra of ∆7-14-epithalianol, ∆7-thalianol and 14-
epithalianol. 
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Figure F1.4. GC-MS TIC and EI mass spectra of ∆8(26)-polypodatetraenol-9βH. 
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Figure F1.5. GC-MS TIC and EI mass spectra of ∆8(26)-seco-β-amyrin. 
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Figure F1.6. GC-MS TIC and EI mass spectra of 17-epilupeol. 
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Figure F1.7. GC-MS TIC and EI mass spectra of 18-lupane-3b-ol. 
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Figure F1.8. GC-MS TIC and EI mass spectra of 25-nor-9β-methylpodioda-5(10),17E,21-
trien-3-ol. 
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Figure F1.9. GC-MS TIC and EI mass spectra of achilleol A. 
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Figure F1.10. GC-MS TIC and EI mass spectra of arabidiol and 14-epiarabidiol. 
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Figure F1.11. GC-MS TIC and EI mass spectra of bauerenol. 
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Figure F1.12. GC-MS TIC and EI mass spectra of butyrospermol. 
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Figure F1.13. GC-MS TIC and EI mass spectra of camelliol C. 
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Figure F1.14. GC-MS TIC and EI mass spectra of curcurbitadienol. 
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Figure F1.15. GC-MS TIC and EI mass spectra of cycloartenol. 
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Figure F1.16. GC-MS TIC and EI mass spectra of dammara-20(22)E,24-dien-3β-ol. 
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Figure F1.17. GC-MS TIC and EI mass spectra of dammara-20(22)Z,24-dien-3β-ol and 
dammara-20,24-dien-3β-ol. 
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Figure F1.18. GC-MS TIC and EI mass spectra of dammara-20,24-dien-3β-ol. 
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Figure F1.19. GC-MS TIC and EI mass spectra of DB-friedo-lup-5-en-3β-ol and lup-
19(21)-en-3β-ol. 
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Figure F1.20. GC-MS TIC and EI mass spectra of euphol. 
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Figure F1.21. GC-MS TIC and EI mass spectra of germanicol. 
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Figure F1.22. GC-MS TIC and EI mass spectra of glutinol. 
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Figure F1.23. GC-MS TIC and EI mass spectra of isobauerenol. 
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Figure F1.24. GC-MS TIC and EI mass spectra of isoeuphol. 
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Figure F1.25. GC-MS TIC and EI mass spectra of isotirucallol. 
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Figure F1.26. GC-MS TIC and EI mass spectra of isoursenol. 
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Figure F1.27. GC-MS TIC and EI mass spectra of lanosterol and parkeol. 
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Figure F1.28. GC-MS TIC and EI mass spectra of lupane-3β,20-diol. 
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Figure F1.29. GC-MS TIC and EI mass spectra of lupeol. 
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Figure F1.30. GC-MS TIC and EI mass spectra of multiflorenol. 
237 
 
 
Figure F1.31. GC-MS TIC and EI mass spectra of nematocyphol. 
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Figure F1.32. GC-MS TIC and EI mass spectra of neolup-13(18)-enol. 
239 
 
 
Figure F1.33. GC-MS TIC and EI mass spectra of neolupenol. 
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Figure F1.34. GC-MS TIC and EI mass spectra of polypoda-7,13E,17E,21-tetraen-3β-ol. 
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Figure F1.35. GC-MS TIC and EI mass spectra of seco-α-amyrin. 
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Figure F1.36. GC-MS TIC and EI mass spectra of seco--amyrin. 
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Figure F1.37. GC-MS TIC and EI mass spectra of taraxasterol. 
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Figure F1.38. GC-MS TIC and EI mass spectra of taraxerol. 
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Figure F1.39. GC-MS TIC and EI mass spectra of tarolupenol. 
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Figure F1.40. GC-MS TIC and EI mass spectra of thalianol. 
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Figure F1.41. GC-MS TIC and EI mass spectra of tirucalla-7,24-dien-3β-ol. 
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Figure F1.42. GC-MS TIC and EI mass spectra of tirucalla-8,24-dien-3β-ol. 
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Figure F1.43. GC-MS TIC and EI mass spectra of tylolupenol A. 
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Figure F1.44. GC-MS TIC and EI mass spectra of α-amyrin. 
251 
 
 
Figure F1.45. GC-MS TIC and EI mass spectra of β-amyrin. 
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Figure F1.46. GC-MS TIC and EI mass spectra of γ-amyrin. 
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Figure F1.47. GC-MS TIC and EI mass spectra of δ-amyrin. 
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Figure F1.48. GC-MS TIC and EI mass spectra of ψ-taraxasterol. 
 
 
 
 
 
 
 
